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ABSTRACT 
The thesis is divided into two parts. 
The first project involves studies towards the total synthesis of the 16- 
membered ring of the macrolide antibiotic, mycinamicin III and also of the putative 
biosynthetic precursors, the mycinoic acids. 
The rigid conformation of the starting material, bicyclo[3.3.0]octenone (82), 
ensured facial selectivity creating prochiral centres on the template, and thus directed 
stereoselective syntheses towards both fragments of the aglycone of mycinamicin III 
(39), and to the methyl mycinoates 1 (10) and 11 (11). The successful addition of a 
4ec-methyl group to (82) was achieved; with further manipulation this would lead to 
the Cj-CjO fragment with the methyl in the P-configuration at C-4 of (39). The 
removal of the oxygen at C-3/17 of (82) was required to yield the C-17 methyl 
functionality, thus techniques for deoxygenation were investigated. The reduced 
derivatives containing an ethyl group, e. g. (157), were treated with a variety of 
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The second part involves research towards the synthesis of lp, 2(x-dimethyl 
gibberellins, e. g. (28), which are potentially 'superactive' in enhancing stem growth. 
Displacement of the allylic carboxylate from 7-methyl ester, 3-OTHP GA3 (73) by use 
of lithium dimethylcuprate enabled the insertion of a 2(x-methyl to give (97). 
lodolactonisation of (97) followed by treatment with CsOAc gave (102), rather than 
the desired I(x-acetate; aqueous hydroxide did not displace the iodide, but caused 
epimerisation of the 3-alcohol. The ketone (110) was prepared from the 3,13-diacetate 
derivative of (97), via a peracid-mediated cyclisation and subsequent mild oxidation, 
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1.1 General Introduction to Antibiotics 
There are 87 antimicrobials on the UK market for human usel which are 
classified as antibiotics, sulfonamides, quinolides, antimycobacterials and those of 
miscellaneous structure; of the antibiotics there are many sub-classes, those of greatest 
economic importance are penicillins and cephalosporins (and the related P-lactams and 
carbacephems), aminoglycosides, tetracyclins, quinolones and macrolides2. Antibiotics 
are defined as agents produced by living organisms which act in low concentration to 
inhibit the action of other organisms3; antibiotics are secondary metabolites (i. e. they do 
not appear to have an essential function for the producing organism). 
The first of the macrolide antibiotics to be identified was picromycine in 1950, 
isolated from Streptomyces fellens (a soil bacteria). The macrolide was characterised as 
having an amino sugar attached to a 14 membered lactone with one degree of 
unsaturation4. Subsequently several similar structured antibiotics were recognised, and 
the term "macrolide" was used by Woodward to describe the new class of anti- 
infectives5; however, "macrolide" is now used to describe all medium to large ring 
lactones, thus antibiotics with at least one sugar attached to a multi-oxygenated partially 
unsaturated macrolide are called the polyoxomacrolides. Some examples of 12,14 and 
16-membered ring structures of polyoxomacrolide antibiotics are depicted in figure 1.1; 
rings devoid of the sugar moieties are called aglycones. 
Of all the wide range of polyoxomacrolide antibiotics developed, it should be 
noted that only erythromycin (Erymax, Stiemycing) and derivatives with modified 
sugar groups (e. g., Eryped, Erythrocin, Ilosoneg), clarithromycin (Klaricidg) and 
azithromycin (Zithromaxg) are currently licensed for human use in the UK. 
Spiramycin (Selectomycin, Rovamycing) is used for antimicrobial vetinary practice and 
tylosin (TylarO) is a growth promoter in animal feed2. The original polyoxomacrolide 
antibiotic available for clinical use was erythromycin, a 14-membered ring macrolide 
extracted from Streptomycetes erythreus, first used in 19516. The other two licensed 
agents are semi-synthetic derivatives of erythromycin: azithromycin is an azalide, a 15- 
membered ring containing a nitrogen, whilst clarithromycin has a 6ec-methoxy group 
1 
which prevents the 6-hydroxyl interacting with the 9-carbonyl to form a lactol, thereby 
preventing the initial degradation step of the ring as occurs in vivo with erythromycin. 
The newer polyoxomacrolides show less activity against Gram-positive and more 
against Gram-negative bacteria than erythromycin7. 
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Figure LI: Examples of polyoxomacrolide antibiotics. 
Mycinamicins are a class of polyoxomacrolides first isolated in 1980 from 
Micromonospora griseorubida, a soil actinomycete; these macrolides have a 16- 
membered ring aglycone ("mycinolide") with 5-0-p-D-desosaminylose and 17-0-p-D- 
mycinosylose sugar derivatives attached8. Mycinamicins have a higher activity against 
Gram positive bacteria than erythromycin, including against Staphlococcus aureus 
which has become a problem in hospitals by being resistant to a wide range of 
antibacterials9. Hence, the simultaneous application of both mycinamicins and 
currently licensed erythromycin derivatives in clinical practice may provide synergistic 
effects in eradication of bacterial infections. 
2 
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Scheme I. I: The pathway of mycinamicin biosynthesis in M. griseorubidalO. 
Dextrose is the substrate for the biosynthesis of both the sugar groups in the 
mycinamicins, indeed in nearly all polyoxornacrolide antibiotics1l. In an analogous 
3 
manner to fatty acid and polyketide biosyntheses, the aglycone is derived from acetyl 
CoA and propionyl CoA and the carboxylated derivatives malonyl CoA and 
methylmalonyl CoA respectively. The units are condensed via the thio-esters as a 
series of pseudo-Claisen condensation, reduction, elimination and reduction reactions, 
12 mediated by carboxylases, decarboxylases, NADPH and polyketide synthase 
By a combination of 13C and 14C labelling studies plus 1H and 13C NMR 
spectra it has been shown that the aglycone is constructed13 as shown in figure 1.3. Use 
of 180 demonstrated that the esterification to form the lactone is the final step in the 
biosynthesis of the aglycone, followed by glycosidation and modification of the 
sugars 14. The 11 ý-N-acetylcysteamine derivatives (mycinamicins X, X', XI and XI') 
are by-products of the biosynthesis with far weaker biological activity than 




Figure 1.3: Biosynthetic units position in protomycinolide IV (1). 
Only in the case of the mycinamicins16 have coherent derivatives of the 
intermediates which form the macrocycle been isolated. The methyl esters of these 
have been isolated and characterised from the culture broth of M. griseorubida (figure 
1.4). Similar compounds17 were also found from the culture of mycinolide-forming 
Streptomyces spp. The isolation of these intermediates indicates a chain construction 
process consistent with polyketide biosynthesis adding P-ketones and modifying at each 
step before the next unit is added12. The seco-acid was also isolated, which was the 
first seco-acid to be isolated from a fermentation culture18. The protomycinolide IV (1) 
is the final precursor before glycosidation to form mycinamicin VIII. A 13C thioester 
derivative of mycinoic acid I was incorporated into mycinolide IV by biosynthesis19, 
further supporting the theory that the chain elongation process proceeds systematically 
4 
to form mycinolides; a similar continual extension process occurs in the fungal 
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Figure 1.4: Products of biosynthetic route to the aglycone of mycinamicins. 
Fermentation of 30 litres of a microbial culture of M. griseorubida , followed by 
extraction with organic solvents and evaporation gave a crude powder (5.2g) which 
contained a variety of secondary metabolites, which was purified by column 
chromatography to give only 0.15g of mycinamicin 1118. Extensive analysis of the 
anabolic pathways of mutant strains unable to produce mycinamicins by Hayashi et al. 
has indicated the pathway of biosynthesis of the macrolide ring18. 
The methyl esters of mycinoic acids 1 (10) and Id (11) plus epimycinoic acid I 
(15) and decarboxy-mycinoic acid 111 (14) have been synthesised by Takano and co- 
workers2l using an acyclic Precursor (section 1.5). These matched the natural methyl 
esters found by Kinoshita et al. 22. 
Hence, both the aglycone and the mycinoic acid's total synthesis were the target 
of the project to enable a greater supply of the mycinolides, which may be glycosidated 




mycinamicins 111, IV, VI and VII was the target of the project, it should be noted that 
there is a total absence of antibiotic activity by the aglycone alone23. 
1.3 Total Synthesis of Polyoxomacrolides 
The total synthesis of the major classes of antibiotics then in medicinal use, (the 
penicillins, cephalosporins, aminoglycosides and tetracyclins) had been completed by 
the late 1960's. However, as all had proved to be more effectively and quickly 
produced by fermentation technology or semi-synthesis based on a natural building 
block, none were made commercially by total synthesis. This trend has continued to 
date with the exception of the comparatively simple aromatic antibiotic 
chloramphenic012. The only major group of antibiotics in clinical practice in the 1960's 
without a total synthesis of a sample compound was the macrolides, which posed such a 
serious challenge to chemical formation that the Nobel Prize winner Woodward had 
written "erythromycin, with all our advantages, looks at present quite hopelessly 
complex, particularly in view of of its plethora of asymmetric centers...,, 24. 
The three main problems that required resolution were: 
(i) Control of both regio- and stereo-addition of substituents to the proto-aglycone; 
(ii) the selective esterification of the desired alcohol functionality with the 
carboxylic acid to form the macrocylic aglycone25; 
(iii) glycosidation has to date been achieved with few polyoxomacrolides, and 
commercial semi-synthetic processes utilize the fragments with the sugars already 
attached whilst the ring of the antibiotic is manipulated26. 
The first polyoxomacrolide to be completed by total synthesis was methymycin 
in 1975, which showed that a seco-acid could be induced to cyclise to the chosen 
lactone, but a requirement is that the favoured low energy conformation must be 
achieved in order to obtain the correct lactone. The macrocyclisation often requires a 
high dilution factor for effectiveness; also the creation of the asymmetric centres on the 
seco-acid precursor was not facile26. Erythromycin A was synthesised by Woodward et 
al. in 198127 28,29. , and 
both carbomycin B and tylosin by Kinoshita and Tatsuta 7 
6 
however7 these remain as some of the few total syntheses of the polyoxomacrolide 
antibiotics, due to the difficulty of glycosidation. 
Four general pathways to forming the aglycones have been utilized23: 
(a) The ring approach, which makes use of conventional (x and 0 positions on a 
nng carbon as prochiral centres and of stereofacial attack upon the ring, which allows 
the retention of chirality on ring cleavage. Examples from such a pathway include 
methymycin26 (12-membered ring), erythromycin A27 and 3 routes to erythronolides30 
(14-membered rings) and the tylonide synthesis by Greico3l (16-membered ring). 
(b) The carbohydrate approach uses the inherent stereochemistry and 
functionality of sugars, which may be transferred to the products; the benefits include 
utilizing a cheap and homochiral starting material. If the enantiomer of a macrolide is 
desired for antimicrobial trials, the (L) (unnatural) sugar may be used with identical 
methodology; biosynthesis will often not allow such a route due to chirally specific 
enzymes. Whilst no syntheses of 12-membered polyoxomacrolides have used this 
approach, it has been used in both the syntheses of erythronolide A32 (14-membered 
ring) and tyolonide and carbomycin B by Kinoshita and Tatsuta28,29 and Nicolaou33 
(16-membered rings). 
(c) The acyclic approach utilizes stereoselective construction by treatment of an 
achiral starting material with chiral reagents to form chiral fragments. Other methods of 
stereocontrol that have been applied are chiral derivatisation agents or chiral 
chromatography25. Examples of products from such a route include methylnolide (12- 
membered ring)34, narbonolide35 (14-membered ring) and the tyolonide synthesis by 
Masamune (16-membered ring)36. 
(d) The macrocyclic approach of controlling reactions via an intact large ring 
with pre-existing asymmetric centres to induce further diastereoselecive 
functionalisation. This route has been utilized far less than the previous three routes, 
largely due to the requirement of pre-formation of a ring from partially derivatised 
components, which themselves are not simple, e. g., the total construction of racernic 
deoxyrosaranolide hemiacetal utilized the aldehyde derivative of mycinoic acid as a 
construction unit for the aglycone37. 
7 
The first three approaches require a cyclisation reaction to form the aglycone, 
but as the cyclisation of such large rings is generally disfavoured and requires an 
intermediate that can assume the low energy and diamond lattice shape of the final 
aglycone, this is often a problem stage in the formation of the macrolide38. 
Consequently, much research has gone into solving the problem of cyclizing 
intermediates that do not favour the desired products25. 
1.4 Previous Syntheses of Mycinamicins and Mycinolides 
Mycinarnicins have been subject to only one total synthesis39, by Suzuki in 
198840, but two aglycones have been completed, plus several syntheses of fragments. 
As one of the proposed targets was the aglycone common to mycinamicins III, IV, VI 
and V111, the previous syntheses will be briefly outlined. 
The mycinolide IV synthesis by Suzuki4l, 42 using an acyclic approach gave an 
overall yield of only 1.8% in 28 steps from propargyl alcohol (17) (scheme 1.2) and the 
bis-epoxide (31) (scheme 1.3), derived from (S) lactate and (L) tartrate respectively, but 
required resolution. Interesting features of the synthesis include the triethylaluminium 
catalysed rearrangement of the secondary alcohol (22) via the methansulfonate - 
aluminium alkoxide intermediate (23) to the primary alcohol (24), with total 
stereocontrol. The subsequent aldehyde reacted with chromyl chloride and crotyl 
bromide forming two new asymmetric centres. Asymmetric control was also obtained 
upon reaction of (28) with dry HCI(g) and dithioketal removal with mercuric chloride to 
form (29). The bis-epoxide derived alcohol (34) was also rearranged by a Lewis acid 
again with no isOmerisation to form (35). Macrocyclisation of (30) and (37) was 
achieved in 21 % yield over the two steps, and the protective groups oxidatively cleaved 
to give mycinolide IV. The addition of the sugar residues was achieved utilizing a 
novel modified Koenigs-Knorr glycosidation using fluorinated glycosyl groups 
activated by CP2ZrCI2-AgCI0443; initially P-D-desosaminose was added to the 
aglycone giving mycinamicin VII (3) in 72% yield, then P-D-5,6-dimethoxy-mycinose 
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Scheme 1.2: Suzuki synthesis of fragment Cl-Clo of mycinolide IV. 
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Scheme 1.3: Suzuki synthesis of fragment C11-C17 and cyclisation to mycinolide IV. 
Suzuki and co-workers improved dramatically the yield of the aldehyde, (37) by 
use of a ring approach to forming the carbon skeleton, using a chiral glycerin derivative 
(40) (scheme 1.4)44; the initial route using the bis-epoxide (31) (scheme 1.3) gave a 
yield of (36) of only 13% over 8 steps, but use of (40) returned the allyl alcohol (36) in 
40% over 13 steps. The dioxolane (40) was opened, selectively protected and 
deprotected to give the primary alcohol (41) which was oxidised to an aldehyde; an 
ethyl group was added to the ketone to give the secondary alcohol followed by a second 
Swern oxidation to give (42). Further oxidation and cerous chloride mediated coupling 
of the organolithium (33) with (42) gave the alcohol (43) in 95% yield. The alcohol 
(43) was rearranged and modified in a similar manner to the original route to obtain the 
allylic alcohol (36), which was subsequently oxidised to the conjugated aldehyde (37) 
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Scheme 1.4: Modified route by Suzuki to form C11-C17 fragment of mycinolide IV. 
Hoffman's synthesis of mycinolide V was based upon a chiral starting material 
in a combined acyclic and carbohydrate approach, utilising only one of the three 
asymmetric centres in D-ribonolactone (45)45 (scheme 1.5). A summary of the route 
includes the complex divergence and convergence stages of converting the ester (48) to 
the partially protected diol (52); the use of LDA with benzyliodomethyl ether as 
electrophile epimerised the carbon a to the carbonyl, and on saponification gave a 3: 2 
mixture of the two esters (49) and (50). Saponification with aqueous potassium 
hydroxide and use of cyclohexylamine enabled preferential crystallisation of the more 
prevalent salt (49) from the mother liquors. Two differing routes allowed (52) to be 
synthesised from either ester, which was further oxidised to the conjugated aldehyde 
(53). The 'Masamune aldehyde' (54)46 (an intermediate in the total synthesis of 
tylonide by the Masamune group) was reduced with concurrent high asymmetric 
induction by the chiral Z-pentenylboranate (55) to give the 5-lactone (56) in 80% yield 
and 94% d. e. The overall number of steps to obtain the aglycohe (61) was only 21 in 
an overall yield of 2.7% (scheme 1.6). 
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The synthesis of fragment Cl I to C17 of mycinolide III by Takano was based 
upon a Sharpless epoxidation to induce chirality into an acyclic starting matefial (62)47 
(scheme 1.6). The [2,3]-Wittig rearrangement of (65) gave the alcohol (66) as the only 
product in 97% and generated a second stereo-centre. The fragment (70) was made in 
12% overall yield in 18 steps; and the ingenious use of the temporary tetrahydrofuran 
moiety in (68) and (69) avoided any hydrogenation of the double bond, but enabled 
reduction of the alkyne. However, the molecule could not be extended further to form 
more of the mycinolide. 
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Scheme 1.6: Takano et al. route to CI I to C17 fragment of mycinolide 11147. 
The mycinamicin precursor protomycinolide IV (1), which has a very similar 
structure to the subsequent mycinamicins but for the presence of a 14-methyl group 
instead of a 14-hydroxymethyl group (as have the precursor mycinoic acids), has been 
subject to total synthesis by four different groups; however all made use of an acyclic 
precursor and all coupled both fragments at the C(10)-C(l 1) and C(1)-O(I 5) bonds 
(figure 
13 
Protomycinolide IV was first synthesized by Yamaguchi and co-workers in 
198448 utilizing meso-2,4-dimethylglutaric anhydride and propargyl alcohol as the 
initial substrates for synthesis, both of which are achiral; the macrolide was obtained in 
33 steps and in 0.38% yield, although the final stage to enable macrocyclisation was 
acheived in only 53% yield; however, a new route to Prelog-Djerassi lactonic acid (16) 
was also evolved. Suzuki et al. 42 (1986) used a very similar pathway to that developed 
for synthesis of mycinolide IV41, but required 46 steps for 0.92% conversion of ethyl 
lactate derivatives to protomycinolide IV. The Takano group utilized homologous 
techniques to those used in the synthesis of the fragment C11-C1747, and with further 
modifications gave the methyl esters of mycinoic acids 1 (10) and 11 (11), epimycinoic 
acid 1 (15), and decarboxymycinoic III also (14)21; protomycinolide IV (1) was 
obtained in 2.2% yield over 26 steps, including use of just one chiral building block as 
the basis for production of both the methyl esters of mycinoic acids and 
protomycinolide IV, demonstrating useful transfer of methodology. The last total 
synthesis of protomycinolide IV was developed in 1992 by Miyashita and co- 
workers49' utilizing a technique based upon stereocontrolled opening of epoxy acrylates 
with trimethylaluminium, completing the synthesis in only 23 steps in 8% yield; a 
similar route using a Lewis acid rearrangement in a fundamental step gave a novel 
procedure to obtain Prelog-Djerassi lactonic acid (16). 
1.5 Previous Synthesis of Mycinoic Acids 
The methyl esters of mycinoic acids I and II, epimycinoic acid I and 
decarboxymycinoic have been synthesised by Takano et al. 21 (figure 1.7); this is the 
only chemical synthesis of the polyketide intermediates of the mycinolide aglycone. S- 
(0)-benzylglycidol (71) was opened with the lithium alkyne to give the terminal alkyne 
(72) which was rearranged by base to an internal alkyne (73). Partial reduction of the 
acetylene, a modified Williamson ether coupling and protection of the terminal 
acetylene with a TMS group gave (74). A Wittig rearrangement of the allyl alcohol 
followed by removal of the silyl functionality gave (75), which was used in the 
synthesis of all four mycinoic acid derivatives (schemes 1.7 and 1.8). In a series of 
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modifications that were very similar to those used in the synthesis of fragment C11 to 
C 17 of mycinolide III (scheme 1.6)47, the methyl ester of epimycinoic acid was 
synthesised by formation of a bromo ether, the alkyne hydrogenated and by use of zinc 
powder in hydrochloric acid the olefin regenerated (77). Protection of the secondary 
alcohol, followed by sequential deprotection, oxidation via (78) and methylation of the 
allylic alcohol gave a silyl ester, which was de-silated with mineral acid to give a 
product (15), that was identical to that of natural methyl epimycinoate I (figure 1.4) by 
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Scheme 1.7: Takano route to methyl epirnycinoate 121. 
Inversion of the tertiary alcohol of (75) by a Mitsunobu reaction gave (79) for 
use as a common intermediate for the synthesis of decarboxymycinoic acid III and the 
methyl esters of mycinoic acids I and II (scheme 1.8). Identical treatment of (79) to that 
used upon the diastereomer (75) to derive (78) (scheme 1.7), gave the conjugated 
ketone (80). Oxidation, methylation and removal of the silyl protecting group gave 
methyl mycinoate 1 (10). Treatment of (80) with a Homer-Emmons reagent yielded the 
intermediate (81), which was de-silylated with acid to give methyl mycinoate 11 (11). 
Dibal-H reduction of the methyl ester of (81) to an allylic alcohol and oxidation to the 
15 
aldehyde enabled addition of an ethyl group via a Grignard reaction, the resultant allyl 
alcohol was again oxidised and the TBDMS group removed to yield 
decarboxymycinoic acid 111 (14). Thus four of the isolated intermediate mycinoic acid 
precursors to the aglycone ring of protomycinolide IV (1) had been formed. 
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Scheme 1.8: Takano route to methyl mycinoates I, H& decarboxymyinonic acid 11121. 
1.6 Proposed Route to the Synthesis of Mycinolide HI 
There have only been two reported total syntheses of mycinolides, that of the 
complete antibiotic mycinornicin IV by Suzuki et al. 40,43 and mycinolide V by 
Hoffman45. Numerous other polyoxomacrolides have been isolated and characterised 
(figure 1.1) and our aim was to develop a flexible approach to the total synthesis of a 
range of mycinolides. As detailed in section 1.2, usually during the biosynthesis of 
polyoxomacrolides the intact macrocycle is formed prior to release from the 
intracellular polyketide synthase. However, the mycinoic acids, the putative 
biosynthetic precursors to the mycinolides, have been isolated from the culture media. 
of M. griseorubida22 (figure 1.4). Thus the proposed targets of synthesis were the 
aglycone of mycinarnicin IV (39) (which is identical to the ring of micinamicin's III, VI 
and VH) and the mycinoic acids I and 11. 
Lactone (82) has been used extensively as the starting material for the synthesis 
of natural products, e. g., prostaglandins and desoxyprostaglandins (prostaglandin 
16 
antagonists)50, Prelog-Djerassi lactonic acid (16)23,51, cis-Jasmone52 and is currently 
under investigation in our group in the total synthesis of pseudomonic acids53. 
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Scheme 1.9: Overview of proposed route to the aglycone. 
The lactone (82) was chosen as the basis for the syntheses for several reasons. 
(a) Development of a total synthesis of both the aglycone and the inherently 
closely related mycinoic acids via a convergent approach from common starting 
material (82) would allow the transfer of synthetic methodology between routes. 
(b) The lactone is readily prepared in homochiral form (section 1.7). 
Homochiral (-) lactone (85) may be used as the basis to make the correct enantiomer of 
each product once synthetic methodology is optimised. 
(c) The previous syntheses of mycinolides had not made full use of chiral 
centres present in the starting material (Hoffman45), or had utilized achiral substrates 
17 
(Suzuki4l, 42, Takan047), whilst none had used the ring approach proposed in our 
strategy. The lactone (82) confers effective regio- and stereo- control due to the bridged 
nature of the bicycle. 
(d) Synthesis of unnatural or isotopically labelled mycinoic acids and incubation 
with mutant strains of bacteria (that have partially blocked biosynthetic pathways, 
preventing synthesis of mycinoic acids) may enable the enforced uptake of such 
unnatural mycinoic acids, to allow production of novel antibiotics. 
(e) The closely related intermediate protomycinolide IV (1) might be made by a 
very similar route to that to form mycinolide 111, and any desired variations in structure 
installed by chemical means. All four previous routes to protomycinolide IV used an 
acyclic starting material, none had used macrocyclic, carbohydrate or ring approaches, 
thus new methods may be generated by this route. 














The starting material for the synthesis of lactone (82) was dichloroketone (86) 
prepared via a [2+2] cyclisation reaction between dichloroketene and cyclopentadiene. 
The work described in this thesis is with racemic material. The lactone denoted'(82)'is 
the racernate, and that labelled (85) the desired enantiomer. Even though all structures 
depicted are the desired enantiomers for the target molecules, in order to obtain the 
appropriate enantiomer a separation would have been required at some point, (unless 
homochiral starting material had been used). Both the (-) lactone (85) desired for the 
synthesis of the aglycone or mycinoic acids and the enantiomer (+) (88) are available 
commercially54. 
18 
Several methods have been reported to obtain the homochiral bicyclic heptanone 
or lactone. Endo-a-hydroxysulfoximines (89) and (90) formed by Johnson and Zeller55 
from racemic ketone (87) were separated by column chromatography and the 
homochiral ketones (91) and (92) regenerated by thermolysis; however, the low yield of 
the products of sulfoximide anion attack prevents use of such a route on a large scale. 
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Scheme 1.11: Chemical resolution of the racemic ketone (87). 
A bakers yeast reduction of (87) followed by separation to the homochiral 
alcohols and reoxidation gave the enantiorneric ketones (91) and (92), which were 
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Scheme 1.12: Reduction of racernic ketone (87) and subsequent oxidations. 
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The racemate of the endo-alcohol (95) was selectively oxidised by a whole cell 
culture giving (91) and the alcohol (94); the latter might be chemically oxidised to the 
corresponding lactone (88) if so desired57. 
HO 0 HO 
HH Bacillus stearothennophilus IND.. H+ Hill IIIH Heptane 
W (S) () 100% ee 100% ee 
(95) (91) (94) 
Scheme 1.13: Whole cell stereoselective oxidation of the racernic alcohol. 
A whole cell culture can convert the racemic ketone to lactones58; however, 




Actinetobacter spp. TD63 
0 




W (85) (96) 
(87) 46%; >95% ee 46%; >95% ee 
Scheme 1.14: Whole cell enzymatic Baeyer-Villiger of the racemic ketone (87) 
The use of an esterase upon the achiral diester (97) gave the mono-ester (98)59; 
treatment of (98) as detailed in scheme 1.15 by Kond060 gave, via a Johnson ortho ester 
reaction and a Claisen rearrangement, (99) which led to homochiral (85). 
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esterase Hydroquinone 










o (85) H _H %%, %H 4 
1) KOH(aq) \lf"ý 
(99) H"' 2) HCI(aq) 0 
Scheme 1.15: Semi-synthetic route to enantiornerically pure lactone (85)59,60. 
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A chemical synthesis of chiral lactones (scheme 1.16)61 was based upon 
treatment of the prochiral epoxide (100) with a chiral base to form the chiral alcohol 
(101); this may be reacted with an ortho ester and then cyclized to the lactone (88), in a 
similar manner to scheme 1.15. The desired enantiomer (85) could be formed by basing 















Scheme 1.16: Route to homochiral lactones from prochiral epoxide. 
Use of the cyclopentadiene anion with methyl bromoacetate gave an ester which 
was reacted immediately with an asymmetric hydroboration agent to form the 
cyclopentenol derivative (103). Formation of the methane sulfonate ester and 
saponification of the carboxylate ester gave a carboxylate anion, which on treatment 
with mineral acid enabled esterification to form chiral lactone (85). The route enables 
the isolation of the cyclopentenol (103) as a stable intermediate for further purification 
if the hydroboration was not sufficiently enantioselective62. 
1) Na / -78*C / THF BH 
2) Me02CCH2Br "ýý( Y C02Me 
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Scheme 1.17: Route to homochiral lactone (85) using asymmetric borane. 
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An alternative method was based on work by Corey63. Opening the racernic 
lactone (82) with hydroxide, acidification in the presence of ethyl acetate to give the 
hydroxy acid and reaction with (+)-(x-methylbenzylamine formed the diastereomers 
(104), which were separated by recrystallisation from ethyl acetate and methanol. The 
methylbenzylamine was removed by aqueous base and the enantiomeric lactones 
reformed by treatment with acid. 
1) NaOH(,, q) 
HO C02 1) Separation 
000 
1( 
0 2) HCI(ikq) HN H H3N+ 2) NaOH(aq) 
5ý, e + 






W (82) (+) (88) (85) 
Scheme 1.18: Separation of homochiral lactones by formation of diastereomers. 
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PARTIAL SYNTHESIS OF MYCINOLIDE III AND THE 
MYCINOIC ACIDS 
CHAPTER TWO: 
Results and Discussion 
2 Results and Discussion 
2.1 Synthesis of Bicyclic Lactone (82) 
In order to obtain the lactone (82), the dichloroketone (86) was dechlorinated by 
treatment with zinc dust in acetic acid, and purification by distillation gave (87) in 99% 
yield (scheme 2.1). The distilled ketone was added to one equivalent of peracetic acid 
made in situ from hydrogen peroxide and acetic acid to give the lactone (82) in 
quantitative yield on work-up; no further purification was necessary. The complete 
regiocontrol of oxidation to form lactone (82) is due to the higher electron density at the 
bridgehead carbon, C(5), than at C(7) of ketone (87), thus C(5) migrates during the 
Baeyer-Villiger reaction. None of the regioisomer (105) was seen, unlike the 
Acinetobacter spp. oxidation of the racemate64. Nor was any epoxidation of the olefin 
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Scheme 2.1: Preparation of lactone (82). 
2.2 Alkylation at C-4 of Lactone (82) in Studies Towards Fragment B 
For the synthesis of the 1-10 fragment of mycinamicin III from lactone (82) to 
be achieved, a methyl group must be introduced at C-4. The methyl group needs to be 
in the endo position ((x) to give the 4(S)-methyl group in fragment B (84), as indicated 












Scheme 2.2: Proposed intermediates to Fragment B. 
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Thus to prepare (106) from lactone (82) it is necessary to introduce the methyl 
group to the more sterically hindered face of the molecule, not the more easily obtained 




Figure 2.1: Epimers of 4-methyl derivative of bicyclic lactone (82). 
I jLevious studies 
D-- 65 had shown that the 40-methyl isomer (107) could be prepared 
directly in 100% yield by reacting lactone (82) with LDA and methyl iodide. Inversion 
of the 4p-methyl to the required (x-stereochemistry was investigated via the 
intermediate enolate generated from lactone (107) with LDA. A range of electrophiles 
was examined to achieve protonation of the enolate from the P-face. However, the 
results were disappointing giving at best, a 78: 22 mixture of the P: cc-methyl derivatives 
((107) and (106) respectively) when saturated ammonium chloride solution was used as 
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Scheme 2.3: Previous "one-pot" route to 4(x-methyl lactone65 
Since this method was unsatisfactory for the preparation of the 4(x-methyl 
derivative, a different approach was investigated65. Enamine (108) was prepared from 
(82) in good yield using Bredereck's reagent66. However repeated attempts to convert 
(108) to (109) using Dibal-H, based upon the work of Ziegler and Fang67, gave (109) in 
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Scheme 2.4: Previous synthesis of 4(x-methyl lactone65. 
Hence if this approach to the 4(x-methyl lactone is to be synthetically valuable, 
an improved method for the reduction of the enamine is required. Recently Young et 
al. 68 have reported that, although treatment of enamine (111) with Dibal-H did not give 
satisfactory yields of the olefin (112) (and by-products such as (113) were formed), 
direct reduction of (111) with 50%w/w palladium on carbon in ethyl acetate gave the 
required P-methyl derivative (114) in 78% yield. 
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Scheme 2.5: Young's reduction of enamino-N-carboxy-amide68. 
Hence our investigations into methods for alkylation at the endo-face of C-4 of 
lactone (82) began with the direct catalytic hydrogenation of enamine (108). Treatment 
of (82) with Bredereck's reagent gave (108) in 49% yield. Stirring (108) in ethyl acetate 
with 10% palladium on calcium carbonate (20%w/w) under a hydrogen atmosphere led 
solely to reduction of the 6,7-double bond giving (115) in 44% yield. When palladium 
on carbon (50% w/w) was used as the catalyst in either ethyl acetate or a mixture of 
25 
ethyl acetate and acetic acid, again enamine (115) was the only product recovered (in 
53% and 92% yield respectively). 
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Scheme 2.6: Attempted reduction of vinylogous carbamate (108). 
(110) 
Since no reduction of the carbamate had been observed when the reduction was 
carried out at atmospheric pressure, a medium pressure hydrogenation was attempted 
but again this led simply to reduction of the 6,7-double bond giving (115) in poor yield 
(33%); no other products could be identified by 1H NMR spectroscopy. It is not clear 
why attempts to reduce enamine (108) under catalytic hydrogenation conditions failed 
when (111) was smoothly reduced under similar conditions69. However it was apparent 
that a different method for the introduction of a 4a-methyl substituent was required. 
The second approach to the problem of introducing a 4(x-methyl group involved 
alkylation of lactone (82) followed by elimination of a suitable leaving group to give 
the exocyclic methylene (109) (Scheme 2.7). From previous studies65 it is known that 
catalytic hydrogenation of the double bond occurs from the exo face giving the 4(x- 
methyl lactone (110). 
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Scheme 2.7: Proposed route to 4(x-methyl lactone. 
Treatment of lactone (82) with LDA followed by either diiodomethane or 
chloroiodomethane gave a complex mixture of products which could not be identified 





Paterson and FlemiTig7O have reported that (x-methylenation of a y-lactone may 
be achieved using chloromethylphenylsulfide as the electrophile and subsequent 
oxidation with sodium periodate to the sulfoxide and syn elimination to the cj- 
unsaturated lactone. Grieco and Miyashita7l have used a similar approach for (x- 
methylenation using chloromethylphenylselenide. 
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Scheme 2.8: Proposed route using chloromethylphenylselenide. 
Chloromethylphenylselenide was prepared according to the procedure described 
by Beckwith and pigou72. Reaction of diphenyldiselenide with sodium borohydride in 
methanol gave the phenylselenide anion, which was added to DCM to form 
chloromethylphenylselenide. Treatment of lactone (82) with LDA followed by 
chloromethylphenylselenide simply returned starting material. To determine if the 
problem was the lack of activity of chloride as a leaving group, a primary alkyl 
chloride, 2-phenylethyl chloride, was reacted with the y-enolate; again only starting 
material was recovered. This indicates that an electrophile with a better leaving group 
than chloride was required to react with the enolate. 
It has been reported73 that (x-methylenation of a 8-lactone may be achieved by 
generation of the enolate with LDA and quenching with gaseous formaldehyde 
followed by dehydration of the resultant P-hydroxy-lactone. Treatment of lactone (82) 
with LDA and gaseous formaldehyde (generated from paraformaldehyde) gave a 
mixture of two products which were separated by flash chromatography. The IH NMR 
spectrum of the more polar product showed a characteristic ABX pattern (3.88ppm, dd, 
J 11 and 4.5,4-CHHOH and 4.02ppm, dd, J 11 and 4.5,4-CHHOH) and was assigned 
as the P-hydroxy lactone (116). The less polar product was the unsaturated lactone 
(109) (5.62ppm, d, J 2,4-C-HH and 6.12ppm, d, J 2,4-CHHD. 
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Scheme 2.9: Pathway to 4(x-methyl lactone (110). 
Alcohol (116) was treated with methanesulfonyl chloride in pyridine to give 
mesylate (117) and the elimination product (109) which were separated by flash 
chromatography. Reaction of the mesylate with DBU gave the alkene (109) in 
quantitative yield. Catalytic hydrogenation of (109) gave 4oc-methyl lactone (110) in 
77% yield. Even though this has reduced the 6,7-double bond, this was not important in 
the final synthesis of the target 4,6,8-trimethylated lactone as the double bond would be 
utilised by other reactions prior to the introduction of the 4(x-methyl group. 
The alkene (109) is potentially a valuable intermediate in the synthesis of a 
range of macrolides. Since the exocyclic methylene is conjugated, it will be susceptible 
to copper catalysed conjugate additions and so could be used to allow the introduction 
of other groups for microbiological screening. 
Although the introduction of the 4(x-methyl substituent has been achieved, the 
overall yield from the lactone (82) was rather disappointing (42% overall yield). A 
more direct approach would involve introduction of the 40-methyl substituent via 
enolate chemistry (i. e. correct regiochemistry but incorrect stereochemistry), and 
inversion of the stereochemistry by ref6rming an enolate and protonation from the less 
hindered exo-face at C-4. As stated at the beginning of this section this had been 
28 
previously attempted with only limited success by Fraser65. The electrophile added was 
saturated ammonium chloride; use of other proton sources (water or dilute hydrochloric 
acid) gave lower yields of products. 
Reaction time before electrophile Temperature when % 4(x-methyl (106) isomer 
added (minutes) quenched(*C) 
2 -78 0 
10 -25 9 
30 -5 22 
60 +2 19 
Table 2.1: Treatment of lactone (82) with LDA and methyl iodide, then LDA and 
saturated ammonium chloride solution by Fraser65. 
From the data obtained it appears that using longer reaction times and a higher 
temperature allows more of the endo isomer to be formed. 
However from these studies it was apparent that no attempt had been made to 
isolate the 40-methyl derivative (107) prior to inversion of stereochemistry at C-4. 
Hence lactone (82) was treated with LDA followed by methyl iodide to give the 4p- 
methyl lactone (107) in quantitative yield. Treatment of (107) with LDA to generate 
the enolate and quenching with water indeed led to selective protonation of the exo-face 
at C-4 giving a 98: 2 mixture of the (x: p-isomers, (106) and (107) respectively (scheme 
2.10). The products were separable by flash chromatography. The percentage of each 
isomer was calculated from the integrals of the methyl doublets of the 4(x- and 4p- 
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Scheme 2.10: Route using LDA / methyl iodide to unsaturated lactone (106). 
29 
It was fascinating to compare the results from the "one-pot reaction" (in which 
lactone (82) was treated with LDA / MeI then LDA / NH4CI(aq) giving a 22: 78 mixture 
of (106) : (107), scheme 2.3)65 with the two step process (in which the 40-methyl 
derivative (107) was isolated prior to reaction with LDA/H20). The difference may be 
due to the presence of either excess diisopropylamine or lithium iodide in the "one-pot if 
procedure which are not present in the inversion of stereochernistry step of the 11two- 
stage" reaction. This was confirmed by treatment of (107) with LDA in the presence of 
1 equivalent of diisopropylamine giving, after a standard work-up, a 49: 51 mixture of 
(106) : (107). When the enolate of (107) was generated under standard conditions but 
diisopropylamine was then added at -78"C rather than water, then a yield of 60% of 
(106) was obtained. Thirdly, diisopropylamine was used to quench the enolate and the 
reaction then heated to 67*C, which gave 43: 57 ratio (106) : (107). There were no 
significant differences between the ratio of Products, though the use of higher 
temperature perhaps should have increased the proportion of (107). However, all 
reactions showed a lower degree of conversion from (107) to (106) than using water as 
the electrophile, due to diisopropylarnine being a weaker acid and more sterically 
hindered than water. Similarly, only 55% conversion of (107) to (106) was obtained 
using t-butyl alcohol as the electrophile. 
In contrast, when the reaction was repeated in the presence of an excess of 
lithium iodide and quenching with water, >85% of the desired 4cc-methyl derivative 
(106) was obtained. Hence the presence of excess diisopropylamine leads to a different 
ratio of products in the "one-pot" versus the "two-pot" reaction. 
Thus the preferred route for the introduction of a methyl group into the 4(x 
position of lactone (82) is to prepare the 4p-methyl isomer (107) with LDA/Mel and 
then to invert the methyl via formation of the enolate giving the required 4(x-methyl 
isomer (106) in 97 % overall yield from (82) (scheme 2.10). 
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The introduction of further substituents and work towards the synthesis of 
fragment B (84) of mycinolide, III is reported in the PhD theses of C. Clissold74 and J. 
Fraser65. 
2.3 Studies Towards the Synthesis of Fragment A (Cll 10 C171 
2.3.1 Synthesis of Benzvlidene Protected Diol (127) 
The proposed route for the synthesis of fragment A (Cll-C17) (83) of 
mycinolide 111 (39) was based upon previous work by Robinson in our group75 (scheme 
2.11). The strategy involved introduction of a hydroxymethyl group at C(6) (to become 
the 14-hydroxymethyl in mycinolide 111 (39)) and a potential leaving group at C(7) (to 
aid formation of the olefin at Q12) to Q13) in (83)). Manipulation of lactone (118) to 
a cyclopentanol (119) would then be followed by sequential oxidations to a ketone and 
a regioselective Baeyer-Villeger reaction to 8-lactone (120). Finally, reduction of the 
lactone to a lactol and elimination would give the (x, 0 -unsaturated aldehyde (83) 
required for macrocylisation to form (39) (scheme 1.9). 
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Scheme 2.11: Proposed strategy for the synthesis of fragment A (83). 
The lactone (82) was reacted with fonnaldehyde and sulfuric acid in a PrinS76 
reaction to give the diol (121) which was acetylated in situ to form the diacetate (122), 
according to a method of Kovacs77 (scheme 2.12). The diol (121) is so polar that it is 
difficult to extract directly from the reaction mixture, so the product had to be 
acetylated in situ to enable extraction as the diacetate (122). The diacetate was then 
treated with sodium methoxide to give (121). 
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Although this reaction sequence to form (121) from the lactone (82) was 
reliable, the overall yield of diol (121) was only 62%. To investigate whether this yield 
may be improved by isolation of the diol (121) directly from the Prins reaction, on one 
occasion only sodium acetate, but not acetic anhydride, was added during work-up, 
giving diol (121) in only 53% yield after column chromatography. It has been proposed 
that the Prins reaction upon lactone (82) proceeds via either the cyclopropylinium 
(123)78 or the oxetanium (124)79 cations, but mechanistic studies have shown a simple 
secondary carbocation (125) is not the intermediate (scheme 2.13). This may account 
for the lack of observation of regio and stereoisomers of (122). 
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Scheme 2.13: Proposed mechanisms for formation of the diol (121) from lactone (82). 
The next step in the proposed synthesis of mycinoic acids and fragment A of 
mycinamicin III was to protect the hydroxyl groups of the diol (121). Previous 





protected as the TBDMS ether, the reaction with 2-methoxyethoxymethyl chloride and 
diisopropylethylamine caused migration of the silicon group to the secondary alcohol. 
Thus a new stable protection group was required. Treatment of diol (121) by Robinson 
with dimethoxypropane and para-toluenesulfonic acid did not give the desired ketal, 
however, the addition of a benzylidene group to give (126) was achieved using (X, (x- 
dimethoxybenzaldehyde acetal and CSA; use of zinc chloride with benzaldehyde (with 
or without azeotropic distillation), or benzal bromide and pyridine were far less 
successful75. 
In this project, it was found that treatment of (121) with (x, (x- 
dimeth oxy ben zaldehyde acetal and CSA in DMF at 45*C under a vacuum of 
approximately 20mmHg gave the acetal (126) in quantitative yield on successive 
occasions (scheme 2.14). However, although this reaction had been repeated twenty- 
four times, in the latter stages of this research the acetal inexplicably failed to form. 
The reagents and starting materials were pure by IH NMR spectroscopy and melting 
point determination. Hence an alternative appoach to (126) was examined using 
PhCHO in the presence of CSA which gave the required product, albeit in only 50% 
yield. A reaction analogous to that with benzaldehyde was attempted using 2- 
nitrobenzaldehyde to form a derivative, in which the aromatic protecting group can be 
removed by uv irradiation80. However, none of the nitroaromatic acetal product was 
isolated, and only 22% of the starting material (121) was recovered. The next stage in 
the proposed pathway invoked formation of a ethanolic group for reduction to the ethyl 
group. The benzylidene protected derivative (126) was reduced with lithium aluminium 
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Scheme 2.14: Synthesis of diol (127). 
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2.3.2 PreDaration f Cyclopentanol (129) from Diol (127) 
The next stage of the synthesis required the selective deoxygenation of the 
primary alcohol of (127) (which will be the 15 position in mycinamicin 111) in the 
presence of the secondary alcohol. The deoxygenation procedure used previously75 
was to prepare the thiocarbonate (128) from the diol (127) using phenyl 
thionochloroformate and pyridine in DCM at O*C followed by reduction under radical 
conditions with tri-n-butylstannane (scheme 2.15). On repeating the first stage of this 
reaction, the thiocarbonate (128) was isolated in only 50-55% yield (compared with 
74% yield reported by Robinson75). Hence a range of different conditions were tried in 
order to improve the yield. 
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Scheme 2.15: Overview of route to cyclopentanol (129). 
(129) 
Due to the diol (127) being poorly soluble in DCM (indeed without the presence 
of pyridine it would not dissolve at all), a variety of more polar solvents were used in 
attempts to improve yield of the thiocarbonate (128), see table 2.2. Either the use of 
acetonitrile or the absence of solvent gave even lower yields of product than other 
conditions, but no consistent improvement was shown by any one solvent system. In an 
attempt to improve the yield, the reaction was repeated at a lower temperature than O*C, 
which should further have favoured the esterification of the primary alcohol and not the 
secondary alcohol. The alcohol (127) was completely insoluble at -78*C in DCM (even 
with the addition of base), so a more polar solvent was used, either a mixture of DCM 
& THF (1: 1), acetonitfile or THF alone. However, the lowest temperature that enabled 
(128) to form was -12*C, and yields at this temperature were no improvement upon 
reaction at O*C, except under use of ether as solvent. Reaction at room temperature 
34 
enabled formation of the bis product (130) also, although the maximum yield obtained 
was only 8%. 
Solvents used Two highest yields obtained 
Acetonitrile 41 & 19% 
Chloroform 86 & 43% 
DCM 55 & 52% 
DCM & ether 40% 





Table 2.2: Effect of solvent variation on yield of phenoxythiocarbonate (128). 
As the anion of N-hydroxysuccinimide is a better leaving group than a chloride 










Scheme 2.16: Formation of intermediate (131). 
However, upon treatment of diol (127) with phenyl chlorothionoformate, 
pyridine and N-hydroxysuccinimide, the yield of the monothiocarbonate (128) fell to 
28% and the yield of the di-protected derivative (130) increased to 55% (scheme 2.17), 
as well as the cyclic ether (132) also being formed. Bisthiocarbonate (130) was readily 
identified in the 1H NMR spectrum by the downfield shift of the signal assigned to 8-H 
from 4.26ppm in the monothiocarbonate (128) to 5.63ppm in (130). The intermediate 
(131) appeared too effective an electrophile and enabled reaction of both hydroxyl 
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Scheme 2.17: Use of N-hydroxysuccinimide on thiocarbonate formation (128). 
The use of one equivalent of a metal hydride (as an alternative base to pyridine) 
with 18-c-6 and phenyl chlorothionoformate upon (127) was undertaken, as an alkoxide 
anion would be a more effective nucleophile than the free alcohol, and kinetic control 
should ensure preferential attack by the far less hindered primary alkoxide. However, 
results were far worse than with organic base: sodium hydride gave only 30% of the 
required product (128) and 27% starting material was returned, whilst potassium 
hydride yielded only 17% of (128), with no other products found. 
In an attempt to check the displaced chloride anion was not affecting the 
thiocarbonate formation, the diol (127) was reacted with silver fluoride, pyridine and 
phenyl chlorothionoformate, a technique based upon work by Suzuki et a182; however, 
phenoxythiocarbonate (128) was obtained in 22% yield only, with no other compounds 
identified from a complex mixture. 
Use of DMAP (and pyridine as co-base) in the reaction with phenyl 
chlorothionoformate and diol (127) did not increase yields of (128) appreciably (40% 
and 44%), whilst replacing the aromatic bases with diisopropylamine gave a 51% yield 
of thiocarbonate (128) (plus 16% starting material was returned); the results suggest 
formation of the N-thiocarbonyl quarternary ammonium derivative of the base was not a 
factor in the yields of (128) being below quantitative. However, the use of imidazole 
was more beneficial, the thrice performed syntheses with this as base had yields of 
thiocarbonate of 90,86 and 68%. This may not be due to the higher pKa of the 
conjugate acid of imidazole (6.95) compared to pyridine (5.25)83, as the more basic 
diisopropylamine gave a lower yield of (128) than pyridine, but the improved yield 
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using imidazole was perhaps due to the low steric bulk of the five membered ring. The 
preparation of a dithioimidazolide was not attempted, as Fraser65 had shown addition of 
1,1'-thiocarbonyldiimidazole to the diol (121) to give (133) had occurred in lower yield 
than the corresponding yield of diphenylthiocarbonate (134); also the radical reagents 










Figure 2.2: Bis-thiocarbonyl products prepared previously by Fraser65. 
Hence the use of the phenyl chlorothionoformate, imidazole and incongruously 
ether, a solvent in which the starting diol (127) would not dissolve without addition of 
other reagents, stirred under a nitrogen atmosphere at -12 to O*C for several hours was 
the most efficient method to obtain thiocarbonate (128) giving the required product in 
90% yield. 
Having optimised the selective formation of the thiocarbonate on the primary 
alcohol, disappointingly it was found that free-radical reduction of (128) with tri-n- 
butyl tin hydride, the Barton-McCombie reaction, gave variable results ranging from 0- 
75% of the desired product (129), as noted previously84. Thus numerous changes were 
made to the technique in an effort to improve both yield and the reproducibility of the 
reaction (scheme 2.15). 
Unreacted starting material (128) was but rarely returned, however the reaction 
frequently produced complex degradation products, some of the identified and 
postulated products and intermediates85 are depicted in scheme 2.18. 
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Scheme 2.18: Products, postulated and obtained, from radical reduction of (128). 
If insufficient free radical initiator, AIBN, was being cleaved to generate the 
radical, which can enable tri-n-butyltin hydride to form tributylstannic radical (135), the 
thioformate (128) would not be able to react (schemes 2.18 and 2.19). To determine if 
sufficient AEBN was breaking down, AEBN was heated to reflux in benzene for 2 hours; 
analysis by NMR spectroscopy showed that the ratio of the dimer : AIBN was 
approximately 1: 1; if the reaction was heated to reflux for longer than 2 hours, complete 
degradation of AIBN should occur. But on heating (128), nBu3SnH and AIBN 
overnight on four separate occasion, the yields of product (129) were 52,29,0 and 0%. 
Whilst the stannyl hydride reduction of primary thiocarbonates takes longer than 
secondary thiocarbonates86, heating to reflux overnight should have been sufficient 
time to enable reduction, hence the lack of consistent conversion of (128) to (129) is 
probably not due to insufficient reaction time. 
The amount of AIBN was increased to a greater than stoichiometric amount in 
four reactions, but yields of (129) obtained were only 36,0,0 & 0%. Some of the by- 
products produced were white crystalline needles of indeterminate structure, although 
the characteristic benzylidene peaks were visible in the 1H NMR spectrum (a singlet at 
5.58ppm assigned to 5-H and a multiplet at 7.45ppm due to the aromatic protons); 
elemental analysis found no tin, but contained a large proportion of nitrogen (9.8- 
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18.2%) suggesting the products were derived from AIBN. Thus the use of an excess of 
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Scheme 2.19: Thermolysis of AEBN and subsequent reactions. 
Barton and Motherwell found high temperatures were required to enable 
primary alkyl radicals to form87 , thus in an attempt to generate (140) more effectively, 
the reaction temperature was raised. However, upon heating (128) with tri-n-butyltin 
hydride and AIBN at a variety of temperatures, no definite pattern can be seen across 
the range of calidity (table 2.3). Barton and McCombie found that aromatic 
hydrocarbon solvents enabled the highest yield of products upon stannyl reduction of 
thiocarbonates84. Due to the inconsistency of the reaction using toluene or benzene as 
solvents, a variety of other solvents were used instead. However table 2.3 indicates 
hydrocarbon solvents ensured the highest yields, which are the least polar solvents, 
suggesting that an unstabilised radical was able to react more quickly and form the 
cyclopentanol (129) most efficiently. No highly dilute solvent systems were used, as 
research of the stannane hydride reduction of cholesterol dithiocarbonates and 
thiocarbonates by Robins, Wilson and Hansske has shown the absence of concentration 
effectS88. 
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Solvent used Reaction temperature ("C) Two highest yields of (129) 
Nitrobenzene 210 0 (& 43% ether (132)) 
Benzonitrile 188 16,0 
para-Cymene 176-8 0 
para-Xylene 138 69,29 
Toluene ill 73,70 
Dioxane 100-102 36 
Benzene 86 75,66 
Glyme 85 21 (& 15% (132)) 
Acetonitrile 82 42,30 (& 38% (128)) 
Carbon tetrachloride 77 0 (& 2% (128)) 
THF 67 0 
Table 2.3: Effect of altering temperature and solvent in tin hydride reductions of (128). 
Whilst initially only one equivalent of tri-n-butyltin hydride was used to reduce 
each equivalent of thiocarbonate to alkane, in order to determine if the number of 
equivalents of radical hydride was a factor in the variable results from reduction of 
(128), the amounts of tin hydride were varied; however, the yield of product did not 
correlate with the relative quantity of hydrogen radical (table 2.4). The nBu3SnH used 
was obtained from various commercial sources (Aldrich, Avocado, Lancaster chemical 
companies); in order to determine if the activity of that sourced externally was not 
sufficient, nBu3SnH was made directly from LiAlH4 and tri-n-butyltin chloride; whilst 
09 the product correlated with the literature" , upon treatment of 
(128) with the same, the 
yield of (129) was only 41 %. Hence it was concluded that the number of equivalents of 
radical hydride could not be correlated to products, except that using less than one 
equivalent tended to increase the chance that starting material would be returned. 
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N' of equivalents of radical Yields (%) obtained of (129) 
0.5 54,30 (& 38% starting material, (128)) 
0.9 37 (& 8% (128)) 
1.0 51 (&16% ether (132)), 0 
1.1 75,70,63,62,52,47 (&17% (132)), 45,38,29,29, 
20,6,0,0,0; 0 (& 4% (128)); 0 (& 2% (128)). 
1.2 73,66,60,42,36,11,0 










Table 2.4: Variation in number of equivalents of tin hydride. 
Each reductive reaction upon (128) was conducted under a nitrogen or argon 
atmosphere and several techniques were investigated to remove the last traces of 
oxygen (Table 2.5). However, results did not improve with use of any such de-aeration. 
Technique of oxygen removal Yields (%) 
De-gassing under vacuum (=20mmHg) 58 & 47 (&17% (132)) 
Bubbling nitrogen through solution 70,41,20 &0 
Bubbling argon through solution 45,29 &0 
Sonication bath 16 
Table 2.5: De-aeration methods utilised for radical reduction of (128). 
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Triphenyltin hydride is an alternative source of hydrogen radicals to the tri-n- 
butyl functionalised molecule, with aromatic rings that can stablise the stannous radical 
by mesomerism. Whilst cleavage of chloride90 and carbon- sulphur9l bonds is more 
efficient and in higher yield than by tri-n-butyltin hydride, little research has been made 
upon reduction of thiocarbonyl compounds with the Ph3SnH. Barton and Motherwell 
found the deoxygenation of a primary xanthate functionality of a hederagenin derivative 
by triphenyltin hydride less effective than with tri-n-butyltin hydride87. Treatment of 
(128) with triphenyltin hydride in the presence of AIBN in benzene gave (129) in yields 
of only 47,26 and 0%. 
Triethyl borane was used by Nozaki and co-workers92 as the radical initiator in 
a reduction using tri-n-butyltin hydride in benzene at room temperature to reduce a 
secondary phenoxythiocarbonate. This technique was modified for treatment of (128) 
by adding di-t-butylpyridine, to prevent degradation of the acetal; however, on use of 
the borane / hydride reduction system, only starting material (76%) was returned. 
Repetition of the experiment without di-t-butylpyridine gave an unidentifiable mixture 
of compounds, as did heating tri-n-butyltin hydride, di-t-butylpyridine, thiocarbonate 
(128) and triethylborane to reflux in benzene for 1.5 hours. 
Robinson had used phenylsilane as the hydride source with benzoyl peroxide as 
the initiator with the phenoxythiocarbonate (128) giving only 23-30% yield of 
cyclopentanol (129)75. As Barton et a193 had found a greater degree of conversion of 
thiocarbonates to alkanes with di- and tri- phenylsilane than with phenylsilane, 
triphenylsilane was used as the hydride source with benzoyl peroxide as the radical 
initiator, but gave only = 13% of impure starting material (128) after flash 
chromatographic purification. Treatment of (128) with triphenylsilyl hydride and AEBN 
in toluene heated to reflux returned only starting material (89%). From the results 
obtained, use of alternative radical initiators to AIBN lowered yields further, as had the 
use of aromatic silyl reducing agents. 
Treatment of (128) with tris(trimethylsilyl)silane as the hydride source was 
proposed, as the silicon-silicon bond. enables easy lysis of the weakened silicon- 
hydrogen bond94. Use of tris(trimethylsilyl)silane on the phenoxythiocarbonate (128) 
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gave odd results. The use of 3.5 equivalents gave a 45% yield of the desired ethyl 
derivative (129). However, using 1.1 equivalents for only 0.5 hours resulted in 65% of 
(129), whilst heating for 2.75 hours gave no isolable components. From these results it 
was concluded that silylsilanes were no more consistent in reducing the thiocarbonate in 
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Scheme 2.20: Plausible breakdown pathways of (128) to unwanted products. 
A possible reason for the poor results of the reduction of (128) is the ring 
alcohol may form a weak van der Waals type linkage to the thiocarbonyl carbon, 
thereby inhibiting the tin linking to the sulphur; or the free alcohol may enable the 
cyclisation to the ether (132) via the thiocarbonate leaving group (scheme 2.20). 
Forming the cyclopentanone derivative of the thiocarbonate (141) was proposed, as 
radical reductions do not usually affect ketones95. Thus use of PDC and crushed 
anhydrous 0.4nm diameter molecular sieves in DCM enabled oxidation of (128) to give 
(141) in 74% yield, the product being characterised by the presence of both the carbonyl 




H Op" PDC / DC 
Crushed anhydrous 
0.4nm diameter 

















Scheme 2.21: Synthesis and reduction of keto-phenoxythiocarbonate (141). 
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However, reduction of (141) was as erratic as with the 2" alcohol: thrice reacted 
with tri-n-butyltin hydride, yields of the cyclopentanone (142) were only 37% (solvent: 
MeCN), 19% (solvent: PhMe) & 0% (solvent: PhMe). 
Several methods for forming an aromatic xanthate derivative96 of (127) were 
tried, and phenyl chlorodithioformate has the added benefit of being cheaper than 
phenyl chlorothionocarbonate97. Treatment of (127) with phenyl chlorodithioformate 
in the presence of pyridine and / or N-hydroxysuccinimide simply returned starting 
material. Treatment of (127) with potassium or sodium hydride with 18-c-6 prior to 
addition of phenyl chlorodithioformate merely caused degradation of starting material, 
as had occurred upon use of metal hydrides with (127) and phenyl chlorothionoformate. 
Another method for forming a xanthate is to use carbon disulphide, methyl 
iodide and base84. Under these conditions the crude product (143) was obtained in 94% 
yield, the signal in the 13C NMR spectrum at 216ppm being in the characteristic region 
of a dithiocarbonate. Radical reduction of (143) gave the desired cyclopentanol (129) in 
40% yield with tri-n-butyl tin hydride and in 43% yield with triphenyl tin hydride. On 
purification of the xanthate (143) prior to reduction, (129) was obtained in only 12% 
yield. An attempt to use the crude phenoxythiocarbonate (128), i. e. without column 
chromatography, ' in a fashion analogous to that for the methyl. xanthate (143), in a 
radical reduction yielded only 4% of the cyclopentanol (129), so was abandoned. 
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Scheme 2.22: Path for deoxygenation of diol (127) via xanthate (143). 
Although the crude methyl xanthate (143) had formed in good yield and had not 
required purification by column chromatography to enable reduction by tin 
hydride 
reducing agents, the yields of (129) were not a vast improvement upon radical reductive 
treatment of (128); the use of carbon disulfide was not a reagent of choice, hence the 
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use of the less malodorous phenyl chorothionoformate as thiocarbonate derivatisation 
agent was retained. 
A further radical deoxygenation procedure was attempted based on the work of 
Oba and Nishiyama98, via reacting the proposed N-acyl thioxocarbamate (145) with tri- 
n-butyltin hydride with AIBN in benzene. The oxoisothiocyanate (144), which is not 
isolated in the literature procedure, was presumably formed and the alcohol (127) was 
added to the oxoisothiocyanate and heated to reflux overnight in a 'one-pot' reaction; 
however, as indicated none of the thioxocarbamate (145) could be isolated, and only the 
diol (127) was identified in 5% yield (scheme 2.23). 
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Scheme 2.23: Proposed route to form N-acyl thioxocarbamate from diol (127). 
Thus a variety of radical hydride sources, initiators and thiocarbonyl derivatives 
were employed in many attempts to reduce a primary alcohol to an ethyl group, to form 
C(16) and C(17) of the target mycinolide; treatment of the phenoxythiocarbonate (128) 
with tri-n-butyltin hydride. and AIBN in heated aromatic hydrocarbon solvents was 
inconsistent, but did return product (129) in widely varying yields. 
Instead of reduction of a thiocarbonate derivative, the use of a halide was 
explored, also to be deoxygenated by a radical hydride source. Treatment of the diol 
(127) with triphenylphosphine, iodine and imidazole99 in an attempt to form the 
primary iodide gave the cyclised ether (132) in 97% yield (scheme 2.24). The primary 
iodide probably did form under these conditions, but was displaced by the secondary 
alcohol. The IH NMR spectrum of (132) was characterised by the collapse of the 
signals at 3.65ppm (dt, J=10 and 2.5Hz, 9'-H) and 3.89ppm (dt, J=10 and 
4Hz, 9'-H) 
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due to the protons ot to the primary alcohol of (127) and the appearance of a large 
multiplet at 3.89ppm, assigned to the two protons at 9' of the ether (132). 
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Scheme 2.24: Attempted formation of the primary iodide. 
The methane sulfon ate (146), trifluoromethanesulfonate (147) or para- 
toluene sulfonate (148) were other derivatives which were considered since both could, 
in theory, be reduced with metal hydridesIO0. However on treatment of (127) with a 
variety of sulfonyl reagents (MsCl, MsBr, MS20, TsCl, TsBr and TfCl) and bases 
(Et3N, DMAP, pyridine and NaH) in each case gave a mixture of unidentifiable 
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The use of trimethylsilyl chloride (after reacting the primary alcohol (127) with 
tosyl chloride in the presence of of DMAP and three equivalents of pyridine) to protect 
the secondary alcohol and prevent cyclising to (132) was attempted; however, the 
secondary alcohol was not protected as the yield of the cyclic ether was 73%. 
Due to the disappointing results from selective reduction of the primary alcohol 
in (127) to (129), an alternative approach was examined involving reduction of a 
derivative of the corresponding lactol / hydroxy aldehyde (149) (scheme 2.25). 
Reduction of the lactone (126) with Dibal-H gave (149) in 74% yield (plus 11 % starting 
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material). Lactol (149) was characterised by the absence of a carbonyl moiety by either 
IR or 13C NMR spectra. A Huang-MinlonlOl modified Wolff-Kishner reaction upon 
the lactol (149) was undertaken but gave no isolated compounds upon work-up, which 
may be due to the presence of strong base at high temperature degrading the molecules. 
The literature notes that ketones are more stable to such hydrazine based reductions, and 
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Scheme 2.25: Treatment of (126) to form hydroxy-carbonyl compounds. 
A modification of the Wolff-Kishner reaction is the treatment of a carbonyl with 
tosy1hydrazine and catalytic tosic acid to produce a tosylhydrazone, which may be 
reduced to an alkane with a mild hydride source such as sodium cyanoborohydride103. 
Thus lactol (149) was stirred with 1.2 equivalents of tosy1hydrazine (to prevent 
degradation of the acetal) and 0.2 equivalents of tosic acid in an attempt to form the 
hydrazone, which was to be reacted with a silyl group to protect the secondary alcohol, 
followed by reaction with sodium cyanoborohydride and final deprotection of the 
alcohol with TBAF. However, the hydrazone did not form, but 83% of the starting 
material was returned. 
As the hydrazones of lactol (149) could not be formed, it was proposed that a 
highly nucleophilic arnine anion would open the y-lactone ring of (126) to form an 
amide, which after reduction may be able to undergo a Hoffman elimination (scheme 
2.26). Treatment of P-phenylethylamine with butyl lithium at -78*C gave an anion, 
which upon addition to lactone (126) formed the amide (150) in 59% yield; the 
carbonyl signal in the IR spectra was 1617cm-1, a value characteristic for a saturated 
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amide. However, on addition of lithium aluminiurn hydride to the amide, a complex 
mixture of products was formed, from which none of the required amine could be 
identified. Attempted protection of the secondary alcohol in (150) simply returned 
starting material. 
Another method which was considered was reduction of a dithiane (152) with 
Raney@ nickeI104- The dithiane could not have been added to upon the benzylidene 
protected ^f-lactol (149) directly, because the strongly acidic conditions would degrade 
the benzylidene group. The great polarity of the diol (121) made handling difficult, 
hence this approach was investigated on a model system (scheme 2.27). 
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Scheme 2.26: Proposed route to cyclopentanol (129) from diol (121). 
Lactone (82) was reduced by one equivalent of Dibal-H to form the lactol (153) 
as a mixture of epimers. Reaction of the masked aldehyde functionality of (153) with 
ethanedithiol in the presence of titanium tetrachloride as a Lewis acid catalyst gave the 
dithiane (154) in 72% yield. However, on treatment of (154) with commercially 
obtained Raney Nicke197 in anhydrous methanol or ethanol, none of the desired 
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Scheme 2.27: Model study of an attempted reduction of lactone (82). 
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As the several pathways to obtaining the desired ethyl group for positions C(16) 
and Q17) of the target mycinolide by avoiding the necessity to use radical 
deoxygenations had failed, the use of tri-n-butyltin hydride upon phenoxythiocarbonate 
(128) in an aromatic hydrocarbon solvent in the presence of AIBN as the radical 
initiator was used in the synthesis of the desired ethyl group of (129). The most logical 
reason for the lack of consistent reduction is that the route generates a primary radical, 
which is not as stable as a secondary or tertiary radical105. However, Freidline and co- 
workers106 noted "In the case of less stable (secondary, primary) radicals, 
fragmentation competes with hydrogen abstraction from Bu3SnH by the radical 
[(136)1". The secondary alcohol at C-8 of the cyclopentanol (129) also could cyclise to 
enable formation of the tetrahydrofuran acetal (132) (or form unidentifiable products), 
and the secondary alcohol proved difficult to protect in order to prevent reaction with 
substituents on the primary alcohol. 
2.3.3 Studies Towards the Synthesis of Fragment A from (129) 
The next 3 steps in the synthesis of fragment A of mycinamicin 1111 and mycinoic 
acid 11 proceeded smoothly following similar procedues to those used by Robinson 
(Scheme 2.28)75. Oxidation of cyclopentanol (129) using PDC and anhydrous crushed 
sieves in DCM gave the required ketone (142) in 74% yield with no apparent 
epimerisation (x to the carbonyl group. Other methods were briefly examined to see if a 









PDC 0 DCM 
dried mol. Ph sieves 
(142) 74% (156) 78% 








Treatment of cyclopentanol (129) with anhydrous pyridinium chlorochromate 








benzylidene protecting group) gave only 30% of ketone (142). A related oxidation 
method to that of PCC was the use of 2,2'-bipyridinium chlorochromate107 (158), 
which has a second heterocyclic nitrogen which can prevent the acidic by-products 
degrading the benzylidene group. This enabled oxidation of (129) to give (142) in a 
yield of 70% which was not an improvement upon use of PDC with molecular sieves, 
and was not significantly faster either, as the bipyridinium-based reaction required 
stirring for 2.75 hours to enable all starting material to disappear by TLC analysis. 
\\ // Cr0202 
MQQ 
Cr 0", N N+ Cr I CI 0- OH OH K2C03 
H00 
(158) (159) (160) 
Figure 2.3: Oxidants used to convert cyclopentanol (129) to cyclopentanone (142). 
An alkyl chromate oxidant (160) was first used in catalytic quantity by Corey et 
WIN with a stoichiometric amount of peracetic acid to effect oxidation of secondary 
alcohols to ketones. A modification of this method by Luzzio and Moore109 was to 
effect oxidation with non-purifed (160), which has titanium dioxide and potassium 
carbonate still present; Morin-Fox and Lipton110 utilized the alkyl chromate with 
concurrent use of four equivalents of mCIpBA as co-oxidant to oxidise secondary 
alcohols directly to lactones. Treatment of cyclopentanol. (129) according to the method 
of Luzzio and Moore with four equivalents of non-purified (160) gave the ketone (142) 
in 72% yield, but even with stirring for approximately 96 hours, none of the . 
cyclopentanone was converted to 8-lactone (156); also the reaction took almost 24 
hours to form the ketone, which is far longer than the ionic chromate agents. 
Sulfur trioxide pyridine complex in DMSO can oxidise alcohols readily (the 
iekishan modification of the Moffat oxidation) to aldehydes or ketones and the oxidants 
give easily removable by-products once reactedl 
II. Treatment of (129) with pyridine 
sulfur trioxide, in the presence of triethylamine to prevent breakdown of the acetal, 
returned the ketone (142) from alcohol (129) in 64% yield, but the product was not as 
pure as that from chromate oxidations, and it was necessary to remove 
DMSO under 
high vacuum. Use of TPAP, and NMO as co-oxidant112, to oxidise cyclopentanol 
(129) 
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gave the ketone (142) but the yield obtained was only 62% and the reaction was no 
faster than with PDC and molecular sieves. 
Considering the efficacy, cost, convenience and speed of of the reagents used in 
the oxidation of (129) to (142), none were an improvement upon the use of PDC and 
crushed 0.4nm diameter anhydrous molecular sieves in a chlorinated solvent, which was 
the reagent of choice. 
Treatment of ketone (142) with mCIpBA / NaHC03(s) gave the required 8- 
lactone (156) with complete regio- and stereo-control in 78% yield (scheme 2.28). 
Reduction of the lactone (156) to the 8-lactol (157) with Dibal-H also proceeded 
smoothly in over 90% on virtually all occasions. 
With quantities of the lactol (157) in hand, to complete the synthesis of fragment 
A of mycinolide III it was simply necessary to effect a P-elimination of the benzylidene 
group giving (83). 









Scheme 2.29: Proposed mechanism to give fragment A (83). 
Robinson75 had previously shown that reaction of (157) with LDA returned 
starting material. Addition of D20 to the reaction mixture confirmed that the enolate 
had indeed been formed, but surprisingly no P-elimination had occurred. 
HO 0 %J 
HO 0 HO 0 
LDA D+D 
D20 / DO D: 
0 
)", 00 "'ýr 00 "*'ýr 0 Ph Ph Ph 
(157) (161) 44% (162) il% 
Scheme 2.30: Deuterium incorporation into lactols (157)75. 
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Therefore it was deemed necessary to remove the benzylidene group before 
elimination to the required oc, p-unsaturated aldehyde (83). 











Scheme 2.3.1: Proposed route to (83) via free hydroxyl derivative (158). 
Several methods were examined to convert (157) to (163). Reaction of the 
lactol with methanol and acidic Dowexg resin followed by an acidic work-up gave a 
complex mixture of products. Attempted deprotection of (157) by using either acidic 
Dowex@ resin in anhydrous DMSO, or dilute hydrochloric acid and TBF returned only 
starting material in low yield after an alkali extraction and work-up. Thus other 
methods of removal of the benzylidene acetal to give either the (x, P-un saturated 
aldehyde (83) or the tri-hydroxy precursor (163) were proposed. 
The dihydroxy lactol (163) was predicted to be very polar and hence difficult to 
extract into organic solvents, thus the use of a biphasic system consisting of an upper 
organic layer and a lower aqueous acidic layer was considered. As the benzylidene is 
cleaved, it was proposed that the resulting benzaldehyde should pass into the organic 
solvent, and the diol remains in the aqueous layer and could be recovered by removal of 
the water. A model study on an acetal (126) using a mixture of petrol, ether and CSA 
dissolved in water returned the diol (121) in 92% yield from the aqueous portion after 
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Scheme 2.32: Model study: removal of benzylidene group of (126). 
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Treatment of (157) under similar conditions gave =40% return of starting 
material but no other compounds were characterised. Stirring (157) in petrol, methanol 
and water with para-toluenesulfonic acid gave the methoxy acetal (164) in 45% yield, 
which was readily discernible by the appearance of singlets at 3.30 and 3.49ppm, in a 
ratio of 3: 1, due to the methoxy groups of the two isomers; no other components of the 
reaction were characterised. Treatment of (157) with para-toluenesulfonic acid in a 
biphasic system of petrol and water resulted in the return of no identifiable components. 
On one occassion, treatment of (156) with Dibal-H did not completely reduce 
the lactone to the lactol, but gave a mixture of (156) and (157) (in a ratio of 3: 5) which 
could not be separated by column chromatography. Interestingly, treatment of the 
mixture with anhydrous methanol and CSA gave (164) and (165) (scheme 2.33), which 
were extracted from an alkaline work-up procedure and the diols separated by column 
chromatography. This yield of the methoxy acetal (164) was much higher than that 
obtained when (157) was stirred in petrol, methanol and water with para- 
toluenesulfonic acid, which only gave (164) in 45% yield; this suggests the anhydrous 
conditions prevented some of the decay of the acetal functionality. 
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Scheme 2.33: Removal of benzylidene protecting group. 
Dibal-H reduction of (165) should lead to the masked aldehyde (163); however 
repeated attempts to reduce (165) with three equivalents of Dibal-H gave a complex 
mixture of products. 
With a small amount of the dihydroxy acetal (164) available, deprotection of the 
acetal and elimination to the (x, p-unsaturated aldehyde was examined. Treatment of 
(164) with CSA, water and petrol in a biphasic system gave no identifiable products and 
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a similar result was obtained when (164) was heated to 66*C in water under vacuum 
(==20mmHg) with acidic Dowex. 
Another approach which was examined to enable production of the dihydroxy 
lactol. (163) was to remove the acetal. protecting group prior to the Baeyer Villiger 
reaction on the substituted cyclopentanone (142). However on heating (142) with 
formic acid in water or with acetic acid, followed by removal of the acid under vacuum 
formed the unsaturated ketone (166) in 46% yield (with HC02H) and 41% yield (with 
CH3CO2H) (scheme 2.35). Interestingly treating the corresponding 8-lactone (156) 
under similar conditions simply returned starting material. 
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Scheme 2.34: One-pot deprotection and elimination from ketone (142). 
It was apparent that neither the alcohol nor the benzylidene derivative at C(3) 
was a good enough leaving group to form the required (x, o-unsaturated aldehyde, thus it 
was proposed to use a better leaving group e. g. an acetate or mesylate (scheme 2.35). 
Treatment of diol (164) with 1 equivalent of acetic anhydride and pyridine gave a 
mixture of the C(2) epimers of the diacetate (167), the required monoacetate (168) and 
starting material. The products were separated by column chromatography. By 
analysis of the IH NMR spectra of the more prevalent epimer of the monoacetate (168), 
the monoacetate was identified by the appearance of a multiplet at 3.85ppm which is 
not visible in the spectra of the diacetate (167); the diacetate has a peak (not visible in 
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Scheme 2.35: Attempted eliminations of methoxy acetals. 
Monoacetate, (168) was treated with methanesulfonyl chloride in the presence of 
triethylarnine to give the methanesulfonate (170) in 75% yield. Repeated attempts to 
deprotect the acetal in either (167) or (170) failed to give the lactols (169) or (171) for 
the final elimination to the unsaturated aldehyde (83). For example, on treatment of 
(170) with dilute hydrochloric acid in acetonitrile, or acidic Dowex in acetone and 
water, or formaldehyde with TiC14 in THF, or dilute hydrochloric acid in THF, or 
pyridine and DMAP in DCM, starting material was returned in varying proportions. 
Likewise, the diacetate (167) was returned in 30% yield only from an attempted 
elimination with dilute hydrochloric acid in ether, and approximately quantitatively 
from a media of acidic Dowex resin in acetone; however, the use of DMAP and 
pyridine destroyed the diacetate (167) and nothing was identifiable on extraction. 
Due to the repeated failure to remove the methoxy acetal, further methods were 
investigated on a model system. Thus dihydropyran was reacted with CSA in methanol 
and upon purification gave the methoxy acetal (172); subsequent reaction with acidic 
Dowex in a mixture of acetone and water gave the 8-lactol (173) (scheme 2.36). Thus 
the reason the diacetate (167) and methanesulfonate (170) acetal functionalities failed to 
be removed is unclear, as the steric effects of groups 
P andy to the acetal carbon of both 
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Scheme 2.36: Removal of methoxy acetal from a model. 
Due to the lack of success using diols (164) or (165) as intermediates in the 
synthesis of fragment A of mycinolide III, an attempt was made to add a halogen (either 
Br or 1) (x to the masked carbonyl of lactol (157). Reduction and elimination of the 
halide from (174) with zinc in a manner not dissimilar to that of dichloroketone (86), 
should give the unsaturated aldehyde (83). However, treatment of lactol (157) with 
either LDA and NIS or pyridine and NBS led to oxidation of the lactol to the lactone 
(156), no incorporation of a halogen was apparent by NMR or mass spectrometry. 
When the reaction was repeated under acidic conditions with iodine and acetic acid a 
complex mixture of products was formed. 
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Scheme 2.38: Oxidation of lactol functionality of (157). 
In an novel approach to obtain (163), the ec, p-unsaturated ester (178) (derived 
from (157) in studies towards mycinoic acid 11, section 2-4) was to be cleaved at the 
(157) 
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olefin functionality by use of ozone to give the trihydroxy-aldehyde (163), based upon a 
method of Gensler et all 13. Thus (178) was dissolved in ethyl acetate at -780C and 
treated with ozone to give a pale purple liquid. After destroying excess 03 with 
dimethyl sulfide, the solution became colourless. However, on evaporation of the 
solvents and analysis, no discernable products were isolated. 
Hence it has been shown that a variety of techniques for removal of the 
benzylidene group from 8-lactol (157) resulted in degradation of the products in situ. 
However, treatment with methanol and acid gives the stable acetal (164), which may be 
manipulated to form further derivatives, such as the acetate and methane sulfonate esters 
(167), (168) and (170). The benzylidene protected 5-lactone (156) was also readily 
deprotected by use of acid and methanol to a stable dihydroxy lactone (165). However, 
repeated attempts to form the aldehydes (163) or (83) were unsuccessful. Whilst the 
(x, P -unsaturated ketone (166) could be obtained reproducibly from (142), no further 
derivatisation from this was possible, nor was isolation of the lactone analogue from 
(156). Interestingly, the treatment of (157) with base and either NIS or NBS caused 
oxidation of the lactol to the lactone (156), the proportion of lactone being greater with 
the stronger oxidant NIS. Lysis of the alkene functionality of (178) (section 2.4) by 
ozonolysis returned no identifiable components. The cumplative information suggests 
that (163) is too unstable to be isolated, possibly degrading by a retro-aldol. mechanism, 
whilst (83) was never isolated due to the immediate precursors not being isolated, 
2.4 Studies Towards the Synthesis of Methyl Mycinoate 11 (11) 
One of the aims of the current work was to prepare mycinoic acid Il from the 
bicyclic lactone (82) via the intermediate lactol (157). It has previously been shown75 
that a Wittig chain extension of the lactol (157) gave the unsaturated ester (175). 
Protection of the secondary alcohol as the SEM ether proceeded smoothly but repeated 
attempts to remove the benzylidene group (e. g., with FeC13 on silica; Dowex 
in MeOH 
or catalytic hydrogenation) and eliminate to the 
dienoate (177) had failed; the primary 















Scheme 2.439: Previous studies towards the synthesis of methyl mycinoate J175. 
Hence a different approach was required to remove the benzylidene group and to 
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Scheme 2.40: Proposed approach to mycinoic acid III. 
It was proposed to use (157) as the substrate for the 2 carbon homologation and 
then to eliminate the benzylidene group from (175) to give the dienoate (177) (Scheme 
2.40). An alternative approach was to activate the alcohols in the triol (178) as good 
leaving groups (e. g., acetates) and then to selectively eliminate only the 5-hydroxy 
derivative. One obvious potential flaw with this approach is the need to control the 
reaction conditions such that all three leaving groups are not concomitantly eliminated. 








Treatment of 8-lactol (157) with methyl (triphenylphosphoranylidene) acetate 
gave the desired trans- cc, 0-unsaturated ester (175) as the major product (69%) which 
was readily separated from the cis isomer (180) by column chromatography (Scheme 
2.41). The E-isomer (175) was identified by a characteristic trans olefin coupling 
between 2-H and 3-H of J= 16Hz; the Z-isomer (180) gave a coupling between 2-H and 
3-H of J= 11.5Hz, typical of a cis bond. 
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Scheme 2.41: Wittig chain extension of lactol (157). 
The E-benzylidene protected ester (175) was reacted with LDA in an attempt to 
induce elimination, derived from a technique of Holmes et al. 114, by the mechanism 
shown in Scheme 2.43. 
However under the reaction conditions the preferred pathway involved 
deprotonation of the 7-alcohol followed by a 6-exo-trig cyclisation of the resultant 
alkoxide on C-3 giving the cyclic ethers (181) and (182). The two diastereomers were 
identified by the differences in the IH NMR spectra of the 1OP-H: (181) gave ddd of 
J=127 4.5 and 2Hz at 2.03ppm, which are due to a geminal coupling, and two equatorial 
- axial couplings to 1P-H and 9P-H protons; the minor product (182) also had a peak 
split to ddd, at 2.06ppm (J= 13,6 and 1.5Hz), the J values being typical of a geminal, an 
equatorial - axial (10P-H to lp-H protons) and an equatorial - equatorial 
(100-H to 
9(x-H protons) coupling respectively. 
The 7-alcohol in (175) was then protected with a TMS group, and the reaction 
with LDA was repeated upon the silyl alcohol (183). However, whilst TLC, 
IH NMR 
spectra and MS analysis indicated the alcohol had been protected as a silyl ether and 
(183) was stable for over 24 hours at room temperature in air, the products again were 
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Scheme 2.42: Proposed and actual results of treating the E-ester (175) with LDA. 
Removal of the benzylidene protecting group by treatment of (175) with 
methanol / petrol / HCI(aq) gave the triol (178) in 34% yield. When the reaction was 
repeated on the Z-isomer (180), the corresponding triol (184) was isolated in 69% yield. 
Stirring E-triol (178) in MeOH with 10M aqueous hydrochloric acid at either 
room temperature or 39*C returned starting material quantitatively; heating (178) in 
methanol with Dowex to reflux returned starting material in only 20% yield, but the 
desired elimination product (177) was not characterised by IH or 13C NMR 
spectroscopy, although both (178) (M+ = 232) and (177) (M+ = 214) were tentatively 
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A different elimination route (scheme 2.44) was conceived using the Z-triacetate 
(185), (no more E isomer (178) remained to be reacted with the anhydride) which may 
isomerise during elimination to the E-(x, p-E-y, 8-diunsaturated ester (187). Use of 
dilute aqueous hydrochloric acid and MeOH upon (185) returned starting material 
quantitatively; however heating with DBU in TBF gave products that were apparently 
an impure mixture of diacetates Z-((186))and E-((187)) in a combined yield of 
approximately 31%. The 1H NMR spectra of the mixture is given on page 62; the 
signals at 6.28ppm (dd, J=15.5 and 11Hz) and 6.00ppm (dd, J=15.5 and 9.5Hz) are 
characteristic of trans olefin bonds conjugated to a carbonyl functionality, suggesting 
some conversion of (185) to the E-cc, P-E-y, 8-diunsaturated ester (187), whilst those 
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Scheme 2.44: Formation and derivatisation of Z-triol. 
Due to a lack of further time, no more research into the synthesis towards 
mycinoic acid 11 was undertaken. 
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Figure 2.4: IH NMR spectra (30ONMz) of mixture of triesters Z-((186))and E-((187)). 
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2.5 Conclusions and Future Research 
The summary of the most successful route to the 8-lactol (157) is shown in 
scheme 2.45, giving (157) in 23% yield from lactone (82) in 10 steps. 
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Scheme 2.45: Route and intermediates to fragment A of mycinolide HI. 
Whilst the synthesis of the target mycinamicin aglycone or mycinoic acids was 
not acheived, several novel intermediates towards mycinoic acid H were developed, and 
the addition to (82) of a 4(x-methyl group gave (106), a precursor in the development of 
fragment B (83), in high yield. Many methods of deoxygenation towards an ethyl 
functionality at C(16) to C(17) of (39) were extensively investigated, concluding that 
the problems with the synthesis of intermediate (129) were problably 
due to the lack of 
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stability of the primary radical. The problems encountered in the proposed eliminations 
from a variety of precursors to the target conjugated unsaturated carbonyl compound 
(83) proved insurmountable. 
The two main areas requiring further research are the effective synthesis of the 
ethyl functionality for the C(16)-C(17) portion of the mycinolide and the successful 
formation of fragment A and by closely related studies, a route to mycinoic acid I. 
Further work to obtain the ethyl group of the mycinolide may be undertaken 
with modified xanthate derivatives, as whilst carbon disulfide is toxic, the development 
of activated thionoformates, e. g., PhSC(S)OTf, may enable coupling of the primary 
alcohol of (127) to an aromatic xanthate. The reaction between phosgene and selenol 
gives PhSeC(O)CI115, which may be reacted with diol (127) to form a selenocarbonate; 
treatment of the selenocarbonate with a radical hydride should give (129). 
Whist previous work on silyl derivatives of diol (121) by Robinson75 had been 
unsuccessful, with migration of the silicon groups between hydroxyl funcionalities, 
work recently in the group by Al-Mutairi has enabled stable protection of the alcohol 
groups of (121)116. Subsequent opening of the lactone group to a protected diol (189) 
and protection of the ethanolic alcohol in high yield enabled manipulation of the ring 
hydroxyl. This may allow the deoxygenation step of the ethanolic hydroxyl to give the 
desired C(16) to C(17) ethyl functionality of mycinolide 111 (39) to be undertaken at a 
later stage. 
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Scheme 2.46: AI-Mutairi route silyl protected polyhydroxyl (190) 116. 
None of the elimination techniques to date has succeeded in producing the 
trihydroxy precursor of fragment A (163) or fragment A itself (83). Although an 
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ozonolysis upon the (x, P -unsaturated ester (178) had failed, the triacetate derivative 
(185) (with the hydroxyl groups protected) might give a stable aldehyde functionality 
upon treatment with ozone, which should eliminate with ease in syntheses towards 
fragment A (83) and methyl myinoate 1 (10). Alternatively, the proposed and attempted 
halide introduction into the lactol (157) (schemes 2.37 and 2.38) may be modified by 
use of the 8-lactone (156) as the substrate for addition of the haldide (x to the carbonyl, 
which might be reduced to a lactol with Dibal-H and eliminated to the unsaturated 
aldehyde (83) with zinc and acetic acid, as proposed previously. 
The research towards the synthesis of the methyl ester of mycinoic acid 11 (11) 
might be adapted to allow the formation of fragment C, the 14-hydroxymethyl analogue 
of (11). This might be utilized, as proposed in scheme 2.48, as an alternative pathway 





LG -- 2 
0 
Fragment D 
1) Reformatsky reaction 
2) Removal of P' 
3) Macrocyclisation 
4) Removal of P 
P, P' Protecting groups 
LG Leaving group 







PARTIAL SYNTHESIS OF MYCINOLIDE III AND THE 
MYCINOIC ACIDS 
CHAPTER THREE: 
I Experimental and References 
3 Experimental and References 
3.1 General EXDenmental Details 
Glassware for anhydrous reactions was dried under a positive pressure of 
nitrogen whilst flame-dried with a Bunsen burner. Air or moisture sensitive reagents 
were added via a dropping funnel, Gooch tube, spatula under a fast stream of nitrogen, 
or injected through Suba-SealsO. Syringes, needles and crushed anhydrous 0.4nm 
diameter molecular sieves were kept in a drying oven at 142-144*C before use. 
Acetonitrile, benzene, DCM, diisopropylethylamine, DMF, ether, THF, toluene, 
and triethylamine were used in an anhydrous form unless noted otherwise. Ether and 
THF were redistilled from sodium benzophenone ketyl; benzene and toluene from 
sodium metal; anhydrous DMF was purchased as such; the remainder were redistilled 
from calcium hydride. When required, anhydrous methanol was redistilled from 
magnesium methoxide and iodine; anhydrous acetone was redistilled from magnesium 
sulfate. Petrol was redistilled before use. When purification was required, other 
reagents were treated according to the methods of Perrin and Armerego 117. 
The crude product of the reaction was obtained by adding aqueous sodium 
hydrogen carbonate until pH =8.5 was attained, the organic and aqueous portions 
separated, and the aqueous layer repeatedly extracted with ethyl acetate. The combined 
organic liquors were washed with brine, separated from the brine, dried with anhydrous 
magnesium sulfate, filtered and the solvent evaporated in vacuo to give crude product. 
All TLC were run on Merck silica gel 60F254 on aluminium sheets 0.2mm thick 
in a closed chamber with a saturated atmosphere. Visualisation of TLC plates was by 
either UV light at 254nm, or an aqueous dip of 5%v/v sulfuric acid, 5%w/v ammonium 
molybdate tetrahydrate and 0.2%w/v Ceric sulfate, which when heated showed the 
sample as deep blue colour upon a pale blue background. Dithiane (10) was observable 
with aqueous KMnO4, giving white marks upon a purple background. 
Solvents were removed on a rotary evaporator (a BuchiO 461) under water 
vacuum pressure (=12mmHg); substances of a higher boiling point were removed under 
a vacuum of the range 0.1-2mmHg, using a Javac@ double stage JDX 
120 pump. 
66 
Flash chromatography columns were made with Fluka 0.035-0.070mm diameter 
particles. Samples were pre-dried onto silica, then loaded onto the column wetted with 
petrol, and by eluting with ethyl acetate, petrol and/or methanol, the compounds were 
isolated, according to a method based on the work of Still and co-workersl 18. 
Bulb-to-bulb distillation was performed using a Kugelrbhr distillation apparatus. 
Melting points quoted are uncorrected. These were measured on an 
ElectrothermalO IA6301, of the range 0-360*C. 
IR spectra were run on a double beam continuous wave Perkin ElmerO 881 or a 
Perkin Elmer 1600 FTIR spectrophotometer, the latter marked "*". Solid samples were 
suspended within KBr discs made in a Specac@ 15.011 press at 10 tons pressure; liquids 
were added directly onto desiccated NaCI plates. Values quoted are for bond stretching. 
NMR spectra were recorded at room temperature on a Jeol GNM GX270 FT (1H 
270MHz, 13C 67.8MHz) spectrometer, except where stated when a GX400 FT (1H 
400NMz, 13C 10OMHz) or a Lambda (1H 30OMHz, 13C 75NMz) was used. Samples 
were dissolved in deuteriochloroform with tetramethylsilane as the internal standard. 
Mass spectra were determined on either a double focussing VG 3D8/RS2MS9 
MicromasO (marked "*"), or with a Fisons AutospecO. Samples were submitted in 
CHC13 and/or CDC13, unless otherwise stated. The samples were run via EI, unless 
denoted "Cl" or "FAB". High resolution samples were obtained from the AutospecO. 







HHH an- H 
AcOH 4 A 
(86) (87) 
Acetic acid (30ml) was added to zinc powder (54g, 0.83mol) at O*C, 
immediately prior to addition of (±)cis-7,7-dichlorobicyclo[3.2.0]hept-2-en-6-one 
(86) 
(30g, 0.17mol) over 1.5h. The reaction mixture was heated to 70*C for 2h. On cooling, 
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the suspension was filtered. Potassium carbonate powder and saturated aqueous 
solution were added to the filtrate until the solution became pH 5. The organic layer 
was separated and the aqueous layer extracted with DCM Qx 100ml portions). The 
combined organic layers were washed with distilled water, brine, dried over anhydrous 
magnesium sulfate and filtered. The solvent was evaporated in vacuo, and the product 
distilled at 16mmHg at 60*C to give the bicyclic ketone (87), a clear moderately free - 
flowing liquid, (18.1g, 1.68mol, 99%)119; Rf = 0.54 (ethyl acetate : petrol, 20: 80); 8H 
2.49 (IH, m, 7 P-H), 2.69 (2H, m, 4-H2), 3.32 (1H, m, 7cc-H), 3.48 (1H, m, 1-H), 3.87 
(1H, br m, 5-H) and 5.82 (2H, m, 2-H, 3-H); mlz* 108 (M+, 4%), 95 (49), 91 (24), 83 
















Glacial acetic acid (70ml) and the ketone (87) (27.0g, 0.25mol) were stirred at 
O*C; a mixture of 30% w/v hydrogen peroxide (30ml, 0.29mol peroxide) and acetic 
acid (30 ml) at O*C was added over 3h. Maintaining a temperature of O*C, excess 
saturated aqueous sodium sulfite solution was added, then potassium carbonate 
(aqueous and solid) was added to pH 5. Extraction of the aqueous layer with ethyl 
acetate (4 x 100ml), followed by washing the combined ethyl acetate fractions with 
brine and saturated potassium carbonate, separation from the aqueous layer, drying 
with anhydrous magnesium sulfate, filtration and the solvent evaporation in vacuo 
yielded the lactone (82) (31.03g, =100% yield), a clear, colourless slightly viscous 
liquid which had a pleasant and sweet odour119; Rf = 0.55 (ethyl acetate : petrol, 
50: 50);, umax/cm-1 1620 (C=C), 1770 (C=O) and 3059 (C-H, olefinic); 
8H 2.45 (1H, dd, 
J 18 and 1.5,40-H), 2.72 (2H, m, 8-HI), 2.79 (lH, dd, J 18 and 
9.5,4(x-H), 3.53 (IH, 
68 
m, 5-H), 5.14 (1H, m, 1-H), 5.60 (1H, m, 7-H) and 5.80 (1H, m, 6-H); m1z 124 (M+, 










Lactone (82) (0.124g, 1.0mmol) and tris(dimethylamino)methane (0.2ml, 
1.16mmol) were heated at 75T for 5h with stirring under nitrogen. On cooling, the 
reaction mixture was purified by column chromatography eluting with ethyl acetate : 
petrol (60: 40), yielding the vinylagous carbamate (108), a yellow solid in yellow liquor 
(which could not be recrystallised), (0.88g, 4.92mmol, 49%)65; Rf = 0.53 (ethyl 
acetate); 6H 2.73 (2H, m, 8-H2), 3.09 (6H, s, 2x CH3), 4.24 (1H, dd, J 5.5 and 1.5,5- 
H), 4.99 (1H, m, 1 -H), 5.59 (1H, m, 7-H), 5.71 (1H, m, 6-H) and 7.12 (1H, d, J 1.5,4- 







5% Pd. C 
EtOAc / AcOH 
(115) 
The enamine (108) (179mg, lmmol) was dissolved in ethyl acetate (15ml) and 
acetic acid (lml), and 5% palladium on DegussaO carbon (50mg, 0.0235mmol) added. 
The reaction mixture was stirred under an atmosphere of hydrogen gas. 
23.5ml 
(0.979mmol) of hydrogen was absorbed. The suspension was filtered and evaporated in 
vacuo, to give the crude product (65mg). The solid was purified 
by column 
chromatography using ethyl acetate : petrol (50: 
50), to give the viscous deep brown 
69 
vinylagous carbarnate (115), (167mg, 0.92mmol, 92%); Rf = 0.38 (ethyl acetate: petrol, 
65: 35); (Found: M+, 181.1103. CjOH15NO2 requires M, 181-1103); 10max/cm-1 1627 
(C=C), 1719 (N-H) and 1767 (C=O); 8H 1.71 and 2.01 (6H, m, 6-H2,7-H2,8-H2), 3.01 
(6H, s, 2x CH3), 3.59 (1H, m, 5-H), 4.81 (1H, m, 1-H) and 7.06 (1H, d, J 1.5,4-CH- 
N(CH3)2); 8C 22.91,34.16 and 36.45 (C-6,7,8), 41.56 ((CH3)2), 41.75 (C-5), 82.16 
(C-1), 93.64 (C-4), 146.96 (4--CH-N(CH3)2) and 176.15 (C-3); m1z 181 (M+, 67%), 166 
(5), 152 (44), 138 (15), 136 (20), 124 (8), 111 (13), 97 (37) and 77 (58). 
(±) - cis- 4 P- Hydroxymet hyl - 2-oxabi cycl o [3.3.01 oct-6- en- 3-on e (116) and (±)-cis-4- 
methylen-2-oxabicyclo[3.3.0]oct-6-en-3-one (109) 
0 OH 
000 -ÄY HH LDA / THF HH+ Hm\ 
-1()OC / CH2O(g) 
' uz 
(82) (116) (109) 
n-Butyl lithium (2. Oml of a 2.5M solution in hexanes, 5mmol) was added to 
diisopropylamine (0.9ml, 6.4mmol) in THF (50ml) at OOC, and stirred for 0.5h to 
prepare a solution of LDA. The temperature was then lowered to -78"C. Lactone (82) 
(507mg, 4.09mmol) was added directly by injection and the temperature was allowed to 
reach -10"C for 2h to form the enolate. 
Dried paraformaldehyde was transferred to a dried 2-neck round bottom flask 
and nitrogen pumped over the formaldehyde and out through a glass tube of 0.25 inch 
diameter which had QuickfitO inlet for insertion into the reaction vessel. Nitrogen 
pressure was increased to the maximum rate into the 2-neck flask, which was lowered 
into a silicone bath at 140*C (below the evaporation point of formaldehyde), and the 
glass tube was then inserted into a port of the enolate - containing flask with a pressure 
outlet fitted to the enolate flask. After approximately 2g of formaldehyde 
had passed 
over, the formaldehyde tube was removed, the inlet port was stoppered and the reaction 
flask left under anhydrous conditions at O*C for 3h. 
70 
The reaction mixture, which appeared as a mixture of several compounds by 
TLC analysis, was quenched with 1M hydrochloric acid (approximately 20ml), and 
extracted by the standard method, but for acidic conditions. The crude product was 
purified by column chromatography, eluting with ethyl acetate : petrol (30: 70), to give 
the colourless liquid dialkene (109) (35mg, 0.257mmol, 6%)120; Rf = 0.73 (ethyl 
acetate: petrol, 50: 50); 8H 2.68 (2H, m, 8-H2), 3.97 (1H, m, 5-H), 5.04 (1H, m, 1 -H), 
5.47 (1H, m, 7-H), 5.62 (1H, d, J 2,4-CHH), 5.71 (1H, m, 6-H) and 6.12 (1H, d, J 2,4- 
CHHD; m/z* 136 (M+, 49%), 108 (61), 107 (68), 79 (100) and 77 (58). 
Further elution with ethyl acetate : petrol (60: 40) gave the alcohol (116) as a 
clear liquid (406mg, 2.64mmol, 65%); Rf = 0.25 (ethyl acetate: petrol, 50: 50); (Found: 
M+, 154.0635. C8H1003 requires M, 154.0630); 'Umax/cm-1 1764 (C=O) and 3449 (H- 
0); 5H 2.63 (lH, m, 4-H), 2.72 (2H, m, 8-H2), 3.47 (lH, m, 5-H), 3.88 (lH, dd, J 11 
and 4.5,4-CHHOH), 4.02 (1H, dd, J 11 and 4.5,4-CHHOH), 4.87 (1H, br s, 4- 
CH20H), 5.17 (1H, m, 1-H), 5.63 (1H, m, 7-H) and 5.79 (1H, m, 6-H); 6C 39.43 (C-8), 
48.70 (C-5), 49.84 (C-4), 62.54 (4-CH20H), 83.27 (C-1), 129.47 (C-7), 131.05 (C-6) 
and 179.06 (C-3); m1z 154 (M+, 6%), 136 (12), 124 (100), 108 (18), 107 (19) and 106 
(22). 










0 Him ý)z mH 
(1-09) 
The alcohol (116) (3 1 Omg, 2.5mmol) was dissolved in pyridine (1 Oml) at room 
temperature and methanesulfonyl chloride (1.5ml, 19.4mmol) was added with stirring, 
without allowing the temperature to rise above 18"C. After 2.5h 
dilute hydrochloric 
acid (50ml) was added to make the sys-tem acidic and extracted as normal. 
The crude 
product was purified by column chromatography (using ethyl acetate : petrol, 
30: 70) to 
71 
yield the cc, 0 unsaturated lactone (109) (60mg, 0.441mmol, 18%). Spectral data as 
before. 
Further elution using ethyl acetate : petrol (50: 50), gave the mesylate (117) 
(270mg, 1.16mmol, 47%) as fluffy white crystals; mp 70-72*C, (from carbon 
tetrachloride); Rf = 0.50 (ethyl acetate : petrol, 50: 50); (Found C, 46.8; H, 5.2; S, 
13.5%; [MH]+, 233.0482. CgH1205S requires C, 46.5; H, 5.2; S, 13.8%; MH, 
233.0484); 'umax/cm-1 1361 and 1170 (S=O) and 1765 (C--O); 8H 2.75 (2H, m, 8-H2), 
2.81 (1H, td J4 and 2,4-H), 3.05 (3H, s, CH3), 3.55 (1H, ap dtd, J 6.5,4 and 2,5-H), 
4.52 (2H, m, 4-CH2), 5.19 (1H, m, 1-H), 5.64 (1H, m, 7-H) and 5.84 (1H, m, 6-H); 8C 
37.43 (C-8), 39.34 (C-5), 45.69 (CH3), 49.30 (C-4), 69.17 (4-CH20MS), 82.89 (C- 1), 
130.05 (C-7), 130.48 (C-6) and 175.60 (C-3); m1z (CI) 233 ([Mllil+, 100%), 219 (28), 
151 (11), 137 (97), 136 (22), 119 (30), 93 (71) and 91 (46). 
Repeated synthesis of exocyclic alkene (109) 
0 oms 0 
0 ""'? 0 -, DBU/TBF, HHAHH 
R 
(117) (109) 
The mesylate (117), (116mg, 0.50mmol) was dissolved in THF (30ml) with 
DBU (0.1ml, 0.67mmol), and heated to reflux for 1.25h. After cooling, the reaction 
mixture was poured into dilute hydrochloric acid and extracted as for the lactone 
(82). 
No further purification of the methylene lactone (109) was required, (70mg, >100% 
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The exocyclic alkene (109) (70mg, 0.51mmol), in ethyl acetate (25ml) and 
glacial acetic acid (0.5ml), was stirred with 10% palladium on carbon (35mg, 
0.0329mmol) under an atmosphere of hydrogen gas for 0.75h, (25.2ml, 1.05mmol H2 
taken up). The suspension was then filtered, the flask rinsed with ethyl acetate : petrol 
(50: 50) (3 x 20ml), and evaporated in vacuo. The crude solid was then purified by 
column chromatography, using ethyl acetate : petrol (20: 80), to give the saturated 
lactone (110), as a gum (55mg, 0.39mmol, 77%); Rf = 0.46 (ethyl acetate : petrol, 
30: 70); (Found [MHI+, 141.0910. C8H1302 requires MH, 141.0916); 8H 1.21 (3H, d, J 
7,4-CH3), 1.79 (6H, m, 6-H2,7-H2,8-H2), 2.79 (1H, m, 5-H), 2.84 (1H, dq, J 8.5 and 
7,4-H) and 4.87 (1H, td, J 5.5 and 1.5,1-H); 8C 11.25 (4-CH3), 24.27,25.89 and 32.82 
(C-6, C-7, C-8), 38.15 (C-5), 44.11 (C-4), 84.32 (C-1) and 179.66 (C-3); m1z (CI) 141 




LDA / MeI 




LDA (5mmol) in THF (40ml) was made by the same method as for synthesis of 
(116). The temperature was then lowered to -78T. The lactone (82) (478mg, 
3.85mmol) was added and stirred for lh, to forin the enolate. Methyl 
iodide (0.3ml, 
4.82mmol) was added and the reaction mixture allowed to warm to 
O*C over 1.2h. 'ne 
reaction was quenched with 3M hydrochloric acid (10ml) and extracted as usual. 
The 
residue was not purified, as the 
IH NMR and MS spectra of 4p-methyl lactone (107) 
73 
corresponded with previous data, (530mg, 3.84mmol, 99%)65; Rf = 0.56 (ethyl acetate: 
petrol, 25: 75); 5H 1.38 QH, d, J 7.5,4-CHA 2.56 (1H, qd, J 7.5 and 2,4-H), 2.70 (2H, 
m, 8-H2), 3.16 (1H, m, 5-H), 5.16 (1H, m, 1-H), 5.62 (1H, m, 7-H) and 5.78 (lH, m, 6- 
H); m/z* 13 8 (M+, 14%), 123 (2), 109 (14), 79 (5 1) and 77 (17). 
(±)-cis-4(x-Methyl-2-oxabicyclo[3.3.0]oct-6-en-3-one (106) and (±)-cis-40-Methyl-2- 
oxabicyclo[3.3.0]oct-6-en-3-one (107) 
000 
0 1) TIIF / LDA 00 
-780C to OT HHHH+HH 
2) OT to -78*C H20 / HCI(aq) 
(107) (106) 98 2 (107) 
LDA (1.1 mmol) was prepared as previously and the temperature was lowered to 
-78"C. The 40-methyl lactone (107) (138mg, lmmol) was added and over 1.25h 
warmed to =0"C, recooled to -78*C, and water (0.9ml) was added. After 1-5h the 
temperature had risen to -50*C, then the reaction mixture was warmed to room 
temperature and the crude product extracted as for (107); yielding the 4(x-methyl 
lactone, a pale yellow very viscous liquid (0.14g, = 100% yield). The crude product was 
purified by column chromatography (using ethyl acetate : petrol ratios, 20: 80) to yield 
as a colourless liquid the 4(x-methyl lactone (106) (136mg, 0.986mmol, 99%; with 96% 
de, by comparison of integrals due to methyl protons on the 1H NMR spectra); Rf = 
0.50 (ethyl acetate : petrol, 25: 75); (Found: M+, 138.0676. C8HI002 requires M, 
138.0681);, umax/cm-1 1764 (C=O) and 3061 (C=C); 80.27 (3H, d, J7.5,4-CH3), 2.71 
(2H, m, 8-H2), 2.85 (1H, dq, J9 and 7.5,4-H), 3.54 (1H, m, 5-H), 5.02 (1H, m, I-H), 
5.66 (1H, m, 7-H) and 5.83 (IH, m, 6-H); 8C 11.90 (4-CH3), 37.28 (C-5), 
39.59 (C-8), 
50.51 (C-4), 80.52 (C- 1), 127.29 (C-7), 130.57 (C-6) and 178.72 (C-3); m1z 138 (M+, 




H "' , wH AcOH / 120h /Aý H H 2) AC20 / NaOAc /A R 
(82) AcO OAc 
(122) 
Paraformaldehyde (10.0g, 333mmol) was added to a mixture of concentrated 
sulfuric acid (2.5ml) and glacial acetic acid (60ml), and heated to reflux for 0.75h, 
forming a transparent and colourless solution. After cooling to 25*C, the lactone (82) 
(10g, 80.6mmol) in acetic acid (10ml) was added and the reaction heated at 75*C for 5 
days. Sodium acetate (10.0g, 122mmol) in AC20 (10ml, 106mmol) was added and the 
solution heated to reflux for 5h. On cooling, the reaction was raised to pH 5 with 
saturated aqueous potassium carbonate and extracted as usual. The dried residue was 
distilled with bulb-to-bulb apparatus, yielding the diacetate (122), a clear and colourless 
liquid; (17.314g, 67.6mmol, 84%); bp 150-175*C/O. lmmHg77; Rf = 0.38 (ethyl acetate 
: petrol, 65: 35); 10max/cm-1 1740 (C=O acetates) and 1775 (C=O lactone); 5H 1.99 and 
2.03 (each 3H, each s, each 02CCH3), 2.48 (dd, J 18 and 2,4P-H), 2.85 (dd, J 18 and 
11,4oc-H), 2.70,2.31 and 2.16 (4H, m, 6-H, 5-H, 8-H2), 3.98 (2H, m, 6-CH2), 4.98 
(2H, m, 1-H, 7-H); m1z (CI) 257 ([MHI+, 2%), 243 (1), 227 (2), 215 (20), 198 (16), 197 












The diacetate, (122) (5.85g, 23mmol) in dry distilled MeOH (10ml) was added 
to a stirred solution of sodium methoxide at 
O*C, (prepared from sodium (0.38g, 
17mmol) and dry distilled MeOH (20ml) in an ice bath). 
The reaction was stirred for 
75 
2h, warming to room temperature; glacial acetic acid was then added until pH 4 was 
obtained and the solvent evaporated in vacuo. The crude product was purified by 
column chromatography eluting with MeOH : ethyl acetate (10: 90), yielding the diol 
(121), a very viscous colourless liquid, (2.86g, 16.6mmol, 74%)121; Rf = 0.28 
(methanol : ethyl acetate, 10: 90); Umax/cm-' 1762 (C=O) and 3400 (0-H); 6H 
((CD3)2CO) 1.94 (2H, rn, 8-H2), 2.32 (1H, m, 5-H), 2.47 (1H, d, J 15,40-H), 2.76 (1H, 
m, 6-H), 2.79 (1H, dd, J 18.5 and 10.5,4cc-H), 3.48 (2H, m, 6-CH2), 4.09 (1H, m, 7-H), 
4.93 (1H, td, J7 and 2.5,1-H); m1z ((CD3)2CO, Cl) 173 ([MH]+, 77%), 155 (44), 138 
(16), 137 (100), 125 (63), 109 (25) and 91 (29). 














To a solution of the diol (121), (121mg, 0.703mmol) in dry DMF (20ml) was 
added CSA (20mg, 0.0862mmol) and benzaldehyde dimethyl acetal (0.25ml, 
1.67mmol). The reaction mixture was heated at 45*C for 1.75h at 20mmHg pressure 
with an air cooled reflux condenser. The reaction mixture was extracted 
by the standard 
procedure, followed by drying at 0.2mmHg for 1.5h at =40*C 
(removing the DMF) to 
give the acetal protected lactone (126) as a cream coloured solid, 
(190mg, >100%),, 
which corresponded with previous data reported; Rf = 
0.21 (ethyl acetate : petrol, 
50: 50); mp 176-179*C (from ethyl acetate and petrol), 
(lit. 75,175-177*C); 8H 1.91 (2H7 
m, 8-H2), 2.46 and 2.74 (4H, m, 4-H2,5-H, 
6-H), 3.65 (1H, m, 7-H), 3.81 (1H, t, J 10.5, 
6-CHP), 4.46 (1H, dd, J 10.5 and 4,6-CHoc), 4.94 (1H, td, J7 and 
4.5,1-H), 5.51 (IH, 
s, O-CH-0), 7.39 (3H, m, Ar-H3) and 
7.50 (2H, m, Ar-H2); m1z 260 (M+, 44%), 259 
(33), 207 (7), 183 (7), 155 (10), 154 (177), 126 (23), 125 

















Lithium aluminium hydride (63mg, 1.67mmol) was added to TBF (5ml) at OT. 
The benzylidene protected diol (126) (403mg, 1.54mmol) in TBF (4ml) was added to 
the reducing system and the reactants were stirred for 0.25h at =(-5 to 8)OC. The 
reaction was quenched with saturated Rochelle salt solution, (50ml) and then extracted 
as usual. The protected diol (127) was isolated (430mg, >100% possible crude yield), 
but the NMR spectra, mp and MS data were as expected. Rf = 0.29 (ethyl acetate); mp 
123-126T (from ethyl acetate and petrol), (lit. 75,129-131"C); 8H 1.55 (2H, m, 8'-H2), 
1.72 (1H, ddd, J 13,11 and 4.5,9P-H), 1.96 (2H, m, 6-H, 7-H), 2.63 (1H, dt, J 13 and 
7.5,9oc-H), 3.53 (lH, td, J 10.5 and 7.5,1-H), 3.65 (1H, dt, J 10 and 2.5,9'-H), 3.71 
(lH, t, J 10.5,5P-H), 3.89 (lH, dt, J 10 and 4,9'-H), 4.35 (1H, m, 8-H), 4.37 (lH, dd, J 
10.5 and 4.5,5(x-H), 5.51 (1H, s, 3-H), 7.35 QH, m, Ar-H3) and 7.50 (2H, m, Ar-H2); 
m1z 264 (M+, 17%), 263 (19), 245 (5), 233 (4), 189 (31), 172 (28), 146 (34), 121 (43) 






















To dried and distilled ether (50ml) was added with stirring, imidazole (476mg, 
6.99mmol) and the diol (127) (1621mg, 6.14mmol). On cooling to -78"C, phenyl 
chlorothionoformate (0.90ml, 6.50mmol) was added over 0.3h, and maintained at this 
temperature for 1.5h. The opaque deep yellow reaction mixture was raised to -12*C for 
=12h, then allowed to attain =2*C for =12h, and recooled to -12*C and stirred for a 
further 7h. The usual process for extraction gave the crude product (2.88g), which was 
purified by column chromatography, eluting with ethyl acetate : petrol (20: 80) to give 
the phenoxythiocarbonate (128), a yellow viscous oil, (2210mg, 5.53mmol, 90%)75; Rf 
= 0.32 (ethyl acetate : petrol, 30: 70); 8H 1.60 (2H, m, 8'-H2), 1.89 and 2.11 (3H, rn, 6- 
H, 7-H, 9ß-H), 2.29 (lH, br s, OH), 2.65 (lH, dt, J 13.5 and 7.5,9cc-H), 3.51 (lH, td, J 
10 and 7.5, I-H), 3.75 (1H, t, J 10.5,5P-H), 4.26 (1H, m, 8-H), 4.43 (1H, dd, J 10.5 and 
4.5,5oc-H), 4.58 (2H, t, J 6.5,9'-H2), 5.53 (1H, s, 3-H), 7.14 (2H, m, Ar-H2), 7.39 (6H, 
m, Ar-H6) and 7.54 (2H, m, Ar-H2); m1z 400 (M+, 1%), 307 (1), 306 (2), 294 (1), 246 
(20), 140 (13), 123 (25), 107 (28), 105 (48) and 94 (100). 
Attempt to optimise the preparation of (±)-trans-7(x - (2- 
phenoxythiocarbonyloxyethyl)-3-phenyl-2,4-dioxabicyclo[4.3.0]nonan-8cc-oI (128) 
OH PhOC(S)O PhOC(S)O 91 
PhOC(S)CI 
HO Pyridine HO PhOC(S)q - -H H H TBF HH9 7 
-78'C to OT /++ 
N-Hydroxy- z 20 3 04 
00 succinimide 000 *ý 
0T 
Ph 
Ph Ph Ph (132) 
(127) (128) (130) 
To THF (25ml) was added with stirring, pyridine (0.5ml, 6.18mmol), 
N- 
hydroxysuccinimide (catalytic amount) and the diol (127) (430mg, 1.63mmol) and the 
mixture was cooled to -78*C. Phenyl chlorothionoformate 
(0.3ml, 2.17mmol) was 
added over 0. lh. The opaque deep yellow reaction mixture attained 
O*C over 3h, and 
by TLC analysis some of the desired product and some 
diphenoxythiocarbonate ester 
were formed, but no starting material remained. 
The usual extraction process followed. 
The crude extract was purified by column chromatography, eluting 
initially with ethyl 
78 
acetate : petrol (10: 90), to give (±)-trans-8(x-(phenoxythiocarbonyloxy)-7(x-(2- 
phenoxythiocarbonyloxyethyl)-3-phenyl-2,4-dioxabicyclo[4.3.0]nonane (130) (484mg, 
0.902mmol, 55%); Rf = 0.68 (ethyl acetate: petrol, 30: 70); (M+ not found); umax/cm-1 
1204 and 1277 (2 x C=S); 8H 2.11 (5H, m, 6-H, 7-H, 8'-H2 and 9P-H), 2.95 (1H, dt, J 
14.5 and 7.5,9(x-H), 3.65 (1H, td, J 10 and 8,1-H), 3.83 (1H, t, J 10.5,5P-H), 4.50 (IH, 
dd, J 10.5 and 4,5a-H), 4.56 (2H, m, 9'-H2), 5.56 (1H, s, 3-H), 5.63 (1H, m, 8-H), 7.11 
(4H, m, Ar-H4), 7.26, (3H, m, Ar-H3), 7.38 (6H, m, Ar-H6) and 7.53 (2H, m, Ar-H2); 
m/z (CI) 535 ([M-14]+, 1%), 459 (1), 441 (2), 432 (2), 431 (9), 413 (4), 337 (28), 295 
(8), 277 (92), 259 (98), 139 (37) and 105 (100); molecular ion not found. 
Further elution with ethyl acetate : petrol (20: 80) gave the colourless liquid 
cyclic ether (132) (24mg, 0.0976mmol, 6%); Rf = 0.28 (ethyl acetate : petrol, 25: 75); 
(Found M+, 246.1257. C15H1803 requires M, 246.1256); 8H 1.77 and 2.17 (5H, m, 6- 
H, 7-H, 8'-H2,9P-H), 2.53 (1H, dt, J 12 and 7,9(x-H), 3.50 (1H, ddd, J 12,10.5 and 6.5, 
1-H), 3.78 (IH, t, J 10.5,5P-H), 3.89 (2H, m, 9'-H2), 4.42 (1H, dd, J 10.5 and 4,5a-H), 
4.47 (1H, m, 8-H), 5.50 (1H, s, 3-H), 7.10 (3H, m, Ar-H3) and 7.41 (2H, m, Ar-H2); 8C 
30.11 (C-8'), 37.00 (C-9), 41.03 and 45.61 (C-6, C-7), 67.38 (C-9'), 72.13 (C-5), 79.94 
(C-8), 80.94 (C-1), 101.99 (C-3) and 126.24 128.34 128.99 and 137.99 (C-aromatics); 
m1z 246 (M+, 23 %), 245 (14), 140 (11), 139 (19), 123 (26) 105 (3 8) and 94 (100). 
Lastly, elution with ethyl acetate : petrol (25: 75), returned the desired 
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Phenoxythiocarbonate (128) (172.5mg, 0.431mmol) in dried benzene 
(45ml) 
was heated to reflux for 0.2h under nitrogen. 
AIBN (catalytic quantity) was added 
79 
followed, under continuing reflux, by tri-n-butyltin hydride (0.13ml, 0.483mmol) over 
0.1h. Characteristic bubbling of this reaction was seen, and heated to reflux for 3h. The 
reaction mixture was evaporated in vacuo. Purification by column chromatography, 
initially eluting with ethyl acetate : petrol (5: 95) to remove tin-containing compounds, 
then with 20: 80 eluting the alcohol (129) as a dry white flaky solid, (80mg, 0.323mmol, 
75%); Rf = 0.60 (ethyl acetate : petrol, 50: 50); mp 84-86*C (from carbon tetrachloride 
and petrol), (lit. 75,89-9 1 "C); 8H 0.97 QH, t, J 7.5,9'-H3), 1.45 (5H, m, 8'-H2,7-H, 9p- 
H, 6-H), 2.67 (1H, dt, J 13.5 and 7,9(x-H), 3.51 (IH, td, J 10 and 7.5,1-H), 3.76 (1H, t, 
J 10.5,5P-H), 4.31 (1H, m, 8-H), 4.45 (1H, dd, J 10.5 and 4,5(x-H), 5.52 OH, s, 3-H), 
7.36 (3H, m, Ar-H3) and 7.51 (2H, m, Ar-H2); m1z 248 (M+, 14%), 247 (15), 124 (9)5 
121 (10), 108 ( 12)7 107 (100) and 105 (44). 
(±)-trans-7(x-Ethyl-3-phenyl-2,4-dioxabicyclo[4.3.0]nonan-8-one (142) 
HO 
.1z0 -HI HF H 
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00 
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To DCM (5ml) under an inert atmosphere were added anhydrous crushed 
molecular sieves of 0.4nm diameter (approximately 0.5g) and pyridinium dichromate 
(70mg, 0.185mmol). Alcohol (129) (30mg, 0.121mmol) in DCM (5ml) and added 
dropwise over 0.25h. The reaction mixture was allowed to stir for 2.25h at room 
temperature, during which time the suspension blackened. The contents of the flask 
were then filtered through anhydrous magnesium sulfate, FlorisilO 
(magnesium silicate 
60-100 mesh) and Celite@, and the reaction flask rinsed with DCM 
(8 x 10ml), and 
likewise passed through the filter system; the combined organic phases were evaporated 
in vacuo. The crude cyclopentanone (142) was a white solid, which 
did not require 
further purification (22mg, 0.894mmol, 74%); Rf = 0.71 
(ethyl acetate : petrol, 30: 70); 
mp 71-72"C (from ethyl acetate and petrol), (lit. 
75,70-72*C); 8H 0.95 (3H, t, J 7.5,9'- 
H3), 1.73 and 2.17 (4H, m, 6-H, 7-H, 8'-H2), 2.43 (1H, dd, J 17.5 and 
11.5,9P-H), 2.73 
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(1H, dd, J 17.5 and 7,9a-H), 3.97 (1H, t, J 10.5,5P-H), 4.04 (1H, m, 1-H), 4.53 (1H, 
dd, J 10.5 and 4,5oc-H), 5.74 (1H, s, 3-H), 7.37 (3H, m, Ar-H3) and 7.52 (2H, m, Ar- 
H2); m/z 246 (M+, 32%), 245 (17), 177 (12), 155 (11), 120 (10), 112 (14), 107 (100) 
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The phenoxythiocarbonate (128) (400mg, 1.00mmol) was treated in the same 
way as the cyclopentanol (129) with PDC (624mg, 1.65mmol) and anhydrous crushed 
molecular sieves to give a pale cream solid (333mg, 0.837mmol, 84%). Crystallisation 
from carbon tetrachloride and petrol gave the ketone (141) (174mg, 0.437mmol, 44%) 
as a white solid; a further 121mg (0.304mmol, 30%) was isolated from the filtrate; thus 
a total of 295mg, 0.741mmol, 74% was obtained; Rf = 0.53 (ethyl acetate : petrol, 
30: 70); mp 116-117*C (ftom, carbon tetrachloride and petrol); (Found C, 66.4; H, 5.94; 
S, 7.78%; M+, 398.1175. C22H2205S requires C, 66.3; H, 5.56; S, 8.05%; M, 
398.1188); l0max/cm-l 1202 (C=S) and 1699 (C=O); 8H 2.18 (4H, m, 6-H, 7-H, 8'-H2), 
2.51 (1H, dd, J 17 and 11,9P-H), 2.81 (1H, dd, J 17 and 7,9a-H), 3.97 (1H, t, J 11,5p- 
H), 4.05 (1H, m, 1 -H), 4.59 (1H, dd, J 11 and 
4,5cc-H), 4.61 (2H, m, 9'-H2), 5.71 (IH, 
s, 3-H), 7.10 (2H, m, Ar-H2), 7.29 (1H, m, Ar-H), 7.38 
(5H, m, Ar-H5) and 7.52 (2H, 
m, Ar-H2); 8C 26.44 (C-8'), 43.09 (C-9), 45.60 and 
47.70 (C-6, C-7), 71.34 and 71.78 
(C-5, C-9'), 78.41 (C-1), 102.53 (C-3), 121.88,126.12,126.67,128.41,129.23,129.581 
137.46 and 153.31 (aromatics), 194.85 (C-5) and 211.08 
(C-8); m1z 398 (M+, 2%), 292 
247 (3), 246 (20), 245 (100), 141 (79)q 139 (38), 138 (17), 105 (45) and 
97 (87). 
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The ketone (141) (267mg, 0.671mmol) was heated to reflux with nBu3SnH (0.23ml, 
0.855mmol) and AIBN (=30mg) in MeCN (50ml) for 6.25h. On cooling, petrol (=50ml) 
was added and the biphasic system stirred for =14h. The liquids were separated, the 
acetonitrile portion extracted with more petrol (2 x =50ml) and the acetonitrile evaporated 
in vacuo. Purification by column chromatography (eluting with ethyl acetate : petrol, 















Sodium hydride (27mg, =-16.4mgNaH, 0.674mmol, 60% dispersed in mineral oil) 
was washed twice with hexane, and TBF (10ml) added plus 18-crown-6 (catalytic quantity) 
and stirred for 0.4h, then cooled to O*C. Diol (127) (160mg, 0.606mmol) in TBF (30ml) 
was added to the reaction mixture, allowed to reach room temperature and stirred 
for 0.5h. 
To the reaction was added carbon disulfide (0.038ml, 0.632mmol) and stirred 
for 2.25h. 
Finally, methyl iodide (0.039ml, 0.626mmol) was added. After 2h, no starting material was 
apparent by TLC analysis, so the usual extraction procedure was performed. 
The impure 
product (143) (201mg, 0.568mmol, 94%) was an orange 








(104mg 0.294mmol) was used in an impure state in a subsequent reaction, whilst 97mg was 
purified by column chromatography (eluting with ethyl acetate : petrol, 30: 70) to give a 
pale orange liquid (143) (36mg, 37% of contaminated product added to flash 
chromatography column); Rf = 0.44 (ethyl acetate : petrol, 30: 70); (M+ absent; Found 
[N4H-108]+, 247-1335. C17H2304S (MH-108 (-CH3SC(S)OH)) requires, 247.1334); 
uma,, /cm-l 700 (C-S) and 1226 (C=S); 8H 1.54 (1H, m, 8'-H), 1.69 (1H, ddd, J 13.5,10.5 
and 4,6-H), 1.85 (1H, m, 8'-H), 1.94 (1H, br s, 8-OH), 1.99 (1H, m, 9P-H), 2.16 (1H, m, 7- 
H), 2.58 (3H, s, CHA 2.67 (1H, dt, J 13.5 and 7.5,9oc-H), 3.51 (1H, td J 10.5 and 7.5,1- 
H), 3.74 (1H, t, J 10.5,5P-H), 4.29 (1H, m, 8-H), 4.41 (1H, dd, J 10.5 and 4,5(x-H), 4.67 
(2H, t, J 6.5,9'-H2), 5.51 (1H, s, 3-H), 7.36 (3H, m, Ar-H3) and 7.50 (2H, m, Ar-H2); 5C 
19.18 (CH3), 25-43 (C-8'), 39.59 (C-9), 40.42 and 43-59 (C-6, C-7), 69.27 (C-8), 71.97 (C- 
9'), 72.99 (C-5), 80.96 (C-1), 102.07(C-3), 126.26,128.29,128.99 and 138.01 (aromatics) 
and 216.01 (C=S); m1z (CI) 355 [MH]+, (41%), 307 (5), 248 (15), 247 (71), 246 (9), 245 
(14), 231 (15), 169 (23), 141 (55) and 123 (100). 
Reduction of xanthate (143) to form the cyclopentanol (129) 
OC(S)SCH3 
HO HO 
H 'BU3SnH HH HPw 
-->- PhH / AIBN 
zA 




The crude xanthate (143) (104mg, 0.294mmol) was reacted with tri-n-butyl tin 
hydride (0.15ml, 0.558mmol) and AIBN (catalytic quantity) in benzene (25ml) at reflux for 
2.5h, by the same manner as the phenoxythiocarbonate (128). Post column 
chromatography, the ethyl derivative (129) was obtained, 
data as previously reported 
(29mg, 0.117 mmol, 40%). Treatment of (14 3) with triphenyl tin hydride returned the 
cyclopentanol (129) in 43% yield after purification 
by column chromatography. 
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The column-chromatographed xanthate (143) (35mg, 0.0989mmol) was likewise 
treated, but post purification returned less product, (129) (3mg, 0.0121mmol, 12%). 







Dibal-H / THF 




-\I 5 -- H 
0 )", 0 
Ph 
(149) 
To a stirred solution of the lactone (126) (140mg, 0.538mmol) in THF (20ml) at 
-78*C was added Dibal-H (0.55ml of 1M solution, 0.55mmol) over 0.1h. The reaction 
mixture was maintained at -780C for 0.5h, then the temperature was allowed to rise to 
room temperature over 3.75h. As no change in TLC value from starting material was 
visible at any stage, the reaction was quenched with Rochelle salt solution (5ml), and 
extracted as usual. The residue was purified by column chromatography eluting with 
ethyl acetate : petrol (50: 50), yielding the lactol (149) (120mg, 0.458mmol, 74%), as a 
white solid, which exists as two isomers in 58: 42 ratio, but also contains approximately 
11 % starting material, which proved impossible to separate. Rf = 0.42 (ethyl acetate 
petrol, 65: 35); (Found: M+, 262.1199. C15H1804 requires M, 262.1206); Umax/cm-1 
780 (C-0, acetal), 959 (C-0, lactol) and 3398 (0-H). MajOr isomer, 8H 1-91 (2H, M, 8- 
H2), 2.27 and 2.64 (4H, m, 4-H2,5-H, 6-H), 3.55 (1H, m, 7-H), 3.76 (1H, t, J 10.5,6- 
CH20), 4.42 (1H, dd, J 10.5 and 4,6-CH2(x), 4.67 (1H, m, 1-H), 5.48 (1H, s, O-CH-0), 
5.70 (1H, dd, J5 and 1.5,3-H), 7.36 QH, m, Ar-H3) and 7.48 (2H, m, Ar-H2); 8C 36.36 
(C-8), 37.49 (C-4), 39.76 (C-5), 46.92 (C-6), 71.70 (6-CH2), 79-08 (C- 1), 81-83 (C-7), 
100.49 and 101.72 (0-CH-0, C-3) and 126.23,128.27,128.89 and 
137.80 (aromatics). 
Minor isomer, 8H 1.91 (2H, m, 8-H2), 2.27 and 2.64 (4H, m, 4-H2,5-H, 6-H), 3.55 (1H, 
m, 7-H), 3.76 (1H, t, J 10.5,6-CHA, 4.42 (1H, dd, J 
10.5 and 4,6-CH2(x), 4.67 (1H, 
m, 1-H), 5.49 (1H, s, O-CH-0), 5.64 (1H, m, 
3-H), 7.36 (3H, m, Ar-H3) and 7.48 (2H, 
m, Ar-H2); 8C 36.46 (C-8), 39.03 (C-4), 
40.11 (C-5), 45.49 (C-6), 72.17 (C-9), 81.18 
(C-1), 81.40 (C-7), 101.07 (C-10), 101.86 (C-3) and 126.15,128-21,128.89 and 
137.80 
84 
(aromatics). m/z 262 (M+, 41%), 261 (23), 260 (10), 244 (2), 190 (10), 156 (4), 121 (4), 
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n-Butyl lithium (0.5ml of a 2.5M solution in hexanes, 1.25mmol) was added to 
0-phenylethylamine (1.5ml, 1.19mmol) in THF (20ml) at -78*C, stirred for 0.5h and 
allowed to warm to 8"C, giving a deep orange-red coloured solution of the amide anion. 
The temperature was lowered to -78*C, and lactone (126) (260mg, 1.00mmol) added. 
The reaction was allowed to reach room temperature and maintained for 3.25h at this 
temperature. As no difference compared to starting material was noted by TLC, the 
reaction was heated to 50*C for 15h; however, again no change in Rf was noted, thus 
the reaction was cooled and extracted. Flash chromatography with ethyl acetate yielded 
the amide (150), (223mg, 0.585mmol, 59%), an off-white solid; Rf = 0.51 (100% ethyl 
acetate); mp 180-181'C (from carbon tetrachloride, chloroform and petrol); (Found 
C, 
72.2; H, 7.20; N 3.67%; M+, 381.1942. C23H27NO4 requires C, 72.4; H, 7.13; N, 
3.67%; M, 381.1940); Umax/cm-1 1559 and 1555 (N-H, bending), 1617 (C=O), 3322 (N- 
H) and 3404 (OH); 8H 1.77 and 1.88 (3H, m, 6-H, 7-H, 
9P-H), 2.13 (1H, dd, J 14 and 
3.5,8'-H), 2.58 (2H, m, 12'-H2), 2.77 (1H, m, 9cc-H), 2.79 (1H, m, 8'-H), 
2.97 (IH, m, 
8-OH), 3.53 OH, m, 1-H, 1 l'-H2), 3.69 (1H, t, J 10.5,5P-H), 
4.28 (1H, dd, J 10.5 and 
4,5(x-H), 4.31 (1H, m, 8-H), 5.49 (1H, s, 3-H), 5.76 (1H, br s, N-H), 
7.28 (2H, m, Ar- 
H2), 7.33 (6H, m, Ar-H6) and 7.49 (2H, m, Ar-H2); 8C 34.36,35.46 and 
38.81 (C-8', C- 
11 15 C- 12'),, 40.41 (C-7), 40.57 (C-9), 44.21 (C-6), 68.94 (C-8), 71.71 
(C-5)7 80.54 (C- 
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1), 102.08 (C-3), 126.26,126.65,128.27,128.70,128.80,128.94,138.02 and 138.54 
(aromatics) and 172.89 (C-9'); m1z 381 (M+, 44%), 275 (7), 261 (16), 259 (14), 246 
(11) 219 (63), 203 (11), 202 (16), 163 (35) and 104 (100). 
(±)-cis-2-Oxabicyclo[3-3.0]oct-6-en-3ý-oI (153) 
oý 
-X -H uz 
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Dibal-H (1.3ml of a LOM solution, 1.30mmol) was added to lactone (82) 
(149mg, 1.20mmol) in ether (4ml) at -780C. The reaction was stirred at -780C for 3.5h, 
then quenched with water, acidified with 1M sulfuric acid (2ml) and extracted as 
normal except using ether. Purification by column chromatography, eluting with ethyl 
acetate : petrol (30: 70), yielded the lactols (153), (125mg, 0.992mmol, 82%), as two 
isomers in a ratio of 66: 34; Rf = 0.42 (ethyl acetate: petrol, 25: 75)119; i)ma,, /cm-1 3387 
(0-H). 8H Major isomer, 1.82,2.10 and 2.56 (4H, m, 4-H2,8-H2), 3.35 (1H, m, 5-H), 
4.78 (IH, m, I-H), 5.41 (1H, m, 3-H), 5.55 (2H, m, 6-H, 7-H) and 5.78 (1H, m, O-H); 
minor isomer, 8H 1.82,2.10 and 2.56 (4H, m, 4-H2,8-H2), 3.35 (1H, m, 5-H), 4.78 (1H, 
m, 1-H), 5.26 (IH, m, 3-H), 5.55 (2H, m, 6-H, 7-H) and 5.78 (1H, m, O-H). m1z 126 
(M+, 2%), 125 (13), log (100), 108 (11), 91 (11), 81 (40) and 79 (19). 
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To lactol (153) (19.8mg, 0.157mmol) in DCM (4ml) at -78*C was added ethane- 
1,2-dithiol (0.25ml, 0.298mmol) with stirring, then TiC14 (0.25ml of a 1M solution in 
DCM, 0.25mmol) added over 0.05h, to give a moderately strong yellow coloured 
solution. After 0.5h at -78*C., the impure product was extracted as usual, except using 
ether (30ml). The residue was purified by column chromatography eluting with ethyl 
acetate : petrol (10: 90), yielding the dithiane (154), a pale grey gelatinous solid, (23mg, 
0.1 14mmol, 72%); Rf = 0.54 (ethyl acetate : petrol, 30: 70); (Found: [M-H] +, 201.0416. 
C9H14OS2 requires M-H+, 201.0408); 8H 2.01 (1H, dt, J 14 and 7.5,6-H), 2.18 (1HIP 
ddd, J 14,8.5 and 7.5,6-H), 2.36 (1H, dddd, J 17,6,3.5 and 1.5,5-H), 2.66 (1H, dddd, 
J 17,5.5,3 and 2,5-H), 2.7 8 (1H, m, 2-H), 3.28 (4H, m, 4'-H2 and 5'-H2), 4.45 (1H, m, 
1-H), 4.66 (1H, t, J 7.5,2'-H) and 5.63 and 5.78 (1H, m, 3-H, 4-H); 8C 37.63,38-329 
38.38 and 42.11 (C-5, C-6, C-4', C-5'), 49.97 and 52.48 (C-2, C-2'), 72.41 (C-1) and 
128.37 and 132.45 (C-4', C-5'); m1z 202 (M+, 2%), 201 (36), 200 (19), 184 (39), 174 
(20), 141 (24), 124 (35), 109 (100), 105 (81), 91 (11), 83 (84) and 81 (64). 
(±)-trans-7oc-Ethyl-3-phenyl-2,4,8-trioxabicyclo[4.4.0]decan-9-one (156) 
_eý 8,918' 0H 0ý 07 
H] 
mCIpBA / NaHC03 65 
oyo CHC13 / 21h 20 t 04 
Ph Ph 
(142) (156) 
The cyclopentanone (142) (253mg, 1.03mmol) was dissolved in chloroform 
(60ml), and sodium hydrogen carbonate (=9g, =100mmol) added with stirring. Non- 
recrystallised mCIpBA (3.08g, approximately 50% oxidant -= 1.54g per-acid, 8.92mmol) 
was added over 0.35h. The reaction was stirred for 21h at room temperature, forming a 
gelatinous suspension. Water (20ml) and saturated aqueous sodium sulfite 
(20ml) were 
added, and the organic layer separated; the aqueous layer was 
further extracted with 
chloroform (4 x 20ml). The combined organic layers were washed with aqueous 
saturated sodium hydrogen carbonate and sodium sulfite solution 
(=1: 1,10ml), 
87 
followed by brine (20ml); then dried over anhydrous sodium sulfate, filtered and 
evaporated, (558mg, >100%). The 8-valerolactone was recrystallisedised from carbon 
tetrachloride and petrol (18 1 mg) and the remaining product in the contaminated filtrate 
was purified by column chromatography, eluting with ethyl acetate : petrol (20: 80) to 
obtain a further 28mg, thus a total yield consisting 209mg, (0.798mmol, 78%) of the 
white flaky powder (156); Rf = 0.34 (ethyl acetate: petrol, 30: 70); mp 132-134"C (from 
ethyl acetate and petrol), (lit. 75,130-13 1 *Q; 8H 1.08 (3H, t, J 7.5,9'-H3), 1.57 and 1.76 
(2H, m, 8-H2), 2.07 (IH, qd, J 11 and 5,6-H), 2.67 (1H, dd, J 18 and 11.5,1OP-H), 
3.08 (1H, dd, J 18 and 6,10oc-H), 3.70 (lH, t, J 11,5P-H), 4.08 (2H, m, 1-H and 7-H), 
4.29 (IH, dd, J 11 and 5,5oc-H), 5.57 (lH, s, 3-H), 7.37 QH, m, Ar-H3) and 7.47 (2H, 
m, Ar-H2); m1z 262 (M+, 83%), 261 (100), 185 (8), 175 (9), 127 (8), 107 (21), 106 (16) 
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To a stirred solution of the lactone (156) (87mg, 0.332mmol) in THF (8ml) at 
-78*C was added Dibal-H (0.38ml of a 1M solution, 
0.38mmol) over 0.1h. The 
temperature was allowed to rise to 3*C over 2.25h. As no change in TLC value from 
starting material was apparent, the reaction was allowed to attain room temperature over 
a further 2h. Rochelle salt solution (5ml) and water (5ml) were added and the products 
(157) extracted and dried by the standard technique to give a mixture of two isomers 
in 
a ratio of 71: 29 (83mg, 0.314mmol, 95%); Rf = 0.33 (ethyl acetate: petrol, 
30: 70); mp 
112-113T (from DCM and petrol), (lit. 751114.5-115.5*C). 8H major isomer, 0.96 QH, 
t, J 7.5,9'-H3), 1.52 and 1.84 (4H, m, 6-H, 8'-H2,1OP-H), 
2.13 (1H, ddd, J 12.5,4.5 and 
1, lOcc-H), 3.07 (1H, br s, OH), 3.65 (1H, t, J 11,5P-H), 3.70 (1H, m, 7-H), 4.17 
(lH5 
88 
-3 -1 cid, J 11 and 4.5,5a-H), 4.22 (1H, m, 1 -H), 5.45 (1H, br s, 9-H), 5.60 (1H, s, 3-H), 7.36 
(3H, m, Ar-H3) and 7.48 (2H, m, Ar-H2); minor isomer, 8H 1.00 (3H, t, J 7.5,9'-H3), 
1.56 and 1.84 (4H, rn, 6-H, 8'-H2,1OP-H), 2.29 (1H, ddd, J 12,4.5 and 1, lOa-H), 3.07 
(1H, s, OH), 3.58 (1H, t, J 11,5P-H), 3.73 (2H, m, 1-H, 7-H), 4.19 (1H, m, 5a-H), 4.83 
(1H, br d, J 9,9-H), 5.55 (1H, s, 3-H), 7.36 (3H, m, Ar-H3) and 7.48 (2H, m, Ar-H2)- 
m1z (CI) 265 ([N411]+, 16%), 264 (71), 263 (60), 217 (8), 187 (5), 141 (7), 123 (23), 107 
(69), 105 (69), 95 (26), 85 (52) and 83 (100). 














To benzylidene protected lactone (126) (36mg, 0.209mmol) dissolved in water 
(4ml), ether (lml) and petrol (4ml) was added CSA (catalytic quantity); the reaction 
was stirred for 48h at room temperature. By TLC analysis no starting material was 
present, only a more polar product. Petrol (2 x 5ml) and water (2 x 5ml) were added. 
The bilayer system was mixed, separated, and the aqueous layer further extracted with 
petrol (10ml). The combined organic portions were washed with water (5ml); and the 
accumulated aqueous fractions were made alkaline to pH=8 with solid aqueous sodium 
hydrogen carbonate. The water was evaporated in vacuo , and the resultant solid was 
purified by column chromatography using methanol : ethyl acetate 
(10: 90), to give the 


















The lactol (157 Q1 mg, 0.1 l7mmol) and toluenesulfonic acid (catalytic quantity) 
in water (8ml), pet-rol (5ml) and methanol (1.5ml) were stirred for =48h at room 
temperature. TLC analysis indicated no starting material was present. Thus the 
reaction mixture was quenched with solid sodium hydrogen carbonate. Petrol (5ml) and 
water (5ml) were added, shaken and the aqueous layer removed; the organic layer was 
then re-extracted with water (2 x 5ml). The combined aqueous fractions were washed 
with petrol (10ml), the latter being added to the collated organic extracts. The aqueous 
portion was evaporated in vacuo to yield a solid white lump (730mg). 
The solid was purified by column chromatography using ethyl acetate : petrol 
(65: 35) to elute the clear and colourless liquid (164) (10mg, 0.0526mmol, 45%)75, a 
mixture of two isomers in a ratio of 73: 27, (determined by 1H NMR spectra integral 
values for the methoxy group); Rf = 0.37 and 0.40 (100% ethyl acetate). Major isomer, 
8H 0-99 (3H, t, J 7,8-H3), 1.47,1.69 and 2.07 (5H, m, 3-H2,5-H, 7-H2), 3.30 (3H, 
OCH3), 3.41 (IH, m, 5-CHH), 3.64 (1H, dd, J 10.5 and 7,5-CHH), 3.89 (1H, m, 6-H), 
4.09 (1H, td, J 10.5 and 5,4-H) and 4.80 (1H, ap d, J 3,2-H); minor isomer, 8H 1.01 
(3H, t, J 7,8-H3), 1.47,1.69 and 2.19 (5H, m, 3-H2,5-H and 7-H2), 3.41 (1H, m, 5- 
CHH), 3.49 (3H, s, OCH3), 3.64 (1H, dd, J 10.5 and 7,5-CHH), 3.89 (1H, dd, J 10.5 
and 3.5,6-H), 4.09 (1H, td, J 10.5 and 5,4-H) and 4.30 (1H, dd, J 9.5 and 2,4-H). m1z 
(CI) (M+ absent), 159 [NM-MeOH]+, 84%), 141 (100), 123 (35), 115 (67), 97 (56), 95 
(46), 83 (75), 69 (31), 59 (50) and 57 (41). 
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Concurrent production of (±)-6a-ethyl-4a-hydroxy-50-hydroxymethyl-2c- 
methoxy-l-oxacyclohexane (164) and (±)-6(x-ethyl-4(x-hydroxy-5p-hydroxymethyl- 
I-oxacyclohexan-2-one (165) 
118 
00 HO 0, 
f7 
meo 0 H00 H 
2 6*' HH 
MeOH 45+ 
0+ 000 CSA yy 
HO OH HO OH 
Ph Ph (165) (164) 
(156) (157) 
A mixture of the lactone (156) and lactol (157), (173mg, approximately 3: 5 
respectively, as determined by IH NMR spectroscopy; =65mg, =0.248mmol (156) and 
=108mg, =0.409mmol (157)) was suspended in anhydrous methanol (12ml) under a 
nitrogen atmosphere, and CSA (catalytic quantity) was added. 
After 24h the Rf had changed from 0.70 to 0.15 and 0.20 (ethyl acetate : petrol, 
50: 50). Hence the reaction mixture was extracted as usual, but an attempt to dry the 
organic liquor using anhydrous magnesium sulfate failed as the desiccating agent 
formed a dense, glutinous cake with the products; to remove any compound adsorbed 
onto the magnesium sulfate, hot ethyl acetate was used to rinse the magnesium sulfate 
with filtering. The ethyl acetate was evaporated in vacuo to yield the crude extract 
(154mg). The product was purified by column chromatography eluting with ethyl 
acetate : petrol (50: 50), to give the methoxy acetal (164) (67mg, 0.353mmol, 86%), 
spectral data as previously reported. 
Further elution with 100% ethyl acetate produced the dihydroxy lactone (165) a 
pale grey gel, (34mg, 0.196mmol, 79%); Rf = 0.22 (100% ethyl acetate); (Found 
[NUI]+, 175.0975. C8HI504 requires MH, 175.0970); umax/cm-1 1748 (C=O) and 3449 
(OH); 8H 1.04 QH, t, J 7.5,8-H3), 1.65 (1H, ap quintet, J 7.5,7-H), 1.82 (2H, m, 5-HI, 
7-H), 2.55 (1H, dd, J 17 and 7,3P-H), 2.91 (1H, dd, J 17 and 5.5,3(x-H), 3.70 (1H, dd, 
), 4.11 (1H, ddd, J 10.5,7.5 and J 11 and 6,5-CHH), 3.95 (1H, dd, J 11 and 3.5,5-CHH 
3,6-H) and 4.27 (1H, ddd, 9.5,7 and 5.5,4-H); 8C 8.94 (C-8), 26.16 
(C-7), 38.88 (C-3), 
47.23 (C-5), 61.11 (5-CH2), 66.72 (C-4), 79.53 (C-6) and 171.64 (C-2); m1z (CI) 
157 
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(RvUfl+, 54%), 145 (8), 140 (10), 139 (100), 127 (49), 121 (20), 115 (40), 113 (30), 1 





1) HC02H / H20 
A 
2) O. lmmHg 
'HF 
(166) 
Ketone (142) (23mg, 0.0935mmol) was added to formic acid and water (=1: 3, 
10ml), and stirred at 50*C for 0.75h. The solvents and benzaldehyde were evaporated 
in vacuo by sequentially rotary evaporator and high vacuum mechanical pump. The 
crude product was purified by column chromatography eluting with ethyl acetate : 
petrol (50: 50), yielding the clear liquid cylcopentenone (166), (6mg, 46%)75; Rf = 0.39 
(ethyl acetate : petrol, 65: 35); 8H: 0.94 QH, t, J 7.5,7-H3), 1.56 and 1.81 (2H, m, 6- 
H2), 2.04 and 2.84 (2H, m, 4-H, 5-H), 3.68 (1H, dd, J 10.5 and 6.5,4-CHH), 3.83 (1H, 
dd, J 10.5 and 5.5,4-CHII), 6.22 (1H, dd, J 5.5 and 2,2-H) and 7.68 (1H, dd, J 5.5 and 
2.5,3 -H); m1z 140 (M+, 3 %), 123 (23), 122 (62), 107 (17), 94 (3 1) and 79 (100). 











H starting + 
material 
(164) HO OAc 
(168) 
The diol (164) (17mg, 0.0895mmol) in TBF (8ml) was added to AC20 (dried and 
distilled from calcium hydride, 0. Iml, 1.06mmol) and anhydrous pyridine (0.3ml) at 
O'C, 
and allowed to reach room temperature. Reaction rate appeared slow 
by TLC analysis, thus 
the reaction was not terminated with the standard extraction procedure until after 
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91h. sfirring; which yielded a crude product (22mg). The product was purified by column 
chromatography, eluting with ethyl acetate : petrol (20: 80), to give the di-acetate (167) 
(2mg, 0.00730mmol, 8%) as a colourless film, in a ratio of 72: 28 of the two isomers 
(determined by 1H NMR spectra); Rf = 0.70 (ethyl acetate: petrol, 65: 35); (M+ not found); 
%ax/cm-1 1021 (0-CH3) and 1739 (C=O). Major isomer, 8H 1.00 (3H, t, J 7.5,8-H3), 1.50 
and 1.74 (4H, m, 30-H, 5-H, 7-H2), 2.04 and 2.06 (each 3H, each s, each 02CCH3), 2.22 
(1H, ddd, J 12.5,5 and 1.5,3oc-H), 3.33 (3H, s, OCH3), 3.69 (1H, m, 6-H), 4.04 (IH, dd, J 
12 and 2.5,5-CHH), 4.17 (1H, dd, J 12 and 3,5-CIM), 4.81 (1H, dd, J 3.5 and 1.5,2-H) 
and 5.19 (1H, td, J 12.5 and 5,4-H); 8C 9.40 (C-8), 20.02 and 21.08 (2 x 02CCH3), 25-18 
(C-7), 35.70 (C-3), 44.41 (C-5), 54.56 (OCHA 60.15 (5-CH2), 66.77 (C-6), 69.15 (C-4), 
98.02 (C-2) and 170.26 and 171.10 (2 x 02CCH3). Minor isomer, 8H 1.03 QH, t, J 7.5,8- 
H3), 1.50 and 1.74 (4H, m, 3P-H, 5-H, 7-H2), 2.04 and 2.05 (each 3H, each s, each 
02CCH3), 2.33 (1H, ddd, J 12,4.5 and 2,3cc-H), 3.29A(lH, m, 6-H), 3.51 QH, S, OCHA 
4.04 (IH, dd, J 12 and 2.5,5-CHH), 4.20 (1H, dd, J 12 and 3,5-CIUI), 4.37 GH, dd, J 10 
and 2,2-H) and 4.96 (1H, td, J 12.5 and 5,4-H); 8C 9.48 (C-8), 20.80 and 21-02 (2 x 
02CCH3), 25.24 (C-7), 37.08 (C-3), 44.49 (C-5), 54.51 (OCH3), 60.32 (5-CH2), 66.83 (C- 
6), 68.45 (C-4), 98.10 (C-2) and 170.26 and 171.92 (2 x 02-CCH3); (*Signals overlap with 
water signal; A signal partially obscured by methoxy singlet of major isomer). m1z (FAB) 
297 (100%), 274 (M+, 3%), 243 (15), 214 (4), 183 (39), 157 (7), 154 (4), 147 (6), 123 (67) 
and 113 (6). 
Further elution with ethyl acetate : petrol (40: 60) gave the mono-ester (168) (10mg, 
0.0431mmol, 48%) also as a colourless film, in a ratio of 78: 22 of isomers (determined by 
IH NMR spectra); Rf = 0.43 (ethyl acetate : petrol, 65: 35); (M+ not found); Umax/cm-1 * 
1736 (C=O) and 3436 (OH). Major isomer, 5H 1.00 QH, t, J 7.5,8-H3), 1.49,1.65 and 
1.79 (4H, m, 3P-H, 5-H, 7-H2), 2.10 QH, S, 02CCH3), 2.13A (1H, m, 3a-H), 
2.73 (1H, br 
d, J 3.5, OH), 3.32 QH, s, OCH3), 3.56 (1H, m, 6-H), 3.85 (1H, m, 4-H), 4.05 (IH, dd, J 12 
and 3,5-CHH), 4.62 (1H, dd, J 12 and 3,5-CHH) and 
4.81 (1H, d, J 3.5,2-H) (Apeaks 
partly obscured by methyl singlet); 8C 9.56 (C-8), 
20.95 (02CCH3), 25.18 (C-7), 38.40 (C- 
3), 48.30 (C-5), 54.57 (OCH3), 61.01 (5-CH2), 63.84 (C-6), 69.13 (C-4), 98.56 (C-2) and 
171.98 (02CCH3). Minor isomer, 8H 1.03 QH, t, J 7.5,8-H3), 1.49,1.65 and 
1.79 (4H, m, 
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3P-H, 5-H, 7-H2), 2.09 QH, s, 02CCH3), 2.23 (1H, ddd, J 12,5 and 1.5,3oc-H), 2.73 (IH, 
br d, J 3.5, OH), 3.18 OH, td, J 9.5 and 2.5,6-H), 3.51 QH, s, OCHA 3.85 (1H, m, 4-H), 
4.07 (IH, dd, J 12 and 3,5-CH-H), 4.32 (1H, dd, J 10 and 2,2-H) and 4.59 (1H, dd, J 12 
and 3,5-CHH); 8C 9.76 (C-8), 20.87 (02CCH3), 25.44 (C-7), 39.92 (C-3), 48.10 (C-5), 
56.27 (OCH3), 60.88 (5-CH2), 66.86 (C-6), 73.97 (C-4), 100.74 (C-2) and 171-77 
(0, ), CCH3). m1z (CI) 201 ([NM-MeOH]+, 4%), 197 (2), 185 (2), 154 (33), 123 (21), 85 
(61) and 83 (100); m1z (FAB) 255 (100%), 233 ([MH]+, 2), 231 ([M-H]+, 6), 201 ([M- 
MeO] +, 59), 147 (4), 113 (8), 112 (12), 111 (5 3), 110 (9) and 109 (9 1). 
Further elution with 100% ethyl acetate gave the starting diol (164) (5mg, 













The mono-acetate (168) (10mg, 0.0431mmol) was dissolved at 0"C in TBF with 
triethylamine (0.5ml, 3.59mmol) and methanesulfonyl chloride (0.1ml, 1.29mmol). After 
1.25h no starting material was apparent by TLC, and thus the reaction was worked up as 
usual, except using ether as solvent. Purification by column chromatography ( ethyl acetate 
: petrol, 20: 80) gave the mesylate (170) as a very pale brown liquid, (10mg, 0.0323mmol, 
75%), in a ratio of the two isomers of 82: 18 (determined by 
IH NMR spectra); Rf = 0.71 
(ethyl acetate : petrol, 65: 35); (M+ not found); Umax/cm-1 799 (C-0-S), 
1092 and 1352 
(S=O) and 1740 (C=O). Major isomer, 8H 1.00 (3H, t, J 7,8-H3), 1.51 
(1H, dq, J8 and 7, 
7-HH), 1.76 (2H, m, 5-H, 7-HH), 1.93 (1H, ddd, J 12.5,11.5 and 4,3D-H), 2.09 QH, s, 
02CCH3), 2.44 (1H, ddd, J 12.5,5 and 1,3oc-H), 3.01 QH, S, 03SCH3), 3.32 QH, s, 
OCH3), 3.70 (1H, ddd, J 10.5,8 and 3,6-H), 4.15 (1H, dd, J 12 and 2.5,5-CHH), 
4.27 (1H, 
dd, J 12 and 3,5-Cflli), 4.83 (1H, ap d, J 3,2-H) and 5.09 (1H, td, 
J 11.5 and 5,4-H); 8C 
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9.40 (C-8), 20.83 (02C-CH3), 25.14 (C-7), 37-43 (C-3), 38.38 (C-5), 48.96 (03SCH3), 54.67 
(OCH3), 59.57 (5-CH2), 68.99 (C-6), 74.83 (C-4), 97.88 (C-2) and 170.90 (0,? ECH3)- 
Minor isomer: 8H 1.00 (3H, t, J 7,8-H3), 1.47 and 1.76 (3H, m, 5-H, 7-H2), 1.86 (1H, m, 
3P-H), 2.08 (3H, S, 02CCH3), 2.54 (1H, ddd, J 12.5,5 and 2,3oc-H), 3.04 (3H, s, 03SCH3), 
3.27 (1H, m, 6-H), 3.51 (3H, s, OCHA 4.27 (1H, dd, J 12 and 3,5-CHH), 4.29 (1H, dd, J 
12 and 3,5-CHH), 4.35 (1H, dd, J 9.5 and 2,2-H) and 4.87 (1H, td, J 11 and 5,4-H); 8c 
9.54 (C-8), 20.75 (02C-CH3), 25.23 (C-7), 37.45 (C-3), 39.28 (C-5), 44.90 (03SCH3), 54.67 
(OCH3), 59.57 (5-CH2), 68.81 (C-6), 76.81 (C-4), 98.12 (C-2) and 170.90 (02CCH3). m1z 
(CI) 279 ([NM-MeOH]+, 66%), 237 (6), 219 (14), 184 (14), 183 (79), 157 (27), 155 (65), 












3,4-dihydro-2H-pyran (420mg, 5.00mmol) was dissolved in methanol (5ml) and 
CSA (27mg) and -stirred for 1.25h. Then, as the starting material had disappeared by TLC, 
the reaction underwent the standard work-up. This returned the clear liquid (172) (522mg, 
4.50mmol, 90%)89; Rf = 0.75 (ethyl acetate: petrol, 30: 70); 8H (300 M11z) 1.55 and 1.79 
(6H, m, 3-H2,4-H2,5-H2), 3.32 QH, s, OCH3), 3.61 and 3.82 (2H, m, 6-H2) and 4.38 (1H, 
t, J 5.5,2-H); m1z (CI) 101 (16%), 97 (13), 87 (11), 85 ([NM-MeOHI+, 100), 83 (97), 71 
(18), 69 (11), 61 (35), 59 (13) and 57 (33). 
2ý-Hydroxy-l-oxcyclohexane (173) 
MeO 0 HO 0 
Acetone / wa 
Dowex 
(172) (173) 
The methoxy acetal (172) (522mg, 4.5mmol) was dissolved 
in acetone (3ml), water 
(2ml) and acidic Dowexc (1 lmg) added and stirred at room temperature. 
After 0.5h, all 
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starting material had disappeared by TLC, so the usual extraction procedure was followed. 
Following column chromatography with ethyl acetate : petrol (20: 80), a colourless and 
transparent liquid (173) was obtained (394mg, 3.86mmol, 86%)122; Rf = 0.54 (ethyl acetate 
: petrol, 30: 70); 8H 1.59 (4H, m, 4-H2 and 5-H2), 1.77 and 1.84 (2H, m, 3-H2), 3.51 and and 
3.88 (2H, m, 6-H2) and 4.96 (1H, t, J5,2-H); m/z(CI) 103 ([MH]+, 4%), 101(11), 93 (11), 
85 (77), 83 (100), 81 (3), 79 (32), 71 (11), 69 (8) and 57 (28). 
Reaction of 8-Lactol (157) with NIS and LDA 





Ph Ph Ph 
(157) (156) (157) 
n-Butyl lithium (0.22ml of a 2.5M solution in hexanes, 0.55mmol) was added to 
diisopropylarnine (0.04ml, 0.283mmol) in THF (6ml) at -78"C under nitrogen and 
stirred for 0.25h with warming to =10*C, to prepare a solution of LDA. The 
temperature was lowered to -78"C, then the 8-valerolactol (157) (66mg, 0.25mmol) in 
TBF (3ml) was added; the mixture was allowed to warm to 15"C over 0.5h, with no 
colour change seen in the solution. The reaction mixture was again lowered to -78"C 
and N-iodosuccinimide (65mg, 0.289mmol) added, the reaction mixture retaining the 
pale orange colour of the N-iodosuccinimide. No change in Rf was detected after 1h, 
thus the reaction mixture was held at room temperature for 2.5h. 
However no change was seen still by TLC from starting material, thus dilute 
aqueous hydrochloric acid was carefully added until pH9 was'attained. Extraction 
produced a bright orange solid (160mg), which was several spots by TLC analysis. 
The 
crude mixture was purified by column chromatography, eluting with ethyl acetate : 
petrol (30: 70) yielding a pale yellow solid (1 lmg, =0.042mmol, =17%). 
The product 
was a mixture of starting material (157) and protected 
8-lactone (156), which 
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corresponded with previous data75; IH NMR spectroscopy determined a ratio of 1: 1.3 
respectively. None of the other products could be identified. 









Under anhydrous conditions, pyridine (0.1ml, 1.24mmol) was added to the 
lactol (157) (26.4mg, 0.10mmol) dissolved in TBF (4ml) and stirred for 0.2h. The 
temperature was then lowered to O*C, and NBS (21mg, 0.128mmol) added. After 
=100h stirring no change in Rf value from the starting material (157) was detected, so 
the standard extraction was made to give a pale yellow solid (41mg, >100% possible 
yield). The pure products were obtained by column chromatography, eluting with ethyl 
acetate : petrol (30: 70) yielding a mixture of a white solid and clear liquid of Rf = 0.37 
(17mg, =0.065mmol, =65%), itself a mixture of the starting lactol (157) and lactone 
(156); in a ratio of lactol to lactone of 5.1: 1 by 1H NMR spectroscopy. 
(±)-Methyl (2E, 5R *, 6R *, 7R *) -7- hydroxy-5- 0,6- (methyl- 0) - (benzyli den e)non -2- 
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The lactol (157) (84mg, 0.318mmol) and methyl (triphenyl-phosphoranylidene) 
acetate (789mg, 2.36mmol) in acetonitrile (40ml) were heated to reflux for 19h. Upon 
cooling, the solvent was evaporated and the product was purified by flash 
chromatography. Elution with ethyl acetate : petrol (20: 80), gave the Z-unsaturated 
ester (180) (18mg, 0.0563mmol, 18%) as a colourless film; Rf = 0.49 (ethyl acetate : 
petrol, 40: 60)75; 8H (300 MHz) 1.01 QH, t, J 7.5,9-H3), 1.52 and 2.05 QH, m, 6-H, 8- 
H2), 2.94 and 3.33 (2H, m, 4-H2), 3.53 (1H, m, 7-H), 3.72 (3H, S, C02CH3), 3.78 (1H, 
t, J 11.5,6-CH2D), 3.97 (1H, m, 5-H), 4.24 (1H, dd, J 11.5 and 5,6-CH2a), 5.45 (1H, s, 
O-CH-0), 5.91 (1H, ap dt, J 11.5 and 1.5,2-H), 6.59 (1H, dt, J 11.5 and 7.5,3-H), 7.36 
(3H, m, Ar-H3) and 7.47 (2H, m, Ar-H2); m1z (CI) 321 ([NM]+, 100%), 319 (21), 303 
(8), 221 (14), 215 (76) and 197 (59). 
Further elution with ethyl acetate : petrol (25: 75) gave the E-unsaturated ester 
(175), (70mg, 0.219mmol, 69%) also as a colourless film; Rf = 0.42 (ethyl acetate : 
petrol, 40: 60)75; 8H (300 MHz) 0.99 (3H, t, J 7.5,9-H3), 1.48 and 2.04 (3H, m, 6-H, 8- 
H2), 2.61 and 2.84 (2H, m, 4-H2), 3.51 (1H, m, 7-H), 3.73 (3H, S, C02CH3), 3.74 (1H, 
t, J 11.5,6-CH2p), 3.93 (1H, m, 5-H), 4.25 (1H, dd, J 115 and 5,6-CH2(x), 5.45 (1H, s, 
O-CH-0), 5.94 (1H, ap. dt, J 16 and 2.5,2-H), 7.13 (1H, ddd, J 16,7.5 and 7,3-H), 7.35 
(3H, m, Ar-H3) and 7.48 (2H, m, Ar-H2); m1z (CI) 321 (M+, 50%), 320 (7), 319 (26) 
289 (15), 221 (42)9 215 (45), 165 (69) and 107 (100). 




LDA / THF 
-780C to r. t. to -780C 
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n-Butyl lithium (0.05ml of a 2.5M solution in hexanes, 
0.125mmol) was added 
to diisopropylamine (0.02ml, 0.142mmol) in THF (20ml) at -78*C under nitrogen; the 
mixture was allowed to warm to room temperature and stirred 
for 0.5h to prepare a 
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solution of lithium diisopropylamide. The temperature was then lowered to -78*C. The 
E-unsaturated ester (175) (36mg, 0.1 13mmol) in TI-IF (20ml) was added to the solution 
of LDA over 15 minutes. This was then allowed to reach room temperature over 2.25h, 
then recooled to -78*C. Half of the volume was transferred to another flask containing 
water, and to the remainder was added deuterium oxide. The protic quenching system 
was diluted with more water (4ml), and extracted as normal to yield a gum (70mg). 
The product was purified by column chromatography, elution with ethyl acetate : petrol 
(50: 50), gave the 9oc-ethyl methy1carboxylate bicyclo ester (181) (14mg, 0.0438mmol, 
78%) as a colourless film; Rf = 0.64 (ethyl acetate : petrol, 30: 70); (Found M+, 
320.1616. C18H2405 requires M, 320.1624); umax/cm-1 * 1733 (C: --O); 8H (300 MHz) 
0.94 QH, t, J 7.5,9'-H3), 1.46 (2H, m, 8'-H2), 1.57 (1H, m, 100C-H), 1.79 (1H, dtd, J, 
14,10 and 4.5,6-H), 2.03 (1H, ddd, J 12,4.5 and 2,1OP-H), 2.48 (1H, dd, J 15 and 5.5. 
9-CHH), 2.64 (1H, dd, J 15 and 8,9-CHIHD, 3.07 (1H, ddd, J 10,8.5 and 3,7-H), 3.62 
(1H, t, J 11,5P-H), 3.69 (3H, S, C02CH3), 3.81 (1H, ddd, J 14,10 and 4.5,1-H), 3.96 
(1H, dddd, J 12,8,5.5 and 2,9-H), 4.17 (1H, dd, J 11 and 4.5,5(x-H), 5.58 (1H, s, 3-H), 
7.35 (3H, m, Ar-H3) and 7.48 (2H, m, Ar-H2); 6C 9.43 (C-9'), 25.34 (C-8'), 36.89 and 
41.02 (C- 10,9-CH2), 44.10 (C-6), 51.69 (C02CHA 67.88 (C-5), 72.48 and 76.58 (C-7, 
C-9), 79.02 (C-1), 101.66 (C-3), 126.13,128.36,128.99 and 138.10 (aromatics) and 
171.50 (C02CH3); m1z 320 (M+, 92%), 319 (88), 289 (13), 262 (20), 261 (48), 247 
(10), 243 (16), 217 (14), 140 (55) and 105 (100). 
Further elution with ethyl acetate : petrol (20: 80) produced as a colourless film a 
mixture of the two diastereomers (3mg) which is 72% 9P-CH2CO2CH3 isomer (182) 
(-=2. lmg, 0.00656mmol, 12%) and 28% the main product (181) (=0.9mg, 0.00281mmol, 
5%), by IH NMR spectra integral analysis. The data for (182) was: Rf = 0.48 (ethyl 
acetate : petrol, 30: 70); (Found M+, 320.1610. C18H2405 requires M, 320.1624); 
^Omax/cm- 1* 1743 (Cý--O); 6H (300 MHz) 0.91 (3H, t, J 7.5,9'-H3), 1.44 (2H, m, 
8'-H2), 
1.79 (1H, m, 6-H), 1.90 (1H, ddd, J 13,5 and 1.5,10oc-H), 2.06 (1H, 
ddd, J 13,6 and 
1.5,100-H), 2.54 (1H, dd, J 14.5 and 5.5,9-CliH), 2.92 (1H, dd, J 14.5 and 10,9- 
CHH), 3.33 (1H, ddd, J 11,8.5 and 3,7-H), 3.64 (1H, t, J 11,5P-H), 3.71 (3H, s, 
C02CH3), 3.94 (1H, m, 1-H), 4.18 (1H, dd, J 5.5 and 11,5cc-H), 4.66 (1H, dddd, J 107 
99 
6,5.5 and 1.5,9-H), 5.59 (1H, s, 3-H), 7.36 (3H, m, Ar-H3) and 7.48 (2H, m, Ar-H2); 
8c (300 MHz) 9.40 (C-9'), 25.42 (C-8'), 33.90 and 37.67 (C-10,9-CH2), 44.41 (C-6), 
51-82 (CO2_CH3), 69.98,70.99 and 75.36 (C-5, C-7, C-9), 79.01 (C- 1), 10 1.70 (C-3), 
126.10,128.36,129.03 and 138.21 (aromatics) and 171.27 (C02CH3); m/z 320 (M+, 
48%), 319 (50), 289 (5), 261 (27), 247 (11), 185 (14), 140 (29), 129 (33), 105 (73) and 
57(100). 
The deuterium oxide quench portion was extracted in a likewise manner, to 
yield a mixture (31mg), which by 1H7 13C NMR and MS were identical to products 
found previously ((181) and (182)) and in a very similar ratio; no incorporation of 
deuterium was observed. 













To the E-unsaturated ester (175) (18mg, 0.056mmol) in THF (6ml) was added 
imidazole (28mg, 0.41 Immol) and chlorotrimethylsilane (0.03ml, 0.236mmol), and 
stirred for 17h. The reaction was extracted as normal, except ether was used. 
The 
crude product (183) was a clear liquid (39mg, >100% crude product); 
Rf = 0.81 (ethyl 
acetate: petrol, 30: 70); 8H 0.13 (6H, s, Si(CH3)2), 
0.15 (3H, s, SiCH3), 0.99 (3H, t, J 
7.5,9-H3), 1.22,1.40 and 2.05 (3H, m, 6-H, 8-H2), 2.62 (1H, ddd, J 15.5,7.5 and 
1.5, 
4-H), 2.85 (1H, m, 4-H), 3.64 (1H, m, 7-H), 3.73 (3H, S, C02CHA3.76 
(1H, t, J 11.5, 
6-CH2P), 3.91 (1H, m, 5-H), 4.26 (1H, dd, J 11.5 and 5,6-CH2CO, 
5.46 (1H, s, O-CH- 
0), 5.94 (1H, dt, J 15.5 and 1.5,2-H), 7.12* (1H, ddd, J 15.5,7.5 and 
6.5,3-H), 7.36 
(3H, m, Ar-H3) and 7.48 (2H, m, Ar-H2), 
(* signal obscured by broad singlet at 
7.08ppm); m1z (CI) 391 ([M-H]+, 2%), 369 (1), 301 
(1), 319 (3), 302 (3), 257 (3), 261 
(8), 226 (3), 215 (5), 213 (4), 197 (10) and 100 (100). 
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(181) =7 :1 (182) 
The attempted elimination reaction was repeated using the silyl ether (183) 
(22mg, 0.056mmol). The crude oil (14mg, >100% possible yield (9. Omg, 
0.0281mmol)) obtained from the aqueous quench was identical by TLC and IH NMR 
spectra analysis, and the products in a similar ratio, to the the mixture obtained from the 
analogous reaction on the alcohol (175). 
Upon extracting the the portion reacted with D20, the product also had cyclised 
to the ethers (181) and (182) (37mg, >100% possible yield (9. Omg, 0.0281mmol)) and 
again no deuterium could be found in the molecule by either IH or 13C NMR spectra, 
nor both low and high resolution El and CI MS analysis. 
(±)-Methyl (2E, 5R*, 6R*, 7R*)-5,7-dihydroxy-6-hydroxymethylnon-2-enoate (178) 
0e OH 
ý-Ph 
HO 1110 HO 11 10H 
HCI(aq) / H20 
Petrol / MeOH 
(17 5) C02Me 
(17 8) C02Me 
The acetal (175) (20mg, 0.0625mmol) in methanol (6ml), petrol 
(10ml), water 
(10ml) and 1M hydrochloric acid (lml) was stirred for 2.25h at room temperature. 
The 
reaction system was extracted as normal to yield a 
brown liquor (12mg). The product 
was purified by column chromatography, eluting with ethyl acetate, 
to give the triol 
ester as a clear liquid, (178) (5mg, 0.0216mmol, 
34%); Rf = 0.36 (ethyl acetate); (Found 
[Mlfl+, 233.1387. C11H2105 requires MH, 233.1389); 
8H (300 MHz) 0.99 QH, t, J 7.5, 
9-H3), 1.46 and 1-62 (3H, m, 6-H, 8-H2), 2.43 and 
2.64 (2H, m, 4-H2), 2.82 (1H, br s, 
OH), 3.41 (1H, br s, OH), 3.74 (3H, S, C02CH3), 3.90 (1H, 
dd, J 11.5 and 3.5,6-CHH 
101 
4.00 and 4.33 (2H, m, 5-H, 7-H), 4.14 (1H, dd, J 11.5 and 4.5,6-CHH), 5.94 (1H, ap dt, 
J 15.5 and 1.5,2-H) and 6.98 (1H, ap dt, J 15.5 and 7.5,3-H); SC 10.41 (C-9), 27.97 (C- 
8), 38.29 (C-4), 46.35 (C-6), 51.59 (CO2QH3), 62.51 (6-CH2), 70.38 and 75.43 (C-5, C- 
7), 123.44 (C-2), 145.30 (C-3) and 166.77 (C-1); m1z (CI) 233 ([MH]+, 100%), 215 
(21), 201 (16), 197 (39), 183 (50), 179 (39), 165 (83), 139 (46) and 115 (45). 









The alcohol (178) (5mg, 0.0216mmol) in MeOH (12ml) and 10M hydrochloric 
acid (2ml) was stirred at room temperature for 2.25h, and as no change in TLC value 
was noted, the reaction was heated to 39"C for 5.75h; an apparent increase in Rf value 
was noted (from 0.36 to 0.51,100% ethyl acetate). The product was extracted and 
evaporated in vacuo to give a clear film (21mg, >100% possible yield); analysis by 1H 
NMR spectra appeared to contain starting material only. The CI MS indicated the 
presence of the desired di-ene (177), (Found [MHI+, 215-1285. C11H1904 requires 
MH, 215.1283); m1z (CI) 215 ([MHI+, M, 197(3), 181 (09 179 (1), 167 (4), 149 (8), 
91 (26), 87 (10), 85 (65) and 83 (100). However, dehydration is a highly favoured 
process at low pressure, so the eliminated product probably formed 
in the AutospecO. 




HCI(aq) / H20 
30- 
Petrol / MeOH 
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f-%l T Uri 
HO II 10H 
r, 
ý (184) MeO2C 
The Z-alkene (180) (18mg, 0.0563mmol) was treated in a similar manner to the 
E-product (175) to enable synthesis of the Z-triol (184), purification by column 
chromatography, eluting with ethyl acetate, gave a clear film (9mg, 0.0388mmol, 69%); 
Rf = 0.36 (ethyl acetate); (Found [MH]+, 233.1387. C11H2105 requires MH, 
233.1389); 8H 0-99 QH, t, J 7.5,9-HA 1.52,1.63 and 1.68 (1H, m, 6-H, 8-H2), 2.95 
(2H, m, 4-H2), 3.61 (lH, br. s, OH), 3.74 (M, S, C02CH3), 3.92 (lH, dd, J 11.5 and 4, 
6-CHH), 3.98 and 4.29 (2H, m, 5-H, 7-H), 4.18 (1H, dd, J 11.5 and 4.5,6-CH-H), 5.94 
GH, ap dt, J 11.5 and 1.5,2-H) and 6.42 (1H, ap dt, J 11.5 and 7.5,3-H); 5C 10.37 (C- 
9), 27.97 (C-8), 34.89 (C-4), 47.12 (C-6), 51.35 (C02CHA 62.67 (CH20H), 71.31 and 
75.38 (C-5, C-7), 121.30(C-2), 146.30 (C-3) and 167.24 (C-1); m1z (CI) 233 ([MHI+l 
3 %), 215 (5), 201 (12), 197 (12), 183 (27), 165 (56), 147 (54), 85 (72) and 83 (100). 
(±)-Methyl (2Z, 5R*, 6R*, 7R*)-5,7-diacetoxy-6-acetoxymethylnon-2-enoate (185) 
1-1111 UAC 
HO II IOH AC20 AcO II IOAc 
TSOH 
(184) (185) Me02C MeO2C 
Z-triol (184) (12mg, 0.0517mmol) was stirred in acetic anhydride (3ml) at room 
temperature and tosic acid (17mg) for 17h. The reaction was extracted as normal to yield a 
liquid (20mg). Purification by column chromatography, eluting with ethyl acetate : petrol 
(20: 80), gave the Z-triacetate (185) as a clear liquid (27mg, >100% possible yield); Rf = 
0.68 (ethyl acetate : petrol, 50: 50); (M+ absent. Found [NM-AcOH]+, 299.1508. 
C15H2306 requires MH-60,299.1495); umax/cm-1 1729 and 1742 (4 x C=O); 
8H 0.89 QH, 
t, J 7.5,9-HA 1.67 (2H, m, 8-H2), 2.02,2.04 and 2.07 (each 3H, each s, each 02CCHA 
2.12 (1H, m, 6-H), 3.07 (2H, m, 4-H2), 3.72 (3H, S, C02CHA 4.23 (2H, 
dd, J 12 and 5,6- 
CH2), 4.95 (1H, dt, J 7.5 and 5.5,7-H), 5.32 (1H, td, J 7.5 and 3.5,5-H), 5.89 (IH, ap dt, J 
11.5 and 1.5,2-H) and 6.19 (IH, ap dt, J 11.5 and 7.5,3-H); 
8C 9.73 (C-9), 14.13 (C-8), 
20.95 (C-4), 21.02,22.69,23.48 (3 x 02QCH3), 24.67 (C-6), 43.49,51.21,60.86 and 
61.71 
(C-5, C-7, CO2-C-H3,6-CH2), 121.96 (C-2), 148.99 (C-3), 166.39 (C- 1) and 
170.27,170.51 
103 
and 170.89 (3 x 02-CCH3); m/z (CI) (MH+ absent), 355 (13%), 353 (34), 339 (3), 299 
([MH-601+, 22), 239 (10), 195 (26), 125 (24), 123 (25), 111 (18), 95 (87) and 94 (100). 







OAc AcO AcO 
DBU + (187) 
TBF 
eO2C (185) R Me02C 
(186) 
C02me 
The triacetate (185) ('27'mg =- 18.5mg, 0.0517mmol) was stirred at room 
temperature for 0.75h in TFIF (3ml) and DBU (0.05ml, 0.334mmol), but no change in 
Rf was noted; thus the reaction was heated to reflux for 1.25h and TLC analysis 
indicated no starting material remained. The reaction was cooled and dilute sulfuric 
acid added until pH 3 was attained. The usual extraction procedure was followed, albeit 
acidic, to give a bright brick red semi-solid (50mg). Column chromatography, using 
ethyl acetate : petrol (10: 90), returned a pale yellow liquid containing products 
tentatively identified as the diacetates (186) and (187) (4.8mg, 0.0161mmol, 31%); m1z 
(CI) 299 ([MHI+, 9%), 257 (7), 239 (5), 238 (18), 194 (58), 179 (4), 146 (32), 119 (28), 
96 (94) and 94 (100). IH and 13C NMR spectra and MS did not enable complete 
identification (the high resolution MS of the starting material (185) did not give the 
molecular ion, but eliminated to a diacetate, [NM-AcOHI+ = 299.1508, whilst the 
mixture of (186) and (187) did not give a molecular ion from high resolution MS); the 
IH NMR spectrum is included in the Results and Discussion (section 2.4). 
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STUDIES TOWARDS THE SYNTHESIS OF lpg2a- 
DIMETHYL GIBBERELLINS 
CHAPTER FOUR: 
Introduction, Results, Discussion and Conclusions 
4 Introduction, Results, Discussion and Conclusions 
4.1 General Introduction 
Year 1850 1900 1950 1960 1992 2000 
L_Population (x 109) 1 1.1 1.5 2.5 3.1 5.3 (6) 
__j 
Table 4.1: Global population figures and prediction for the milleniuml. 
The worlds' population has grown following a exponential curve, whilst food 
production has only increased in a linear manner, as predicted by Malthus last century. 
Various factors such as protectionism and war as well as poor methods of cultivation, 
storage or distribution have hindered efforts to eradicate hunger, such that 26 countries 
depended on external food aid in 19922. 
Approaches to arable food production improvements post World War Two have 
advocated high intensity farming, with concurrent high usage of organochemicals, 
which frequently have a negative environmental impact. For example, pesticides, 
herbicides and fertilizers may be toxic to both flora and fauna, require financial outlay, 
need equipment for dispersion and long term effects on food chains are unknown3. 
Used at a high level, as in much of the developed world, organonitrates and phosphates 
can cause stem weakness and lower the quality of grains, and with resistance to 
pesticides increasing, the chances that novel chemicals will enable further production 
enhancement appear slim3,4. Thus the use of genetically produced hybrids has been 
developed which are high yielding, e. g., rice breed 1R8, but these tend to require much 
use of chemical treatment and also have very low resistance to fungal or microbial 
overgrowth5. Also, the breeding programmes are long term and tend to be based in 
developed countries. 
Thus the use of biological control agents has been investigated, from the use of 
predator animals such as spiders to control insects6, to the use of plant growth 
regulators7' such as natural plant hormones, hormone mimics, hormone antagonists, 
growth retardants, growth inhibitors, defoliants, desiccants, ripening agents or 
hormone 
113 
transport inhibitors. The natural phytohormones are: auxin, which is indole acetic acid 
(first identified as an active agent in oat coleoptiles by Charles and Frances Darwin in 
1867); the gibberellins; cytokinins, which are purines derived from nucleic acids, e. g., 
zeatin (identified in 1968); abscisic acid, a terpene-derived unsaturated acid (isolated in 
1963); and ethylene gas, (first isolated as an emittant from apples in 1934)8. All have a 
variety of effects at low concentration, and often work in synergy; however both auxins 
and gibberellins enhance stem elongation by increasing the internodal distance (and 
cytokinins by improving cell division rates) and this is the principal area of application 
for enhanced food production, so that crops may grow faster towards light than weeds. 
Numerous synthetic analogues have been made of the various phytohormones, but 
especially the auxins, such as Agent Orange. 
4.2 Discovely and Structure of Gibberellins 
The bakanae ("foolish seedlings") disease of rice, when excessively tall plants 
were obtained that gave poor crop yields, was first noted in Japan. Initially scientists in 
the 1920's at Tokyo University isolated the fungal culture which caused the disease as 
Fusarium moniliforme (the imperfect form of Gibberella fujikuroi); the active 
compound gibberellic acid (GA3) was first crystallised in 1935 and identified as a 
tetracyclic diterpenoid secondary metabolite, with two more gibberellins characterised 
in 19389,10,11. In 1954 (in Britain) a gibberellin was isolated directly from a higher 
plant, and identified as being the same as the third Japanese product 
isolated and named 
GA18; the structure was determined in 195812. 
To date 108 gibberellinsI3, numbered sequentially upon discovery, have 
been 
found in a variety of fungi and eucaryotic plants, although only a 
few are available 
commercially (GA3,4,7,13), but the first gibberellin 
identified in plants (GA1) (1) is not 
commercially available 11. Total syntheses of gibberellins 
have been reported, but as 
with the steroids these are lengthly and of very 
low overall yield14, hence the 
commercially available compounds are used 
in semi-synthetic procedures to obtain 
target molecules15. The numbering system (the 
C20 gibberellin is numbered as an 
example) is based upon the gibberellane skeleton which 
is itself based upon steroid 
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structure numbering, but all the natural gibberellins have the enantiomeric 
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Figure 4.1: Structure of common C19 and C20 gibberellins. 
4.3 Biosynthesis of Gibberellins 
The biosynthesis of gibberellins has been extensively reviewed17-20. The first 
tetracyclic precursor is ent-kaurene (7) which is derived from mevalonic lactone (6), 
and formation of (7) follows the same path in all eucaryotes (scheme 4.1)21. Variations 
in the biosynthetic pathways and metabolites between different organisms follow from 
(7), but all are based largely upon hydroxylation and oxidation; the path denoted is that 
ftom G. fujikuroi 22. 
The C- 19 of (7) is sequentially oxidised to ent-kaurenoic acid (8) where it may 
be cyclised via a 6,7-epoxide to the kaurenolides, e. g., (9) or oxidised at the 7 position 
to a beta alcohol (10). The latter may be oxidised to the seco-ring B acids (11) or 
undergo a ring contraction to GA12 7-aldehyde (12); the aldehyde is either then 
oxidised to the acid (GA12) (13) which leads to further C20 and C19 gibberellins, or 
hydroxylation occurs at C-3 to give (14) (which is typical of fungi, in higher plants 13- 
hydroxylation tends to occur at the equivalent point in the synthesisl 1). The aldehyde 
functionality of (14) is then oxidised to form C20 gibberellin dicarboxylic acids, e. g., 
GA14 (15), for further gibberellin anabolism. Sequential oxidation of the 20-methyl via 
an alcohol gives an aldehyde which is the immediate precursor to the more prolific and 
potent C19 gibberellins, e. g., (2). From the many side reactions, the possibilities of 
isolating many more kaurenes or gibberellic acids are numerous, as new species of 
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Scheme 4.1: Overview of biosynthesis of gibberellins in G. fujikuroi. 
4.4 Hydroxylation and Catabolic Studies 
Gibberellins are involved in the control of much plant development and 
growth 14,17-19. However, some features added at various positions of the ent- 
gibberellane skeleton confer much improved biological activitY20-22: a 3p-hydroxyl 
derivative is more active than if an (x-OH or no hydroxyl is present, and a free 7- 
carboxylic acid is necessary. A 19,10 y-lactone imparts high activity, the precursor C20 
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gibberellins have lower activity than their C19 successors. The presence of the 13- 
hydroxyl has not been proved as a necessity for activity. 
GA1 (1) has been suggested to be the only active GA in higher plants from 
studies using dwarf mutants of pea and maize9,10, but GA3 (3), which shows similar 
activity in bioassays has been found in the stem fluids of Carica papaya23 (papaya) and 
Camellia sinensis (tea)24. Whilst GA4 has been found in higher plants in ViV025' it is 
metabolized in Zea mays (maize, aka corn) to GA126 and the (inactive) 20-hydroxyl 
metabolite GA34 (16), has not been found, so GA4 is not proven to be inherently 
bioactive. Although hydroxylation can occur in vivo at C-13 and on any primary or 
secondary carbon except at C-1427, the pattern of hydroxylation depends on the 
particular tissue or species concerned28; however, at the end of the useful biological 
role of the GA, the catabolic pathway is entered where the gibberellins are generally 2p- 
hydroxylated, an irreversible method of complete deactivation prior to further 
degradation29. As the mode of deactivation of GA3 is unknown, this is part of the 
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Hydroxylation at C-1 occurs also, e. g., GA60 and GA61 (which have lp-OH) are 
found in Triticum aestivum (wheat)25, and GA16 (which is W-hydroxy GA4) found in 
G. fujikuroi, but as these have lower activity than their non-hydroxylated precursors, 
whether these are degradation products, unwanted metabolites or useful hormones has 
not been determined30. Other positions of hydroxylation and their effects on flora have 
been surveyed by Graebe but whilst these show little difference to the non-hydroxylated 
parent structures on stem elongation3l, they have effects on other functions in higher 
plants (e. g. flowering)26,27. 
4.5 Applications and Commercial Uses 
As noted, the gibberellins cause stem elongation and can cause inhibition of 
flowering in dicotyledon S9,26; but other effects include breaking winter dormancy of 
seeds by inducing the synthesis of (x-amylase, (which is used in the brewing industry 
upon barley to make the wort), promoting fruit growth in grape plants, preventing pre- 
harvest drop of apples, enhancing the actions of other phytohormones (or used as 
alternatives to IAA for stem growth as gibberellins do not have much effect on rooting 
of plants)4,8,11,22. As global sales of agrochemicals were US $20,000,000,000 
in 1989, 
of which plant growth regulators were only approximately 4%, the market 
for the 
commercially underapplied hormone based market can surely expand3. 
4.6 Acid and Alkali Induced Rearrangements of the Carbon Skeleton 
13-Hydroxygibberellins can react with strong acids to form the keto-inverted C 
and D rings via a modified Wagner-Meerwein rearrangement32. 
Thus the use of dilute 
hydrochloric acid in work-up procedures is required. In 
13-dehydro gibberellins, the 
16,17-double bond rearranges to the endo-15,16-olefin. 





Scheme 4.3: Acid catalysed. rearrangements of C and D rings of 13-OH gibberellins. 
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The presence of a 3P-OH in an allylic form, as in GA3, may facilitate reaction 
with base to eliminate the carboxylate via the epoxide, which undergoes nucleophilic 












Scheme 4.4: Base catalysed rearrangements of ring A of an aflylic lactone. 
A non-allylic 3P-OH on ring A of 19,10y-lactones can also rearrange with base, 










Scheme 4.5: Base catalysed rearrangements of 30-hydroxy C19-gibberellins. 
Acid derived rearrangements of the A ring are possible also, the allylic 
stabilisation of the carbocation formed enables formation of the isolactone. However., 
the reaction occurs far more easily with alkyl substitution at the 2 position, as this 





Scheme 4.6: Acid-catalysed rearrangement of ring A. 
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C02- 
4.7 The Effects of 1- and 2- Substituents upon i - 
Biologýical Acý ýlt 
3P-Hydroxylated C19 gibberellins containing a 2(x-methyl, 2(x-ethyl or lp- 
methyl group have a ten to hundred fold increase in potency compared to the non- 
alkylated parent, and have been labelled as "superactive', 29,36,37,38. However, the 
equatorial 2p- or W- alkyl diastereomers have similar bioactivity to the natural 
precursor38,39 (figure 4.2). Larger alkyl groups at C-2 produce GA derivatives with 
little biological activity, possibly due to excessive lipophilicity, but no correlation could 

















"Superactive" "Activity similar to natural analogues" 
Figure 4.2: Effect of ring A substituents on bioactivity of GA1 derivatives. 
Only three 2,2-dialkylated gibberellins have been synthesized: the 2,2-dimethyl 
derivatives of GA140 (21) and GA437,40 (22) and 2,2-diethyl GA437,40 (23) (figure 4.3). 
The dimethyl derivatives are more active than the non-substituted precursors but not as 
potent as the mono axial substituted 2a-methyl compounds (24) and (25)29,37,39 (figure 
4.4); however the diethyl product (23) caused negligible improvement in growth 
compared to GA4 (2) in either maize or lettuce cotyledons39. 
R0 R' R= Me R" = OH (21) 
Rill / ZI R= Me R'=H (22) 90 H ''' * 
HO -H 
C02H 
R=Et R"=H (23) 
Figure 4.3: PreviOusly prepared 2,2-dialkylated gibberellins. 
The difference between the superactive gibberellins" and those of a non- 
enhanced status may be due to the rate of metabolism to 
inactive products, as bioassays 
with Z. mays have shown the molecules to 
have more prolonged rather than more rapid 
activity4l. Oxidation of gibberellins to the 
2P-hydroxylated derivatives (e. g. GAI to 
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GA8, scheme 4.2) has been shown to occur with retention of configuration42' so it 
would seem that the action of alkyl substituents is not to block directly the oxygenation, 
but to either prevent the enzyme proteins binding closely enough, or more probably to 
cause a conformational change in the A ring: axial substituents at C-1 or C-2 cause 
flattening of the ring compared to the non-substituted ring in GA143' which may cause 
the molecule not to fit into the active site. 
R' R" R= Me R" =H R'/ =H (24) 0 R, 
, R= Me R' =H f1f R = OH (25) 
ýo H 
* 
R=H HO - R' =Me R" =H 
(26) 
H C02H R=H R' =Me R" =OH (27) 
Figure 4.4: Gibberellin analogues with either a lp or 2oc-methyl group. 
However, a gibberellin analogue with both lp-methyl and 2(x-methyl (ie both 
diaxial) substituents has not been prepared. lp, 2(x-Dimethyl GA1 (28) was the initial 
target of this project as a potential "'superactive" gibberellin; however, whether the 
effect of two axial groups would flatten ring A and thus cancel each others effects, 
cause an additive effect or give the desired synergy can only be detem-lined upon 
bioassay; the GA4 (29) analogue was a second target. The diequatorial. substituted 
compounds, which would be interesting developments of the mono-equatorial 
derivatives were also required (figure 4.5). 
0 R" R= a-Me W= P-Me R" = OH (2 8) 




P-Me R'= cc-Me R" =H or OH 
C02H 
Figure 4.5: Target 1,2-dimethyl gibberellins.. 
4.8-Previous Syntheses of 1- and 2- Alkylated Gibberellins 
Diequatorial isomers 
Use of 3-oxo-GA9 methyl ester (30) enabled formation of an enolate, which 
could be quenched with a variety of plectrophiles to 
form 2-alkylated derivatives. 
Reaction of (30) with two equivalents of potassium t-butoxide and methyl 
iodide gave 
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the 2,2-dimethyl-3-oxo-GA9 methyl ester (31), plus the A-ring seco-acid (32) and the 
enol ether (33)37 (scheme 4.7 and table 4.2). Sodium borohydride reduction of (31) 
gave the 3p-alcohol (the desired stereoisomer) which on de-esterification gave 2,2- 
dimethyl GA4 (22). 
Repeating the experiment using only one equivalent of methyl iodide gave the 
desired product, 2p-methyl-3-oxo-GA9 methyl ester (34), accompanied by three 
unwanted by-products (scheme 4.7 and table 4.2). Reduction of the ketone of (34) with 






























Scheme 4.7: Enolate of (30) treated with methyl iodide to give (35) via (34)37. 
Amount of Mel added (31) (32) (33) (34) (30) 
Two equivalents 56% 14% 8% Nil Nil 
One e nt 11% 13% <1% 14% 10% 
Table 4.2: Products and yields from treatment of enolate of (30) with methyl iodide. 
Due to traces of water in the potassium t-butoxide, the retro-Claisen reaction to 
form (33) was possible; to avoid this, treatment of the free acid 
(36) with LDA and 
methyl iodide gave (37) as the sole product; the 
ketone was reduced with sodium 
borohydride to give a mixture of the diastereomers (22) and 






LDA 0- 'PrOH , Mel H NaBH4 ý 
(36) (37) 30% 30-OH (2 2) 40% 
3cc-OH (38) 60% 
SCheme 4.8: Preparation of 2,2-dimethyl GA4 (22). 
Due to the higher bioactivity of 2,2-dimethyl GA4 (22) compared to GA4 (2), 
other dialkylated products were required for bioassay. Treatment of 3-oxo-GA9 methyl 
ester with LDA followed by ethyl iodide returned only starting material39. This may be 
due to ethyl iodide being thirty-seven times less active than methyl iodide44; tosylates 
showed no greater reactivity to SN2 attack than iodides. However, the addition of 
HMPA enabled formation of the desired product (41) in low yield, but also aided 0- 
alkylation, so ethyl-enol ethers were formed (scheme 4.9)39. Treatment of the 2,2- 
diethyl-3-ketone (41) with sodium borohydride gave a 1: 1 mixture of diastereomeric 
alcohols, which were separated and the 3P-alcohol was de-esterified with sodium 










































Scheme 4.9: Synthesis of 2,2-diethyl GA4 (23)39. 
H 
(41) 
Treatment of 3-oxo-GA20 methyl ester (the 13-hydroxyl analogue of 
3-oxo-GA9 
methyl ester (30)) with LDA and methyl 
iodide gave a complex mixture of products. It 
C02CH3 
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is not evident why a 13-hydroxyl group should be interfering with this reaction, but 
even when the alcohol was protected, a complex mixture of products was formed in the 
enolate reaction. To overcome the problem, 2,2-dimethyl-GAl (21) was prepared by 
incubation of 2,2-dimethyl-GA4 (22) with G. fujikuroi mutant BI-41a (which can 
hydroxylate at the 13 position) in 60% yield40. 
Due to the inherent problems with this enolate chemistry to prepare 
monoalkylated gibbrellins, an alternative approach was investigated. 
R=Me (46) 0 
Et (47) / -A 90 
nPr (4 8) HO :ý, t 













1) (BU3Sn)20 R/ /- 
2) BU3SnH 90 (45) 
3) AcOH HO 
*H 
Scheme 4.10: SN2' anti cuprate reactions upon GA3 (3). 
Reaction of (3) with lithium dialkyl cuprates (Gilman reagents) resulted in anti- 
SN2' displacement of the allylic lactone to give an acid (44)45. Regeneration of the 
19,10y-lactone by an iodolactonisation procedure derived from a method by Corey46 
gave (45), which, via a radical reduction on the stannane ester, gave 2P-alkylated 
gibberellins (46) to (49). Whilst the 2P-methyl acid (46) formed in 100% yield, 
attempts to form larger 20-alkyl derivatives were limited by steric effects, as seen 
in 
table 4.3; the increase in syn products may be due to interactions between the 3p- 
hydroxyl and the cuprate. Thus an alternative route to addition of more 
bulky alkyl 
groups was required, especially for secondary and tertiary alkyl groups, which 
did not 
add under these conditions39. 
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_R 
group Me Et npr nBu 
% Anti addition 100 90 70-80 60 
% Syn addition 0 Trace 10-15 30- 
Table 4.3: Addition of lithium dialkylcuprates to GA3 (3). 
Similar work by Beale using lithium dimethylcuprate upon GA3 methyl ester 
(50) followed by methylation in situ with diazomethane gave 95% (51) and 5% of the 
1OP-methyl compound (52), indicating some SN2 displacement was occurring (scheme 
4.11). Use of higher order cuprates increased the amount of by-products formed and 
conversion was no longer quantitative47. 
0 kin 
1) Me2CuLi 
2) HCI( ýo H ... aq) 
HO 3) CH2N2 
HO 
H 
H Z-'O 2CH3 C02CH3 
(50) (51) 95% 
C02CH3 
(52) 5% 
Scheme 4.11: SN2' anti cuprate reactions upon GA3 methyl ester (50). 
Reaction of 2-bis(methylthio)methylene-GA9 methyl ester (53) with two 
equivalents of lithium dimethylcuprate gave the dimethylated derivative (54), whereas 
with four equivalents of cuprate the 2p-t-butyl derivative (55) was the major product 
(scheme 4.12)48. Reduction of both (54) and (55) under Luche conditions gave 
predominantly the 3(x-alcohols (56) and (57). However, on 
demethylation of the 7- 
methyl ester, epimerisation occurred at C-3 giving the required 
3P-alcohols (58) and 
(59). Treatment of the dithiomethylene (53) with a zinc-copper couple gave the mono- 
thioenol (60) which on reaction with lithium dimethylcuprate, gave a mixture of 
both 
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Treatment of (63) with Pd(PPh3)4 and nBu3SnH gave both 2cc- and 2p-ethyl-3- 
oxo gibberellins (64). Reaction of (63) with a zinc-copper couple and acetic acid 
did 
not produce the expected 2oc-ethyl GA4, but yielded a mixture of 
2-ethyl-3-oxo 
gibberellins (64) plus 2-(E)-ethylidene-3-epi-GA4 
(65) (scheme 4.13)36 
0 00 
Et Zn-cu n]BU3SnH 
Co + Co AcOH 90 Pd(PPh3)4 
HO 00 
HH 
(65) (64) (63) 
Scheme 4.13: Reduction of (x, p-unsaturated ketone (63). 
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Reduction of 2P -isopropyl- 3 -ketone (62) with sodium borohydride in 
isopropanol gave a mixture of the 3(x- and 3p- alcohols (66) and (67) which were 
separated by flash chromatography (scheme 4.14)48. Treatment of the 3P-alcohol (67) 





















(62) 3a-OH (6 6) 
3D-OH (6 7) 
Scheme 4.14: Preparation of 2p-isopropyl GA4 (68)48. 
Attempts to reduce 2a-isopropyl- 3 -ketone (61) to the corresponding 3P-alcohol 
(70) were unsuccessful. Treatment of (61) with sodium borohydride in isopropyl 
alcohol led to isomerisation at C-2, giving the 20-i sopropyl- 3 -alcohols (66) and (67). 
When the reduction was repeated using sodium borohydride in ether or with sodium 
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Scheme 4.15: Attempted reductions of 2(x-isopropyl ketone. 
(67) 
Using the methods described above, a series of 2p-alkylated gibberellins were 
prepared but the synthetic routes did not give reliable access 
to 2(x-alkylated 














Treatment of GA. 3 methyl ester (50) with a copper catalysed Grignard reagent 
and HMPA (scheme 4.16) gave a mixture of both 2cc and 2P alkyl GAI derivatives (71), 
the ratio of which depended upon the alkyl group being added (table 4.4)49. The 
modified Grignard compound was bulky in comparison with a Gilman organometallic 
reagent due to the HMPA complexed to the magnesium, and steric interactions between 
the Grignard reagent and 30-OH hindered supra-facial attack. Treatment of (71) by 
previously described methods45 gave the de-esterified gibberellic acids (72). 
Direct preparation of 2-alkyl GA4 derivatives was only achieved with lithium 
dimethylcuprate, the use of Gilman reagents with more bulky alkyl groups caused 
elimination of the 3-hydroxyl to form a 2,1-(10)-diene; preparation of other 2-alkyl-13- 
dehydro gibberellins was possible by bridgehead deoxygenation of the appropriate 13- 
hydroxy GA via radical reduction of the oxalate ester36. 
RMgBr 
CUI CO H''i. >- 
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Scheme 4.16: Reaction of GA3 methyl ester with copper catalysed Grignard reagents. 
R group Overall yield of (71) Ratio of a 
Methyl 70% 3: 1 
Ethyl 47% =1: 1 
Propy, 41% 3: 1 
Table 4.4: Results of copper catalysed Grignard reagents addition to (50)36,45. 
Work by Beale using lithium dimethylcuprate upon the 3-tetrahydropyranyl 
ether (73) gave 100% yield of isomers (51) and (74) 
(scheme 4.17). This was due to the 
large THP group preventing the methyl 'anion' approaching the upper side of ring 
A, 
and thus enforcing syn addition. As found with the analogous reactions upon 
the free 3- 












Scheme 4.17: Reaction of (73) with lithium dimethyl cuprate. 
(74) 48% 
Methylation at the C-1 position was achieved by MacMillan and WilliS50, by 
treating the enone (75) with diazomethane to form the pyrazoline (76) and thermolysis 
gave the P-methyl-(x, p-unsaturated ketone (77). Ketone (77) was reduced with sodium 
borohydride and cuprous chloride (to facilitate 1,4 addition of hydride) to give both 1(x- 
methyl GA4 and la-methyl-3-epi- GA4 methyl esters (78) and (79) respectively, along 
with some of the 1,2- reduction product (80) (scheme 4.18). Treatment of (78) with 
sodium n-propylthiolate gave la-methyl-GA4 (81). 
H 0 
CH2N2 Nq 
IND. 0 90 HN 
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The 1-methyl enone (77) was also used a precursor to lp-methyl 
GA4 (27). 
Treatment of (77) with tri-n-butyltin hydride in the presence of palladium 
tetrakistriphenylphosphine gave an inseparable mixture of the saturated 
1-methyl 
ketones (82). Reduction of (82) with sodium borohydride, followed by demethylation 
of the 7-methyl esters and re-oxidation at 
C-3 gave lp-methyl ketone (85) and la- 
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However the mesylate (or indeed the triflate) proved remarkably stable - no 
reaction occurred under a range of conditionS52. Interestingly, displacement of a 13- 
mesylate in (88) occurred readily with Gilman reagents to produce (89)53, but no 














Scheme 4.21: Tertiary mesylate displacement by lithium dimethylcuprate53. 
Thus it was apparent that a new approach to the synthesis of lp, 2(x-dimethyl 
gibberellins was required. The proposed route is shown in scheme 4.22. It is known 
from previous work that a 2(x-methyl group may be introduced via a syn SN2' 
displacement of the allylic lactone moiety of the 3-tetrahydropyranyl ether of GA3 
methyl ester (73)49. 
It is proposed that the 1 P-methyl group is then introduced via displacement of a 
suitable leaving group at the Rx-position. This leaving group will be introduced via a 
Corey-type iodolactonisation46 to reform they-lactone (91); SN2 attack upon the axial 
iodide by an acetate (with cation counter-ion enslaved as a spectator by use of 
18-c-6) 
would give the I-equatorial ester (92), which would 
be de-esterified by aqueous 
potassium carbonate to give an alcohol (93). Use of methanesulfonyl chloride with 
base should react only with the secondary alcohol formed, and not the 
bridgehead 
hydroxyl at C-13, to form a loc-sulfonate ester (94), which a second 
Gilman agent 
should displace to form the required A ring disubstitution 
(95); deprotection of the 3p- 
alcohol and de-esterification would form the acid 
(28) for bioassay. Removal of the 3- 
hydroxyl protecting group prior to the second cuprate reaction's axial attack 
at C- I may 
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Scheme 4.22: Proposed route to lp, 2(x-dimethyl GA1 (28). 
4.10 Results and Discussion 
Gibberellic acid (GA3) (3) is commercially available from fermentation of the 
fungus Gibberella fujikuroi54. Esterification of the acid prevents unwanted side- 
reactions of the carboxylic acid and improves the solubility of gibberellins in organic 
solvents; for example GA3 is insoluble in chloroform, whereas the methyl ester (50) is 
sparingly soluble. Treatment of an available mixture of (3) and (50) with. caesium 
fluoride and methyl iodide according to the method of Otera et a155 gave the required 
ester (50) in approximately 92% yield (scheme 4.23). All subsequent reactions were 
uPon 7-methyl esters. 
0 uti 0 1-1ýn GA3 








C02H 2CH3 =92% 
(3) (50) 
Scheme 4.23: Methylation of 7-carboxylic acid. 
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The 3-THP ether (73) was prepared in 60% yield by treatment of GA3 methyl 
ester (50) with dihydropyran in the presence of CSA followed by purification of the 
reaction mixture by flash chromatography. In addition, the 3,13-diTHP derivative (96) 
(7%) and unreacted starting material (24%) were recovered; the by-product (96) could 
be recycled to (50) quantitatively by stirring in dilute hydrochloric acid, extracting and 
removing solvent; no further purification was necessary (scheme 4.24). 
The next stage of the synthesis of lp, 2oc-dimethyl GAI (29) required the 
introduction of the 2(x-methyl group via a syn SN2' displacement of the allylic lactone 
moiety. Treatment of (73) with lithium dimethylcuprate gave (97) alone, none of the 
2P-methyl derivative was isolated, in contrast with work by both Fowles using copper 
catalysed Grignard reagents49 and Beale using lithium dimethylcuprate47 (schemes 4.16 
and 4.17). 
As scheme 4.24 indicates, the yield of the 2(x-alkyl product, (97), was higher 
than those previously obtained, this may be due to the fact that pure starting material 
(73) was used. Both Beale47 and Fowles49 had previously used the crude mixture from 
the THP reaction and the by-products may have interfered with the cuprate addition. 
This hypothesis is supported by the results of reacting the 3,13-di-OTHP (96) with 
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In the proposed synthetic route to the target dimethylated gibberellin (28) 
(Scheme 4.22), it was necessary to retain a protecting group on the 3P-alcohol almost to 
the final stage of the synthesis. However, it was found that during the work-up of the 
cuprate reaction mixture under acidic conditions, the acetal was repeatedly removed (as 
had been noted previously in this reaction36,47). Only on one occasion was the 
protected derivative (90) isolated, but in a disappointing 10% yield. Thus it would be 
necessary to re-protect the 3P-alcohol at some stage prior to the introduction of a 






















The 19,10y-lactone, characteristic of the C19-gibberellins, was first regenerated 
under standard iodolactonisation conditions46,49 giving (98) in 56% yield (scheme 
4.24). Attempted protection of the 3P-alcohol of iodolactone (98) with a THP group 
failed; this was most probably due to the steric congestion caused by the transannular 
interaction between the lp-iodide and the 3P-alcohol in (98). It has been previously 
shown that the 2(x-alcohol of the 1 P-iodo-2a, 3 P-diol (99) may 
be selectively protected 
as the acetate as a result of this steric crowding of the 
3p-alcohOI56 (scheme 4.25). 
Hence it was decided to delay protection of the 3-alcohol to 
later in the synthesis. 
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6 in toluene to 99*C for 2.5 hours, to determine if a SN1 mechanism was allowing the 
loss of the iodide; however on extraction, quantitative return of starting material (98) 
was found, suggesting that the acetate anion was in fact the active nucleophile. 
Interestingly, in previous work by Fowles36,49 aimed at the preparation of 2-methyl 
GA7, neither the unsaturated alcohol or THP derivatives (105) could be isolated 
(scheme 4.27). In both cases rearrangement to the isomeric 1, (10)-ene-19,2-lactones 
(106) occurred. In the case of the 2P-methyl iodide (104), a simple E2 mechanism 
involving trans-diaxial elimination of HI was possible with the methyl group in the 
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Scheme 4.27: Previous eliminations to a 1,10 lactone36,49. 
The 1 P-1,2P-H ax. -eq. elimination is so inhibited that the iodolactone 
(98) can 
be heated in pyridine at 60"C with quantitative return of starting material (scheme 4.28), 
as the molecule is not aligned for either syn or anti elimination, but would need the ring 
to twist and distort to allow elimination. Therefore it would seem that the la-acetate, 
2(x-methyl gibberellin (101) is being transiently formed, but then immediately 
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Scheme 4.28: 3-D structures of products from treatment of (98) with alkaline reagents. 
An alternative approach for the introduction of a i(x-alcohol was via 
the direct 
SN2 displacement of the lp-iodide of (98) with hydroxide (scheme 
4.26). Ideally it is 
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necessary to protect the 3-hydroxyl group prior to reaction with base to prevent 
epimerisation at C-3 via a retro-aldol reaction35. However, since the iodolactone (98) 
did not react with DHP and CSA to form the 30-OTHP protected iodolactone (91), (N. 
B. scheme 4.25), a model study was done on the free 3P-hydroxy derivative (98), using 
mildly alkaline conditions. Use of O. 1mM NaOH (with a pH 10.2 measured) in a 
solvent that was 80% v/v water and 20% v/v acetone, returned only starting material in 
quantitative yield. Repetition of the experiment using 0.5mM NaOH (using the same 
solvent) gave 36% starting material and 15% 3(x-hydroxy iodolactone (107) (scheme 
4.26). However, the use of 3mM NaOH (in 50: 50 y/v water: TFIF), which was used to 
assess if the hydroxide was sufficiently active to displace the iodide, gave 84% (107) 
plus 12% starting material. This indicates that the nucleophilic substitution of the 
iodide with a hydroxide ion is not feasible. 
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Scheme 4.29: Preparation of ketone (110) from (97). 
OAc 
C02CH3 
Due to the lack of success using an iodolactone to obtain 
further derivatives, the 
proposed synthetic route was modified such that an alcohol rather 
than an iodide was 
introduced at C-1 during the regeneration of the 19,10y-lactone 
(scheme 4.29). 
Murofushi et a159 had treated (113) and 
(114) with 1 eq. of mCIpBA to 
synthesise GA54 (115) and GA55 
(116) respectively; however, both lactones were 
obtained in a yield of only 18% (scheme 
4.30). Treatment of the 7-methyl ester (117) 
with 1.6 eq. of mCIpBA gave the 19,10-lactone epoxide 





of which was returned to the olefin (119) in 58% yield by use of a modified Cornforth 
reaction60. No other products were identified from the peracid mediated cychsation 
reactionS59. 
R, W--H (113) 
R=H, R--OH (114) 
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Scheme 4.30: Previous mCIpBA induced lactonisation reactions59. 
Due to such low yields obtained by Murofushi on cyclisation, (97) was treated 
with acetic anhydride and p-toluenesulfonic acid to give the 3,13-diacetate (108) in 77% 
yield (scheme 4.29). This would limit by steric means the approach of the peracid to 
the exocyclic alkene, and thus avoid the need for a Comforth reaction. 
Treatment of (108) (100mg) with mCIpBA (0.85eq. ) for 26.5 hours gave only 
32% of the desired I P-hydroxy lactone (109) as well as 4% of the 16,17-epoxide 
lactone (112) and 17% starting material. A further mixture of products was obtained 
which could not be identified by IH NMR spectroscopy. Repeating the experiment, but 
using 1.3eq. of mCIpBA upon (108) for only 4.5 hours gave after purification the 
required alcohol (109) (24%), the epoxide (112) (20%), plus a further five impure and 
unidentified compounds (180mg from 370mg). 
Only one isomer of the by-product oxirane (112) was found, which was 
presumed to be the 16(x-epoxide, as work by Murofushi6l using mCIpBA upon a GA5 
derivative (scheme 4.2, GA5 = (20)) had produced only the 16(x-epoxide, probably due 
to the 13-hydroxyl directing attack via the less hindered (x face of the D ring; however 
analogous work by Reeve and Crozier upon 2,3-dehydro GA962, the 
13-dehydroxy 
analogue of GA5, had given both diastereomers of the 16,17-epoxide. 
Although the results from this reaction were disappointing, sufficient lp-alcohol 





To invert the alcohol at C- 1a two step oxidation/reduction procedure was 
favoured. (scheme 4.29). Oxidation of (109) with TPAP and the co-oxidant NMO gave 
a 1-ketone but was accompanied by elimination of the 30-acetate giving the (x, 0- 
unsaturated ketone (120), as the sole product in 83% yield. The 1H NMR spectrum of 
(120) showed a quartet (J=1.5Hz) at 6.68ppm assigned to 3-H and the 13C NMR 
spectrum showed signals characteristic of an (x, p-unsaturated ketone at 190ppm (C=O), 
136ppm (C-2) and 148ppm (C-3). On treatment of the alcohol (109) with PDC, an 
inseparable mixture of (120) and the required acetate (110) was obtained in the ratio of 
2: 1 respectively (scheme 4.3 1). This may be due to the difference in basicity between 
N-methylmorpholine (the redox product) and pyridine, the pKa's of the conjugate acids 
being 7.67 and 5.25 respectively63. 










To prevent elimination during the oxidation, it was apparent that it was 
necessary to use a protecting group on the 3-alcohol which would give a more poor 
leaving group, for example an ether. Protection of the 3- and 13-alcohols as the para- 
methoxybenzyl ethers (PMB) (121) was proposed, such a group would also add steric 
bulk to the 13 position, so inhibiting the formation of the exocyclic epoxide during 
treatment with the peracid, as well as giving a poor leaving group at 
C-3 (scheme 4.32). 
Another potential benefit from the use of a bulky and poor leaving group at the 
3 
position is that it could be put on GA3 methyl ester (50) at the start of the synthesis and 
used to direct the introduction of the 2(x-methyl group 
in the Gilman reaction. 
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Scheme 4.32: Proposed use of PMB protection to form (28). 
However, the addition of 4.5 equivalents of PMBCl with sodium hydride to acid 
(97) in TFIF gave no reaction, and heating to reflux simply led to formation of the 19- 
PMB ester (125) in 7% yield. The structure of ester (125) was determined from the 1H 
NMR spectrum which showed a singlet at 4.94ppm assigned to C02-CH2Ar, which is 
more downfield than would be expected due to an PMB ether. In addition 35% of 










H 18-c-6 C )CHA rn,, C]4,2 02CH3 C02CH3 35% 
C02H C02PN13 
(97) (125) 7% 
Scheme 4.33: The result from reacting PMBCl with the anion of (97). 
Therefore it is apparent that a different protecting group is required at 
C-3. 
Unfortunately, further work on this route was not possible due to lack of time. 
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AJ 1 Conclusions and Suggestions for urther Work 
The synthesis of the 1-oxo, 2(x-methyl intermediate (110) for the procurement of 
the target 1 P, 2(x-dimethyl GA4 (28) was achieved in a poor yield of 2.9% from GA3 in 
six steps, with several novel compounds and by-products obtained en route. 
The method of introduction of a 2(x-methyl to the gibberellin was improved 
compared to previous methods, by purification of the 3-THP protected GA3 methyl 
ester (50). The use of a different 3P-alcohol protecting group, such as a t-butyl 
diphenylsilyl ether, prior to the Gilman reaction may give improved yields by greater 
steric bulk than a THP acetal. A further advantage is that the protecting group may be 
less prone to removal under the mildly acidic work-up conditions during work-up, and 
would facilitate NMR spectra that are more easy to assign as diasteromers would not be 
formed. 
A second problem stage in the synthesis was the per-acid based cyclisation of 
(108) to form (109) (scheme 4.29), where a large amount of an epoxide by-product 
(112) was formed and much of the starting material not recovered. Three methods 
could be considered to improve this reaction: 
i) A more bulky group than the acetate could be put on the C-13 of (97) such that, on 
steric grounds, epoxidation of the exocyclic double bond would be less favourable; the 
3-para-methoxybenzyl ether was not formed, but a silyl group might be added in the 
presence of a free 19-carboxylic acid. 
ii) A more stable protecting group could be put on C-3 (and C-13) of (97) which would 
not be cleaved during the reaction. 
iii) Addition of an excess of per-acid to enable both double bonds to react, then 
regeneration of the exocyclic double bond from the 16,17-epoxide by the Cornforth 
method6O, as has been undertaken previously on gibberellins59,61,62,64. 
Elimination of the acetate in (110) to the unwanted (x, o-unsaturated ketone 
(120) 
may be avoided by use of a more mild oxidant than 
PDC, such as the alkyl 
cyclochromate (figure 2.3) or silver carbonate on celite65. 
Another possibility is the use 
of an alcohol dehydrogenase enzyme66 to form the 
ketone (110); alternatively, a whole 
cell culture, e. g., Rhodococcus erythropolis can invert an alcohol 
directly67, so may be 
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effective upon (109). Similarly an lipase enzyme such as that from Candida rugosa 
(previously named C. cylindracea) in phosphate buffer may lyse an ester without any 
elimination occurring68. 
Formation of the 2p-methyl derivative (126) via a favoured anti SN2' attack 
should proceed in higher yield than syn addition, which could be cyclized with a peracid 
(127) (scheme 4.34). Addition of a poor leaving group added at the 3 position would 
prevent elimination when the 1-keto group was formed (128). Nor would the poor 
leaving group at C-3 eliminate when base was used to invert the 20-methyl, via the 
enolate and quenching with a bulky proton source to the desired 2a-methyl (129), or 
when the la-alcohol (130) was formed by using hydride. The suggested new synthesis 
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Scheme 4.34: Overview of possible route to lp, 2a-dimethyl GA1 (28). 
Thus there are several avenues open for more developments to synthesise the 
possible 'super-active' target molecule GAI 
(28) and the GA4 analogue (29); plus as 
biological controls, the la, 2p-dimethyl GAI and 
GA4 equatorially substituted isomers 
(figure 4-5). 
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STUDIES TOWARDS THE SYNTHESIS OF lp, 2cc- 
DIMETHYL GIBBERELLINS 
CHAPTER FIVE: 
Experimental and References 
5 Experimental Details and References 
5.1 Standard Work-UDProcedure for Gibberellin Products 
The methods were the same as for the intermediates towards the mycinolide 
(section 3.1), but using an acid rather than alkaline work-up media: dilute hydrochloric 
acid was added until approximately pH 3 had been obtained, then extracted with 
organic solvents. Cuprous iodide was recrystallised69 and stored at =125'C and 
=25mmHg until immediately prior to use. The sole UV spectrum was obtained from a 
Shimadzu UV1608 using 1cm path length quartz cells. 
Any deviations from these procedures were noted. 
5.2 EUerimental 
ent-3oc, IOP, 13-Trihydroxy-20-norgibberella-1,16-diene-7,19-dioic Acid 7-Methyl 
Ester 19,10-Lactone (50) 
0 Uktij 0 GA3 
methyl 
Z- 
90 H+ ýo H -CsF ester 
4H 
H HO Mel (50) HO 
4H 
H 
2 M3 C 00,2 TH 
(3) (50) 
r1o a mixture of GA3 methyl ester (50) and GA3 (3) in approximately 2: 1 ratio 
(6.01g, 11.32 and 5.66mmol respectively) in DMIF (50ml) were added caesiurn fluoride 
(2.13g, 14. Ommol) and methyl iodide (1.3ml, 14. Ommol), and stirred under anhydrous 
and light-free conditions for 47h. The reaction mixture was then 
diluted with brine, and 
worked-up as usual. The solvents were removed under 
0.3mm. Hg pressure, to give GA3 
methyl ester (50) (5.96g, 16.55mmol; -11.32mmol = 
5.23mmol, 92%); Rf = 0.68 (100% 
ethyl acetate); mp 203-206*C (from chloroform and carbon 
tetrachloride) (lit. 34,208- 
210"C); 5H ((CD3)2CO) 1.16 (3H, s, 18-H3), 2.71 (1H, d, J 10.5,6-H), 
3.26 (IH, d, J 
10.5,5-H), 3.71 (3H, s, OCH3), 3.83 (1H, br s, OH), 4.06 (1H, m, 
3-H), 4.88 (1H, s, 17- 
H), 5.21 (1H, s, 17-H), 5.89 (1H, dd, J 9.5 and 3.5,2-H), and 
6.30 (1H, d, J 9.5,1-H); 
m1z 360 (M+, 20%), 342 (15), 328 (26), 
316 (23), 298 (58), 255 (41), 238 (70), 209 
(44), 155 (43), and 136 (100). 
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ent-100,13-Dihydroxy-3(x-0-tetrahydropyranyl-20-norgibberelia-1,16-diene-7ý19- 
dioic Acid 7-Methyl Ester 19,10-Lactone (73) and ent-100-Hydroxy-3003-di-O- 
tetrahydropyranyl-20-norgibberella-1,16-diene-7,19-dioic 
Acid 7-Methyl Ester 
19,10-Lactone (96) 
0 OH ol 
DBP 















(96) + (50) 
GA3 methyl ester (50) (1.102g, 3.06mmol) in DCM (50ml) was treated with 
CSA (121mg, 0.5mmol) and 3,4-dihydro-2H-pyran (0.35ml, 3.84mmol) under 
anhydrous conditions at OT. This was allowed to attain room temp. for 29h and made 
to pH =8 with sodium hydrogen carbonate, and then the crude extract obtained as usual 
except utilizing an alkaline process instead of an acidic environment. The product was 
purified by column chromatography eluted with ethyl acetate : petrol (20: 80), to give as 
a pale yellow oil the bis-tetrahydrapyranyl ether (96), (112mg, 0.212mmol, 7%), the 
two diastereomers in a ratio of 59: 41 (measured by 1H NMR spectra integrals); Rf = 
0.84 (ethyl acetate : petrol, 50: 50); (Found [MH]+, 529.2798. C30FI4108 requires MH, 
529.2801); 10max/cm-1 1074 and 1123 (0-C-0) and 1736 and 1777 (C=O). Major 
isomer, 8H 1.18 QH, s, 18-H3), 2.78 (1H, d, J 11,6-H), 3.32 (1H, d, J 11,5-H), 3.73 
QH, s, OCH3), 4.01 (IH, d, J 3.5,3-H)g 4.64 (IH, m, O-CH-0), 4.79 (IH, m, O-CH-0), 
4.99 (IH, s, 17-H), 5.11 (1H, s, 17-H), 6.00 (IH, dd, J 9.5 and 3,2-H) and 6.25 (lH9 d, 
J 9.5,1 -H); 8C 14.41 (C- 18), 16.67 
(C- 11), 19.80,20.11,25.24,25.40,30.53 and 31.68 
(6 x THP: CH2), 38.37. ) 
40.94 and 43.78 (C- 12, C- 14, C- 15), 49.94 and 53.45 (C-4" C- 
8), 50.89,51.05,51.98 and 53-11 (C-5, C-6, C-9, OCH3), 62.73 and 63.05 (2 x THP: 
CH20), 76.66 (C-3)9 83.43 (C- 13), 90.64 (C- 10), 94.69 and 101.94 (0-CH-O)i 108.04 
(C-17), 131.71 and 132.72 (C-1, C-2), 153.96 (C-16)9 
172.52 (C-7) and 178.52 (C-19). 
Minor isomer, 8H 1.28 (3H, s, 18-H3), 2.76 (1H, d, J 11,6-H), 
3.32 (IH, d, J 11,5-H), 
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3.73 (3H, s, OCH3), 4.19 (1H, d, J 3.5,3-H), 4.57 (1H, m, O-CH-0), 4.64 (1H, m, 0- 
CH-0), 4.96 (1H, s, 17-H), 5.26 (1H, s, 17-H), 6.00 (1H, dd, J 9.5 and 3,2-H) and 6.33 
(1H, d, J 9.5,1 -H); 5C 14.81 (C- 18), 16.91 (C- 11), 19.26,20.11,25.29,25.40,30.62 
and 31.69 (6 x THP: CH2), 36.37,41.57 and 44.42 (C- 12, C- 14, C- 15), 49.15 and 53.26 
(C-4, C-8), 50.72,51.38,51.86 and 53.00 (C-5, C-6, C-9, OCHA 62.51 and 62.73 (2 x 
THP: CH20), 70.70 (C-3), 82.40 (C- 13), 90.70 (C- 10), 95.40 and 10 1.94 (0-CH-0), 
108.32 (C-17), 129.66 and 133.17 (C-1, C-2), 154.60 (C-16), 172.58 (C-7) and 178.52 
(C- 19). m1z (CI) 529 ([MH]+, 3%), 473 (3), 459 (1), 445 (21), 427 (15), 361 (16), 343 
(67), 281 (75), 239 (93), 103 (15) and 85 (100). 
Further elution with ethyl acetate : petrol (30: 70) gave the desired 3-0 protected 
alcohol, a crisp white bubbly solid (73), (814mg, 1.83mmol, 60%), of two 
diastereomers in a ratio of 67: 33 (measured by 1H NMR spectra integrals); mp 99- 
101"C (from chloroform and petrol) (lit., product not fully characterised previously47); 
Rf = 0.48 (ethyl acetate : petrol, 50: 50); (Found C, 67.5; H, 7.4%; [MH]+, 445-2214. 
C25H3207 requires C, 67.6; H, 7.2%; MH, 445.2226). Major isomer, 8H 1.19 (3H, s, 
18-H3), 2.75 (1H, d, J 11,6-H), 3.33 (1H, d, J 11,5-H), 3.52 (1H, m, 3-H), 3.73 (3H, s, 
OCH3), 4.65 (1H, dd, J 4.5 and 2.5, O-CH-0), 4.96 (1H, s, 17-H), 5.28 (1H, s,, 17-H), 
5.99 (1H, dd, J 9.5 and 3.5,2-H) and 6.26 (IH, d, J 9.5,1-H); 8C (30OMHz) 14.47 (C- 
18), 17.01 (C- 1 1)q 19.85,25.23 and 30.55 (3 x THP: CH2), 38.26,43.11 and 44.77 (C- 
12, C- 14, C- 15), 50.37 and 53.36 (C-4, C-8), 50.77,51.04,52.20 and 53.15 (C-5, C-6, 
C-9, OCH3), 63.19 (THP: CH20), 76.67 (C-3), 78.24 (C-13), 90.50 (C-10), 102.10 (0- 
CH-0), 107.54 (C- 17), 131.65 and 132.85 (C- 1, C-2), 157.14 (C- 16), 172.80 (C-7) and 
178.91 (C-19). Minor isomer, 6H 1.28 (3H, s, 18-H3), 2.78 (1H, d, J 11,6-H), 3.21 
(1H, d, J 11,5-H), 3.52 (1H, m, 3-H), 3.74 (3H, s, OCH3), 4.81 (1H, m, O-CH-0), 4.96 
(1H, s, 17-H), 5.28 (1H, s, 17-H), 6.02 (1H, dd, J 9.5 and 
3.5,2-H) and 6.34 (1H, d, J 
9.5,1 -H); 6C (30OMHz) 14.81 
(C- 18), 17.02 (C- 11), 19.23,25.29 and 30.62 (3 x THP: 
CH2), 38.31,44.81 and 44.83 (C-12, C-14, C-15), 50.09 and 
53.49 (C-4, C-8), 50.85, 
50.95,52.08 and 52.81 (C-5, C-6, C-9, OCH3), 62.54 
(THP: CH20), 70.69 (C-3), 7 8.24 
(C- 13), 95.36 (C- 10), 94.41 (0-CH-0), 107.51 (C- 17)ý 129.78 and 133.10 
(C- 1, C-2)j 
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153.85 (C-16), 172.82 (C-7) and 178.93 (C-19). m1z (CI) 445, ([MH]+, 18%), 427 (10), 
413 (3), 395 (5), 383 (28), 361 (12), 343 (70), 299 (58), 281 (98) and 239 (100). 
Further elution with ethyl acetate : petrol (50: 50) gave starting material (50), 
(260mg, 0.722mmol, 24%), a white powder, Rf = 0.21 (ethyl acetate : petrol, 50: 50), 
data as previously reported. 










The di-protected alcohol (96) (112mg, 0.212mmol) was dissolved in methanol 
(6ml) and 0.001M hydrochloric acid (3ml) added. TLC analysis after 18h indicated no 
starting material present, so the product was obtained by an alkaline extraction as for 
the THP protection reaction. The crude product obtained did not require further 
purification, as it corresponded by both TLC and IH NMR analysis with GA3 methyl 
ester (50) (80mg, 0.222nunol, an excess of possible maximum yield). 
ent-3a, 13-Dihydroxy-2p-methyl-20-norgibberella-1(10), 16-diene-7,19-dioic 
Acid 7- 
Methyl Ester (97) and ent-13-Hydroxy-2p-methyl-3oc-0-tetrahydropyran-yl-20- 





ýo H 2) dil. HCI(aq) 
HH 
HO 




To a suspension of cuprous iodide (2.51g, 13.2mmol) 
in ether (20ml) at -10*C 
was added methyl lithium in ether (17ml, 1AM, 
23.8mmol) over 0.2h until a clear pale 
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brown solution was formed, and stirred for 0.5h. The dimethyl cuprate solution was 
added to the THP protected alcohol (73) (800mg, 1.80mmol) in ether (20ml) at -78*C 
over 0.25h, and a deep canary yellow solution formed, which was allowed to reach 
room temp., and held thus for 2.25h. The temperature was lowered to O*C and dilute 
hydrochloric acid added dropwise until pH 3-4 was obtained, and left to stir for =0.1 h. 
Saturated aqueous sodium hydrogen carbonate was added until pH =8.5 was reached, 
and the aqueous system extracted with ethyl acetate (6 x 30ml). The combined organic 
fractions were separated, and the pH lowered with dilute hydrochloric acid (20ml) and 
stirred for 3.25h, and the normal extraction procedure followed. Following column 
chromatography, eluting with ethyl acetate : petrol (50: 50), a pale cream solid of bubbly 
appearance was obtained, (97) (480mg, 1.28mmol, 71%), mp 95-98*C (from DCM, 
carbon tetrachloride and petrol) (lit. "a gUM-49); Rf = 0.44 (100% ethyl acetate); 6H 
((CD3)2CO) 1.12 (3H, d, J 7.5,2-CH3), 1.33 (3H, s, 18-H3), 2.99 (1H, m, 5-H), 3.13 
(1H, d, J 6,6-H), 3.70 (3H, s, OCHA 3.87 (1H, d, J 9.5,3-H), 4.95 (1H, s, I-H), 5.00 
(1H, s, 17-H) and 5.07 (1H, s, 17-H); m1z 376 (M+, 8%), 358 (33), 340 (6), 326 (16)) 
316 (17), 283 (14), 254 (14), 253 (100) and 235 (13). 
0 UH 






C02CH3 C02H C02H 
(73) (90) (97) 
Using the previous method of a Gilman reaction upon (73) (252mg, 
0.670mmol), following work-up and column chromatography, upon one occasion only, 
the 3-OTHP protected acid (90) (54mg, 0.099mmol, 10%) was initially eluted as a 
colourless and liquid (ethyl acetate : petrol, 30: 70). Rf = 0.43 (ethyl acetate : petrol, 
50: 50); (Found [MH]+, 461.2552. C26H3607 requires MH, 461.2539); 5H (300 MHz) 
major isomer 1.10 QH, d, J 7,2-CH3), 1.34 QH, s, 18-H3), 
3.01 (1H, m, 5-H), 3.48 
(1H, d, J 6,6-H), 3.59 (1H, d, J 2,3-H), 3.71 QH, s, OCH3) and 4.96 and 4.99 QH, m, 
1 -H and 17-H2); minor isomer 1.12 
QH, d, J 7,2-CH3), 1.39 QH, s, 18-H3), 3.01 (1H, 
m, 5-H), 3.53* (1H, m, 6-H), 3.56* (1H, m, 3-H), 3.66 (3H, s, 
OCH3) and 4.96 and 4.99 
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(3H, m, 1-H and 17-H2); *[signals overlap]. m/z (CI) 461 ([MH]+, 23%), 443 (7), 407 
(30), 389 (36), 377 (29), 375 (26), 359 (60), 327 (63), 299 (91) and 253 (100). 
Further elution with ethyl acetate : petrol (50: 50) gave the 3-hydroxy acid (97) 
(154mg, 0.307mmol, 34%), with spectral data as obtained previously. 
ent-3a-Acetoxy-10P, 13-dihydroxy-la-iodo-2p-methyl-20-norgibberell-16-ene-7,19- 
dioic Acid 7-Methyl Ester 19,10-Lactone (131) and ent-loc-lodo-2p-methyl- 
3a, IOP, 13-trihydroxy-20-norgibberell-16-ene-7,19-dioic Acid 7-Methyl Ester 19, 
10-Lactone (98) 
H Iodine 








The acid (97) (480mg, 1.28mmol) was rapidly stirred in DCM (15ml), THF 
(12ml), saturated aqueous sodium hydrogen carbonate (7ml) and iodine (379mg, 
1.49mmol) at room temp. for 0.9h. Sodium thiosulfate (=lg) was added, followed by 
the standard work-up procedures to yield an off-white solid. 
Subsequent 
recrystallisation returned white flakes of the iodolactone 
(98) (360mg, 0.717mmol, 
56%); Rf = 0.57 (ethyl acetate : petrol, 65: 35); mp 181-83*C 
(from carbon tetrachloride 
and petrol), (lit. 185-C, 49); 8H 1.18 (3H, s, 18-HA 
1.22 QH, d, J 6.5,2-CHA 2.15 
(1H, d, J 15.5,15-H), 2.32 (1H, d, J 15.5,15-H), 2.72* (1H, d, J 10,6-H), 2.75* 
(1H, t, 
J 9,9-H), 3.66 (1H, m, 3-H), 3.75 (3H, s, OCHA 3.78 (1H, d, J 10,5-H), 
4.38 (1H, d, J 
5,1-H), 5.00 (1H, br s, 17-H) and 5.28 (1H, br s, 17-H) [* signals overlap]; m1z 
502 
(M+, 49%), 444 (22), 443 (88), 375 (25), 357 (100), 343 (46), 330 (27), 
329 (95), 325 




From one such reaction as well as the desired iodolactone (98) (154mg, 
0.307mmol, 46%) being eluted from a chromatographic column, initial elution with 
ethyl acetate : petrol (30: 70) gave a clear liquid, the 3-0-acetylated product (131), 
(54mg, 0.0993mmol); Rf = 0.68 (ethyl acetate : petrol, 65: 35); (Found M+, 544-0960. 
C23H29071 requires M, 544.0958); 8H 1.14 QH, s, 18-H3), 1.16 (3H, d, J 6.5,2-CH3), 
2.14 (1H, dt, J 15.5 and 2.5,15-H), 2.32 (1H, d, J 15.5,15-H), 2.66 (1H, d, J 10,6-H), 
2.76 (1H, dd, J 10.5 and 7,9-H), 3.74 (3H, s, OCHA 3.83 (1H, d, J 10,5-H), 4.42 (1H, 
d, J 5,1-H), 5.01 (1H, br. s, 17-H), 5.08 (1H, d, J 3,3-H) and 5.29 (1H, dd, J3 and 2, 
17-H); 8C (300 M]Flz) 14.30 (C- 18), 16.97 (C- 11), 20.50 and 20.73 (2a-CH3,02Q-CH3), 
33.94 and 34.92 (C-1, C-2), 38.07,42.28 and 45.05 (C-12, C-14, C-15), 49.67* and 
53.50 (C-4, C-8), 49.67*, 50.78,51.38 and 52.19 (C-5, C-6, C-9, OCH3), 72.95 (C-3)) 
78.18 (C-13), 95.29 (C-10), 107.84 (C-17), 156.64 (C-16), 170.22 (02CCH3), 172.24 
(C-7) and 176.26 (C-19) [*signals overlap]; m1z 544 (M+, 28%), 502 (8), 485 (16), 418 
(12), 417 (43), 385 (9), 358 (25), 357 (79), 325 (48) and 253 (100). As no acetylating 
agents were used in the process, it was assumed that a small proportion of the starting 
material had been acetylated previously. 















H+ (102) (3: 1) 
(103) 
Rapidly crushed caesium acetate (370mg, 1.93mmol) was added to the 
iodolactone (98) (88mg, 0.175mmol) in DMF (20m1), and 18-c-6 (3 Img, 0.1 17mmol) 
149 
added. After 2.25h at 70-80"C, the products were extracted in the usual fashion to 
obtain ent-3(x, 10P, 13-trihydroxy-2-methyl-20-norgibberella-1,16-diene-7,19-dioic acid 
7-methyl ester 19JO-lactone (102) as a brown semi-solid (70mg, 0.187mmol, i. e. 
excess of possible yield); Rf = 0.47 (ethyl acetate : petrol, 65: 35); (Found M+, 
374.1720. C21H2606 requires M, 374.1729); 8H 1.23 QH, s, 18-HA 1.82 QH, d, J 1.5, 
2-CHA 2.76 (lH, d, J 11,6-H), 3.21 (lH, d, J 11,5-H), 3.73 QH, S, OCH3), 3.92 (lH, 
s, 3-H), 4.96 (1H, br s, 17-H), 5.27 (lH, br t, J 2.5,17-H) and 5.99 (lH, d, J 1.5,1-H); 
8C 14-45 (C- 18), 17.05 (C- 11), 19.46 (2-CH3), 38.32,43.11 and 44.76 (C- 12, C- 14, C- 
15), 48.80 and 53.91 (C-4, C-8), 50.61,51.21,52.10 and 52.92 (C-5, C-6, C-9, OCH3), 
73.46 (C-3), 78.23 (C-13), 91.08 (C-10), 107.53 (C-17), 127.56 (C-1), 140.86 (C-2), 
157.06 (C- 16), 172.68 (C-7) and 17 8.61 (C- 19); m1z 374 (M+, 10%), 3 57 (9), 35 6 (6), 
342 (24), 311 (85), 269 (40), 253 (65), 252 (52), 251 (65) and 83 (100). 
Purification by column chromatography, eluting with ethyl acetate : petrol 
(40: 60), gave an inseparable mixture of both isomers (102) and ent-2p, 3(x, 13- 
trihydroxy-2a-methyl-20-norgibberella-1(10), 16-diene-7,19-dioic acid 7-methyl ester 
19,2-lactone (103) (52mg, 0.139mmol, 79%); analysis by 1H NMR spectroscopy 
indicated a ratio of 1: 3 respectively; both of Rf = 0.47 (ethyl acetate : petrol, 65: 35). 
Data for the isogibberellin (103): 5H (300 MHz) 1.19 QH, s, 18-H3), 1.58 (3H, s, 20- 
CH3), 2.23 (1H, dd, J 16.5 and 2.5,15-H), 2.55 (1H, d, J 6,6-H), 2.61 (1H, m. H-9), 
3.21* (1H, d, J 6,5-H), 3.73 QH, s, OCHA 3.90 (1H, s, 3-H), 4.97 (1H, br s, 17-H), 
5.12 (1H, br t, J 2.5,17-H) and 5.99 (1H, br s, 1-H) [*signal obscured partially by 
isomer]; 8C 17.05 (C- 18), 18.67 (C- 11), 20.80 (2P-CH3), 37.02,3 8.76 and 48.61 (C- 12, 
C- 14, C- 15), 45.36 and 53.94 (C-4, C-8), 45-19,48.80,49.49 and 52.03 (C-5, C-6, C-9, 
OCH3), 78.92 (C-13), 80.42 (C-3), 81.75 (C-2), 106.83 (C-17), 118.48 (C-1), 150.04 
(C- 10), 153.44 (C- 16), 172.25 (C-7) and 176.36 (C- 19). 
Upon repetition of this experiment with acetonitrile as solvent, upon elution 
gave again largely a mixture of both isomers, but also a very tiny sample of 
the 
isogibberellin (103) alone (=lmg) which gave an extremely weak and unclear 
1H NMR 
spectra, but was used for MS analysis: (Found M+, 374.1725. 
C21H2606 requires M, 
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374.1729); m/z 374 (M+, 15%), 357 (11), 356 (8), 343 (17), 342 (31), 312 (35), 311 
(100), 269 (47), 253 (79), 252 (59) and 251 (79). 
















To the iodolactone (98) (25mg, 0.0498mmol) dissolved in TBF (10ml) was 
added, over 0.1h, aqueous sodium hydroxide (10ml, 0.006M, 0.06mmol). By TLC 
analysis after 3.75h most of the starting material had disappeared, so the crude product 
was extracted as usual. Purification by column chromatography (using ethyl acetate : 
petrol, 30: 70) gave starting material (98) (3mg, 12%). 
Further elution with the same solvent system gave ent-l(x-iodo-20-methyl- 
30,10P, 13-trihydroxy-20-norgibberell-16-ene-7,19-dioic acid 7-methyl ester 19,10- 
lactone (107) (21mg, 0.0418mmol, 84%); Rf = 0.28 (ethyl acetate: petrol, 50: 50); mp 
153-55*C (from chloroform and petrol); (Found M+, 502.0838. C21H2706I requires M, 
502.0852); 8H 1.18 (3H, s, 18-H3), 1.25 (3H, d, J 6,2-CH3), 1.37 (1H, m, 2-H), 2.11 
(1H, dt, J 15.5 and 3,15-H), 2.28 (1H, br d, J 15.5,15-H), 2.62 (1H, m, 9-H), 2.73 (IH, 
d, J 10,6-H), 3.34 (1H, m, 3-H), 3.49 (1H, d, J 10,5-H), 3.74 (3H, s, OCH3), 4.53 (1H, 
d, J 5,1-H), 5.00 (1H, s, 17-H) and 5.28 (1H, dd, J3 and 1.5,17-H); 8C (300 Nfflz) 
12.68 (C- 18), 17.18 (C- 11), 21.91 (2oc-CH3), 38.04,42.28 and 45.26 (C- 12, C- 14, C- 
15), 38.95 and 39.73 (C-1, C-2), 50.19 and 54.55 (C-4, C-8), 51.11,51.29,52.22 and 
54.41 (C-5, C-6, C-9, OCH3), 75.63 (C-3), 78.19 (C- 13), 94.26 (C- 10), 107.80 (C- 17), 
156.54 (C- 16), 172.30 (C-7) and 177.03 (C- 19); m/z 502 (M+, 42%), 471 (9), 443 (43), 
375 (27), 358 (35), 357 (100), 343 (34), 329 (32), 315 (32), and 269 (64). 
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(107) 
ent-3a, 13-Diacetoxy-2p-methyl-20-norgibberella-1(10), 16-diene-7,19-dioic Acid 7- 














The acid (97) (500mg, 1.33mmol) was added to acetic anhydride (15ml) and 
tosic acid (19mg) added; the solution was stirred for 17h. By TLC analysis all starting 
material had disappeared to one spot of Rf = 0.74 (ethyl acetate : petrol, 50: 50), thus the 
reaction mixture was diluted with water (30ml) and extracted with chloroform (4 x 
30ml). The combined organic layers were extracted with brine (20ml) to which I drop 
conc. sulfuric acid had been added, then separated, the organic portion filtered and 
evaporated under =0.15mmHg vacuum at 40*C. Following column chromatography 
(eluting with ethyl acetate : petrol, 30: 70), the di-acetylated product (108) was obtained 
as white needles (470mg, 1.02mmol, 77 %); Rf = 0.16 (ethyl acetate : petrol, 30: 70); mp 
129-132*C (from DCM and petrol); (Found C, 64.9; H, 7.1%; [NM]+, 461.2172. 
C25H3208 requires C, 65.2; H, 7.0%; M11,461.2175); omax/cm-1 1616 and 1650 (C=C) 
and 1731 and 1740 (C=O); 8H (300 MHz) 0.95 QH, d, J 7,2-CH3), 1.18 QH, s, 18-H3) 9 
2.00 and 2.12 (each 3H, each s, each 02CCH3), 2.69 (1H, ap dt, J 16 and 3,9-H), 2.92 
(1H, m, 5-H), 3.04 (1H, m, 2-H), 3.25 (1H, d, J 6,6-H), 3.71 (3H, s, OCHA 5.00 
(2H, 
s, 1-H and 17-H), 5.07 (IH, s, 17-H) and 5.47 (1H, d, J 
3.5,3-H); 8C 16.38 (C-18), 
18.32 (C- 11), 20.83,21.91 and 22.13 (2a-CH3,2 x 02CCH3), 32.41 (C-2), 35.46,38.92 
and 44.19 (C- 12, C- 14, C- 15), 46.13,46.19,48.73 and 
51.69 (C-5, C-6, C-9, OCHA 
48.57 and 51.34 (C-4, C-8), 75.18 (C-3), 86.29 (C-13), 
106.23 (C-17), 116.86 (C-1), 
140.64 (C-10), 150.55 (C-16) and 169.95,170.99,176.58 and 177.25 (C-7, 
C-19,2 x 
02_CCH3); m1z (CI) 461 ([ME]+, 16%), 443 (2), 429 
(4), 419 (4), 401 (32), 400 (2 1), 
369 (29), 355 (17), 342 (26) and 341 (100). 
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chloroform at O*C and mCIpBA (40mg, =80% per-acid, =_ 32mg and 0.185mmol) added, 
and stirred for 26.5h. Sodium thiosulfate (=0.5g) was added, then the reaction mixture 
was extracted by the standard method. Column chromatography eluting with ethyl 
acetate: petrol, (30: 70), returned starting material (108) (17mg, 0.0370mmol, 17%). 
Following further chromatography (ethyl acetate : petrol, 40: 60), a white solid 
was obtained (45mg) which contained ent-l(x, 10p-dihydroxy-3(x, 13-diacetoxy-2p- 
methyl-20-norgibberell-16-ene-7,19-dioic acid 7-methyl ester 19,10-lactone (109), 
albeit contaminated with mCIBA, (which was removed on recrystallisation), -=33mg 
lactone (109), 0.0695mmol, 32%; Rf = 0.49 (ethyl acetate : petrol, 50: 50); mp 104- 
106"C (from chloroform and petrol); (Found C, 62.8; H, 7.4%; M+, 476.2046. 
C25H3209 requires C, 63.0; H, 6.9%; M, 476.2046);, omax/cm-1 * 1734 (C=O); 8H 1.01* 
QH, d, J 7,2-CH3), 1.02* QH, s, 18-H3), 2.03 and 2.19 (each 3H, each s, each 
02CCH3), 2.72 (IH, d, J 11,6-H), 3.48 (1H, d, J 11,5-H), 3.73* QH, s, OCH3), 3.74* 
(1H, m, 1-H), 5.00 (IH, br s, 17-H), 5.08 (1H, d, J 4,3-H) and 5.17 (1H, br s, 17-H) 
[*signals overlap]; 8C 14.41 (C- 18), 16.63 (C-1 1), 20.80,21.05 and 22.10 (2oc-CH3,2 x 
02QCHA 34.32 (C-2), 36.35,40.00 and 42.26 (C-12, C-14, C- 15), 46.29 and 53.27 (C- 
4, C-8), 47.62,50.10,50.57 and 52.26 (C-5, C-6, C-9, OCH3), 68.64 (C- 1), 73.94 (C-3), 
84.35 (C-13), 94.64 (C-10), 108.26 (C-17), 153.66 (C-16), 169.98 and 170.10 (2 x 
02CCH3), 172.52 (C-7) and 176.52 (C- 19); m1z 476 (M+, 44%), 445 (14), 435 (27), 
434 (100), 416 (39), 374 (49), 359 (84), 358 (80), 298 (74) and 235 (98). 
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Further elution (ethyl acetate : petrol, 40: 60), gave the epoxide (112), (4mg, 
0.00813mmol, 4%), as a pale yellow gel; Rf = 0.12 (ethyl acetate : petrol, 50: 50); 
(Found M+, 492.1976. C25H32010 requires M, 492.1996); 8H (300 MHz) 1.02* (3H, s, 
18-H3), LOP (3H, d, J 7,2-CH3), 2.01 and 2.19 (each 3H, each s, each 02CCH3), 
2.74* (1H, d, J 5.5,17-H), 2.75 (1H, d, J 11,6-H), 3.13 (1H, d, J 5.5,17-H), 3.48 (1H, 
d, J 11,5-H), 3.73 (3H, s, OCH3), 3.76 (1H, d, J 5,1-H) and 5.09 (1H, d, J 3.5,3-H) 
[*signals overlap]; 8C 14.38 (C- 18), 17.14 (C- 11), 20.80,21.62 and 21.79 (2cc-CH3,2 x 
02C, CH3), 33.24,40.54 and 42.70 (C- 12, C- 14, C- 15), 34.26 (C-2), 46.26 and 53.27 (C- 
4, C-8), 48.32,48.67,51.43 and 52.38 (C-5, C-6, C-9, OCH3), 66-92 (C-17), 68.73 (C- 
1), 73.91 (C-3), 77.50 (C-16), 80.58 (C-13), 94.48 (C-10), 169.91 and 170.07 (2 x 
02CCH3), 172.23 (C-7) and 176.29 (C- 19); m1z 492 (M+, 7 %), 462 (5), 461 (9), 451 
(24), 450 (100), 449 (29), 432 (14), 420 (11), 393 (56) and 315 (40). 
Further elution (100% ethyl acetate) gave a brown liquid, a mixture of 
compounds which appeared, following 1H and 13C NMR and MS analysis, to have lost 
the acetate protecting groups on one or both of the alcohols (40mg). 
ent-13-Acetoxy-IOP-hydroxy-2-methyl-l-oxo-20-norgibbiorella-2,16-diene-7,19- 






TPAP CO H CO H ''' * NMO ýs s- 
AcO4 H H C02CH-4 C02CH3 3 
(109) (120) 
The diacetylated alcohol (109) (33mg, 0.0695mmol) was dissolved 
in 
acetonitrile (10ml) at OT and TPAP (1.6mg, 0.00455mmol) added, 
followed by NMO 
(22mg, 0.188mmol). The mixture became green-brown, and after 2.25h was 
filtered 
through silica on Celitec. IH NMR spectra analysis of the crude product 
indicated an 
eliminated compound (120) was present. Following column chromatography 
(ethyl 
acetate : petrol, 20: 80), the (x, D-un saturated ketone (120) was obtained as an 
off white 
solid, (24mg, 0.0580mmol, 83%). Attempted recrystallisation 
failed. Rf = 0.79 (ethyl 
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acetate : petrol, 50: 50); (Found M+, 414.1674. C23H2607 requires M, 414.1679); 
-umax/cm-1 * 1689,1735 and 1793 (C--O); Xmax/nm (CHC13) 262; 8H (300 MHz) 1.31 
(3H, s, 18-HA 1.83 (3H, d, J 1.5,2-CHA 2.04 (3H, S, 02CCH3), 2.83 (1H, d, J 10.5, 
6-H), 3.38 (1H, d, J 10.5,5-H), 3.75 (3H, s, OCHA 5.01 (1H, br s, 17-H), 5.19 (1H, dd, 
J3 and 1.5,17-H) and 6.68 (1H, q, J 1.5,3-H); 8c (300 MHz) 14.80 (C- 18), 15.25 (2- 
CH3), 17.73 (C-11), 22.05 (02CCHA 36.35,40.15 and 42.34 (C-12, C-14, C-15), 
47.37,51.09 and 52.43 (C-6, C-9, OCH3), 50.54 and 51.15 (C-4, C-8), 62.70 (C-5), 
84.12 (C-13), 93.15 (C-10), 108.54 (C-17), 136.12 (C-2), 147.83 (C-3), 153.08 (C-16), 
169.95 (02CCH3), 171.60 (C-7), 175.41 (C- 19) and 190.82 (C- 1); m1z 414 (M+, 31 %), 
383 (9), 373 (23), 372 (100), 310 (71) and 251 (96). 
Oxidation of the Alcohol (109) with PDC 
OH 00 








DCM -H AcO 
ýOH 
H C02CH3 
(109) (120) 21 (110) 
The alcohol (109) (89mg, 0.18 8mmol) in DCM (1 2ml) was treated with crushed 
and dried 0.4nm diameter molecular sieves (=0.7g) and PDC (96mg, 0.255mmol) at 
room temp. for 14h. The blackened suspension was then filtered through Florisil@ on 
Celite@ to give a yellow-brown semi solid. Following column chromatography (ethyl 
acetate : petrol, 20: 80), a clear and colourless liquid was obtained containing an 
inseparable mixture by flash column chromatography of (x, p-unsaturated 
ketone (120) 
and ent-3(x, 13-diacetoxy-10p-hydroxy-20-methyl-l-oxo-20-norgibberell-16-ene-7,19- 
dioic acid 7-methyl ester 19,10-lactone (110) in a ratio of 
2: 1 respectively (determined 
by IH NMR spectroscopy), (47mg, 0.1 13mmol, 60% and 26mg, 
0.0555mmol, 30% 
respectively); Rf = 0.52 and 0.50 (ethyl acetate: petrol, 
30: 70). Data for 3-acetoxy ester 
(110): (Found [MH]+, 475.1948. C25H3009 requires MH, 475-1968); 10max/cm-1 
* 
1702,1736 and 1793 (C=O); 8H (300 MHz) 1.02 QH, d, J 6.5,2-CH3), 
1.31 QH, s, 18- 
H3), 2.03 (3H, S, 02CCH3), 2.15 (3H, S, 02CCH3), 2.56 (1H, dd, J 12 and 
6,9-H), 2.86 
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(1H, d, J 10,6-H), 3.13 (1H, qd, J 6.5 and 5.5,2-H), 3.46 (IH, d, J 10,5-H), 3.74 (3H, 
s, OCH3), 5.03 (IH, br s, 17-H), 5.18 (IH, m, 17-H) and 5.45 (1H, d, J 5.5,3-H); 5c 
(300 MHz) 8.80 (2(x-CH3), 13.73 (C- 18), 17.29 (C- 11), 20.51 and 21.94 (2 x 02C-CH3), 
36.13,40.08 and 42.17 (C- 12, C- 14, C- 15), 43.26,45.99,51.27 and 54-61 (C-5, C-6, C- 
9, OCHA 50.19 and 53-37 (C-4, C-8), 60.40 (C-2), 74.60 (C-3), 84.00 (C-1 3), 95.00 
(C- 10), 108.63 (C- 17), 152.95 (C- 16), 169.8 8 and 171.52 (2 x 02-CCH3), 171-59 (C-7), 
175.73 (C- 19) and 202.27 (C- 1); m1z (CI) 475 ([MIHI +, 13%), 474 (9), 432 (8) and 311 
(100). 
ent-3oc, 13-Dihydroxy-2p-methyl-20-norgibberella-1(10), 16-diene-7,19-dioic Acid 7- 


















Sodium hydride (280mg, 60% in oil; -=168mg NaH, 7.00mmol) was washed 
with petrol Qx 10ml),, 18-c-6 added (catalytic quantity) and THF (5ml) added and the 
stirred suspension cooled to O*C. The acid (97) (490mg, 1.30mmol) in THF (10ml) was 
added to the hydride under anhydrous conditions; the reaction was allowed to reach 
room temp. for I h. The mixture was again lowered to 0"C and 
paramethoxybenzy1chloride (0.8ml, 5.90mmol). Following no change in the reaction 
when followed by TLC analysis at either O*C or room temp., the reaction was heated at 
reflux for 15.5h; then was cooled and underwent the standard extraction treatment. Post 
column chromatography, (ethyl acetate : petrol, 30: 70), an impure product 
(125) was 
obtained, a pale orange solid; mp 73-76*C (from carbon tetrachloride and petrol); 
(48mg, 0.0968mmol, 7%); Rf = 0.49 (ethyl acetate : petrol, 50: 50); (Found M+, 
496.2450. C29H3607 requires M, 496-2461); 8H 1.12 (3H, d, J 7,2-CH3), 1.33 (3H, s, 
18-H3), 2.97 (1H, m, 5-H), 3.11 (1H, d, J 6,6-H), 3.67 (3H, s, 7-OCH3), 3.71 (3H, 
Ar-OCH3), 3.86 (1H, d, J 2.5,3-H), 4.94 (2H, s, 19-OCH2Ar), 5.00,5.07 and 5.11 QH5 
156 
m, 1 -H, 17 -H2), 6.8 8 (2H, d, J 8, Ar-H2) and 7.26 (2H, d, J 8, Ar-H2); 8C 17.02 (C- 18), 
18.51 (C- 11), 22.13 (2-CH3), 33.29 (C-2), 37.74,39.07 and 45.74 (C- 12, C- 14, C- 15), 
45.98,48.90,49.31,50.06,50.59 and 51.78 (C-4, C-5, C-6, C-8, C-9,7-OCH3), 55.24 
(19-OCH2M, 75.65 (C-3), 79.40 (C-13), 106.33 (C-17), 113.75 (C-1), 115.67,129.53, 
139.93 and 154.18 (aromatics), 141.55 (C-10), 154.00 (C-16), 176.84 (C-7) and 180.00 
(C- 19); m1z 496 (M+, 6%), 478 (9), 448 (2), 360 (15), 297 (12), 253 (41), 137 (14), 122 
(72), 121 (100) and 85 (7 1). 
Further elution with ethyl acetate : petrol (50: 50) gave starting material (97), 
(170mg, 0.452mmol, 35%), a pale brown solid, Rf = 0.16 (ethyl acetate : petrol, 50: 50) 9 
data as previously reported. 
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